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Extracellular	  hyper-­‐osmotic	  (HYPER)	  stress	  increases	  glucose	  uptake	  to	  defend	  cell	  
volume,	  when	  compared	  to	  iso-­‐osmotic	  (ISO)	  conditions	  in	  skeletal	  muscle.	  	  The	  purpose	  of	  this	  
study	  was	  to	  determine	  a	  time	  course	  for	  changes	  in	  common	  signaling	  proteins	  involved	  in	  
glucose	  uptake	  during	  acute	  hyper-­‐osmotic	  stress	  in	  isolated	  mammalian	  skeletal	  muscle.	  	  Rat	  
extensor	  digitorum	  longus	  (EDL)	  muscles	  were	  excised	  and	  incubated	  in	  a	  media	  formulated	  to	  
mimic	  ISO	  (290	  ±	  10	  mmol/kg)	  or	  HYPER	  (400	  ±	  10	  mmol/kg)	  extracellular	  condition	  (Sigma	  
Media-­‐199).	  	  Signaling	  mechanisms	  were	  investigated	  by	  determining	  the	  phosphorylation	  
states	  of	  Akt,	  AMPK,	  AS160,	  cPKC	  and	  ERK	  after	  30,	  45	  and	  60	  minutes	  of	  incubation.	  	  AS160	  was	  
found	  to	  be	  significantly	  more	  phosphorylated	  in	  HYPER	  conditions	  compared	  to	  ISO	  after	  30	  
minutes	  (p<0.01).	  	  It	  is	  speculated	  that	  AS160	  phosphorylation	  may	  facilitate	  an	  increase	  in	  
glucose	  uptake	  under	  hyper-­‐osmotic	  stress,	  possibly	  by	  initiating	  cellular	  signalling	  to	  increase	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   1	  
1.	  Water	  –	  The	  Universal	  Solvent	  	  
1.1	  Introduction	  
Water	  is	  the	  quintessential	  nutrient	  of	  life.	  	  The	  human	  body	  is	  a	  well	  refined	  machine	  
that	  has	  the	  remarkable	  ability	  to	  regulate	  its	  water	  levels	  in	  very	  precise	  quantities.	  	  When	  the	  
human	  body	  is	  placed	  under	  various	  internal	  and	  external	  stresses,	  it	  has	  the	  capacity	  to	  acutely	  
alter	  its	  functional	  capacity	  to	  counteract	  disturbances	  that	  threaten	  homeostasis	  [69].	  	  In	  1994,	  
Dieter	  Häussinger	  introduced	  the	  “Cell	  Swelling	  Theory”.	  	  This	  concept	  suggested	  that	  cell	  
volume	  is	  a	  key	  regulator	  of	  cellular	  metabolism	  where	  cell	  swelling	  induces	  a	  state	  of	  cell	  
anabolism,	  and	  cell	  shrinking	  induces	  a	  state	  of	  cell	  catabolism	  [62].	  	  This	  theory	  attempts	  to	  
explain	  the	  body’s	  ability	  to	  counteract	  disturbances	  (cell	  volume	  change)	  to	  maintain	  
homeostasis.	  	  	  
In	  spite	  of	  tightly	  regulated	  whole	  body	  hydration	  status,	  dehydration	  can	  occur	  and	  
alter	  cardiovascular,	  thermoregulatory,	  central	  nervous	  system	  and	  metabolic	  functions	  in	  
humans	  [70].	  	  During	  exercise	  and	  increased	  physical	  efforts,	  sweat	  output	  often	  exceeds	  water	  
intake,	  resulting	  in	  total	  body	  water	  deficiency	  (hypohydration)	  [70].	  	  A	  modest	  2%	  decline	  in	  
body	  weight	  due	  to	  dehydration	  can	  result	  in	  mild	  dysfunction	  in	  any	  of	  the	  aforementioned	  
systems	  [79].	  	  Hypohydration	  can	  also	  result	  in	  severe	  ramifications	  for	  exercise	  performance	  
and	  prolong	  periods	  of	  dehydration	  can	  prove	  to	  be	  fatal	  within	  several	  days	  or	  sooner	  [62].	  	  	  
Total	  body	  water	  (TBW)	  varies	  from	  person	  to	  person.	  	  Many	  factors	  such	  as	  body	  
composition,	  age	  and	  physical	  activity	  level	  can	  influence	  an	  individual’s	  TBW.	  	  An	  average,	  70kg	  
person	  is	  said	  to	  be	  carrying	  ~60%	  of	  their	  weight	  as	  water.	  	  In	  absolute	  terms,	  this	  would	  
equate	  to	  ~42	  kg	  or	  42	  litres	  of	  TBW	  [61].	  	  Seventy-­‐three	  percent	  of	  TBW	  is	  found	  in	  the	  lean	  
body	  mass	  (skeletal	  muscle,	  bone,	  organs)	  while	  only	  10%	  is	  found	  in	  the	  fat	  mass;	  therefore,	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total	  body	  water	  is	  largely	  dependent	  on	  lean	  body	  mass.	  [69].	  	  Skeletal	  muscle	  accounts	  for	  40-­‐
50%	  of	  total	  body	  mass	  and	  therefore	  it	  is	  considered	  one	  of	  the	  most	  important	  tissues	  in	  
regards	  to	  fluid	  homeostasis	  in	  the	  human	  body	  [58].	  
1.2	  Water	  Compartments	  
Muscle	  cells	  are	  not	  in	  direct	  contact	  with	  the	  “outside	  world”.	  	  Instead,	  extracellular	  
fluid	  (EFC)	  surrounds	  a	  cell’s	  membrane	  and	  acts	  as	  a	  medium	  for	  communication	  with	  other	  
cells.	  	  The	  ECF	  is	  categorized	  into	  two	  different	  compartments	  which	  are	  physically	  separated	  by	  
the	  vessel	  walls	  of	  the	  circulatory	  system.	  	  Plasma,	  the	  fluid	  portion	  of	  blood,	  lies	  within	  the	  
blood	  vessels	  and	  is	  considered	  one	  compartment.	  	  The	  other	  portion,	  known	  as	  interstitial	  fluid,	  
lies	  outside	  the	  circulatory	  system	  and	  outside	  cells.	  	  Not	  only	  is	  interstitial	  fluid	  a	  medium	  for	  
cell	  to	  cell	  communication,	  it	  also	  functions	  as	  a	  nutrient	  source	  and	  waste	  disposal	  site	  for	  cells.	  	  
The	  vast	  amount	  of	  fluid	  exchange	  between	  the	  vasculature	  and	  tissue	  occurs	  at	  the	  level	  of	  the	  
capillaries;	  where	  both	  the	  vessel	  walls	  and	  the	  endothelium	  are	  thin,	  minimizing	  the	  diffusion	  
distance	  between	  the	  two	  compartments.	  	  
Fluid	  exchange	  is	  a	  regulated	  process	  between	  the	  ECF	  (~1/3	  of	  total	  body	  water)	  and	  
the	  intracellular	  fluid	  (ICF;	  ~2/3	  of	  total	  body	  water).	  	  While	  ICF	  is	  primarily	  comprised	  of	  water,	  
it	  contains	  numerous	  molecules	  required	  for	  normal	  cell	  function	  including	  ions	  and	  amino	  
acids.	  	  Cellular	  organelles,	  such	  as	  the	  mitochondria,	  are	  suspended	  within	  the	  ICF	  and	  interact	  
with	  the	  ICF	  to	  regulate	  ion	  concentration	  inside	  and	  outside	  each	  organelle.	  	  Maintaining	  
proper	  water	  balance	  (and	  subsequently	  ion	  concentration)	  between	  the	  ICF	  and	  organelles	  is	  
crucial	  for	  optimal	  function	  and	  even	  cell	  survival.	  	  	  
Osmosis	  is	  the	  fundamental	  concept	  that	  governs	  the	  movement	  of	  water	  between	  
compartments.	  	  It	  is	  defined	  as	  passive	  fluid	  (water)	  movement	  through	  a	  semi-­‐permeable	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membrane	  in	  response	  to	  a	  solute	  concentration	  gradient	  [40].	  Fluid	  movement	  between	  
compartments	  is	  highly	  selective.	  	  Compartment	  barriers	  (cell	  membranes	  and	  capillary	  
endothelium)	  are	  not	  only	  responsive	  to	  ion	  concentration,	  but	  the	  type	  of	  ion	  as	  well.	  	  There	  
are	  four	  mechanisms	  that	  determine	  water	  distribution	  in	  various	  compartments:	  hydrostatic	  
pressure,	  crystalloid	  pressure,	  ion	  pumps	  and	  colloidal	  pressure	  [40].	  	  Hydrostatic	  pressure	  
represents	  the	  pressure	  of	  fluids	  exerted	  against	  membranes	  or	  vessel	  walls.	  	  	  Elevations	  in	  
hydrostatic	  pressure	  force	  fluids	  and	  solutes	  across	  membranes	  (e.g.	  from	  the	  capillaries	  to	  the	  
interstitial	  space).	  	  Crystalloid	  pressure	  is	  the	  pressure	  exerted	  from	  within	  a	  fluid	  due	  to	  
dissolved	  mineral	  salts	  (ie.	  Na+	  and	  Cl-­‐)	  and	  other	  water-­‐soluble	  molecules.	  	  These	  solutes	  
generally	  move	  more	  freely	  across	  membranes	  to	  influence	  osmotic	  pressure,	  however,	  
mammalian	  cells	  lack	  a	  firm	  cell	  wall,	  therefore	  generating	  negligibly	  low	  hydrostatic	  and	  
crystalloid	  pressure	  [42,	  53].	  	  Colloid	  osmotic	  pressure	  is	  defined	  as	  the	  pressure	  exerted	  on	  
membranes	  by	  large	  non-­‐permeable	  solutes	  [40].	  	  Colloids	  do	  not	  move	  as	  freely	  across	  cell	  
membranes,	  and	  as	  such	  the	  cells	  reach	  osmotic	  equilibrium	  through	  the	  movement	  of	  water	  to	  
compensate	  for	  accumulation	  or	  loss	  of	  these	  molecules.	  	  Skeletal	  muscle	  cells	  primarily	  use	  ion	  
pumps	  to	  actively	  transport	  ions	  against	  concentration	  gradients.	  	  This	  concept	  is	  extremely	  
important	  when	  regulating	  cell	  volume	  and	  is	  explained	  below.	  	  Water	  moves	  from	  an	  area	  of	  
low	  solute	  concentration	  to	  an	  area	  of	  high	  solute	  concentration.	  Thus,	  the	  amount	  of	  water	  
movement	  is	  dependent	  on	  the	  osmolality	  of	  the	  solution.	  
	  Molarity	  is	  used	  to	  describe	  the	  concentration	  of	  a	  solute	  in	  a	  solution	  and	  is	  measured	  
using	  the	  unit	  mole/litre	  (mol/L).	  	  	  Consequently,	  molarity	  represents	  the	  number	  of	  molecules	  
(6.02x1023	  molecules/mole)	  in	  the	  solution.	  	  However,	  osmolarity	  is	  a	  more	  useful	  unit	  of	  
measurement	  to	  predict	  osmosis	  and	  it	  describes	  the	  number	  of	  particles	  (not	  molecules)	  per	  
litre	  of	  solution	  (Osmol/L).	  	  Particles	  include	  dissociated	  ions	  and	  fully	  intact	  molecules,	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regardless	  of	  molecular	  size	  and	  weight.	  	  For	  example,	  when	  a	  single	  NaCl	  molecule	  is	  placed	  in	  a	  
solution,	  it	  will	  dissociate	  into	  Na+	  and	  Cl-­‐	  ions.	  	  The	  solution	  would	  then	  contain	  more	  particles	  
than	  a	  solution	  with	  just	  one	  glucose	  particle.	  Two	  solutions	  with	  an	  equal	  number	  of	  particles	  
are	  considered	  iso-­‐osmotic.	  	  A	  solution	  is	  hyper-­‐osmotic	  if	  it	  has	  more	  particles	  relative	  to	  
another	  solution.	  	  Likewise,	  a	  solution	  is	  hypo-­‐osmotic	  if	  it	  contains	  fewer	  particles	  relative	  to	  
another.	  	  Lastly,	  in	  highly	  concentrated	  solutions,	  particles	  can	  significantly	  influence	  the	  weight	  
of	  a	  solution.	  	  Therefore,	  osmolality	  is	  a	  term	  expressed	  in	  osmoles	  per	  kilogram	  of	  water.	  	  
However	  in	  biological	  solutions,	  solutes	  (usually	  measured	  in	  milliosmoles)	  contribute	  very	  little	  
to	  the	  overall	  weight	  of	  the	  solution,	  so	  osmolarity	  and	  osmolality	  may	  sometimes	  be	  
interchanged.	  	  Nevertheless,	  neither	  osmolarity	  nor	  osmolality	  can	  accurately	  determine	  water	  
movement	  between	  compartments,	  and	  as	  such	  tonicity	  must	  also	  be	  known	  [72].	  	  	  	  
Tonicity	  is	  simply	  described	  as	  the	  osmotic	  pressure	  or	  tension	  of	  a	  solution.	  	  When	  a	  
cell	  is	  placed	  in	  a	  hypertonic	  solution,	  it	  shrinks,	  as	  fluid	  is	  drawn	  out	  of	  the	  cell.	  	  The	  opposite	  is	  
true	  when	  a	  cell	  is	  placed	  in	  a	  hypotonic	  solution,	  it	  swells.	  	  Lastly,	  if	  a	  cell	  does	  not	  change	  size,	  
the	  solution	  is	  termed	  isotonic.	  	  Tonicity	  has	  no	  units	  and	  is	  only	  a	  comparative	  term.	  	  The	  
distinction	  between	  osmolarity	  and	  tonicity	  lies	  in	  the	  permeability	  characteristics	  of	  the	  solutes.	  	  
Tonicity	  accounts	  only	  for	  water	  movement,	  dictated	  by	  non-­‐penetrating	  solutes,	  while	  
osmolarity	  is	  dictated	  by	  both	  penetrating	  and	  non-­‐penetrating	  solutes.	  	  Solutions	  containing	  
non-­‐penetrating	  solutes	  can	  only	  equalize	  an	  osmotic	  gradient	  through	  the	  movement	  of	  water.	  	  
However,	  solutions	  with	  penetrating	  solutes	  can	  neutralize	  concentration	  gradients	  through	  
movement	  of	  both	  solutes	  and	  water.	  	  Therefore,	  it	  is	  possible	  for	  a	  solution	  to	  be	  hyper-­‐
osmotic	  yet	  isotonic;	  where	  penetrating	  solutes	  migrate	  out	  of	  the	  cell	  into	  the	  extracellular	  
space	  therefore	  equilibrating	  the	  osmotic	  gradient	  without	  the	  net	  movement	  of	  water	  [72].	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1.3	  Cell	  Volume	  Regulation	  	  
Cells	  react	  to	  volume	  perturbations	  by	  activating	  volume	  regulatory	  mechanisms	  to	  
manipulate	  osmolality	  and	  consequently	  water	  movement.	  	  Osmolality	  manipulates	  cell	  volume	  
through	  the	  uptake	  and	  release	  of	  inorganic	  ions	  and	  small	  organic	  osmolytes	  [75].	  	  Ion	  
movement	  is	  responsible	  for	  two-­‐thirds	  of	  cell	  volume	  regulation	  while	  the	  release	  and	  uptake	  
of	  organic	  osmolytes	  (such	  as	  glucose)	  is	  responsible	  for	  the	  other	  third	  [43].	  	  Regulatory	  volume	  
increase	  (RVI)	  is	  a	  mechanism	  activated	  to	  acutely	  counteract	  cell	  shrinkage,	  usually	  initiated	  in	  
hyper-­‐osmotic	  and	  hypertonic	  extracellular	  environments.	  	  The	  time	  course	  of	  RVI	  is	  dependent	  
on	  many	  factors	  such	  as	  cell	  type,	  however,	  RVI	  stimulated	  by	  inorganic	  ions	  typically	  occurs	  
over	  a	  period	  of	  minutes	  [75].	  	  RVI	  stimulated	  through	  the	  uptake	  of	  organic	  osmolytes	  is	  a	  
slower	  process	  that	  can	  take	  hours	  [75].	  	  RVI	  is	  primarily	  accomplished	  as	  a	  result	  of	  ion	  
movement	  through	  the	  Na+	  -­‐K+	  -­‐2Cl-­‐	  co-­‐transporters	  (NKCC)	  in	  combination	  with	  the	  Na+/H+	  
exchangers	  and	  Cl-­‐/HCO3
-­‐	  exchangers.	  	  The	  NKCC	  results	  an	  inward	  flux	  of	  Na+,	  K+	  and	  Cl-­‐.	  	  The	  
net	  effect	  of	  the	  two	  exchangers	  results	  in	  the	  uptake	  of	  NaCl	  which	  increase	  intracellular	  
osmolality	  and	  promotes	  an	  influx	  of	  water	  into	  the	  cell	  [42].	  	  Throughout	  RVI,	  the	  Na+/K+	  
ATPase	  continues	  to	  expel	  Na+	  thus	  resulting	  in	  a	  net	  uptake	  of	  K+	  and	  Cl-­‐.	  	  The	  Cl-­‐	  ion	  follows	  K+	  
through	  the	  cell	  membrane	  to	  maintain	  an	  electrical	  potential.	  	  RVI	  is	  a	  process	  that	  requires	  
additional	  energy	  due	  to	  the	  increase	  in	  flux	  through	  the	  Na+/K+	  ATPase.	  	  Recall	  that	  RVI	  is	  also	  
accomplished	  through	  the	  net	  uptake	  of	  organic	  osmolytes	  such	  as	  glucose	  [75].	  	  The	  uptake	  of	  
glucose	  serves	  two	  useful	  purposes.	  	  First,	  glucose	  uptake	  will	  increase	  intracellular	  osmolality;	  
secondly,	  it	  can	  also	  be	  used	  as	  a	  substrate	  for	  glycolysis	  for	  increased	  energy	  production.	  	  In	  
addition,	  the	  uptake	  of	  osmolytes	  reduces	  the	  destabilizing	  effects	  caused	  by	  inorganic	  ions	  
and/or	  cellular	  proteins	  [42].	  	  Therefore	  the	  uptake	  of	  glucose	  and	  other	  osmolytes	  is	  more	  
favourable	  than	  the	  uptake	  of	  inorganic	  ions.	  	  Regulatory	  volume	  decrease	  (RVD)	  is	  an	  acute	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mechanism	  activated	  to	  counteract	  cell	  swelling	  in	  a	  hypo-­‐osmotic/	  hypotonic	  extracellular	  
environment.	  RVD	  is	  achieved	  through	  the	  release	  of	  both	  ions	  and	  organic	  oysmolytes;	  this	  is	  
typically	  achieved	  through	  the	  activation	  of	  K+	  channels	  and	  other	  anion	  (chloride)	  channels	  [42].	  	  
Intracellular	  water	  follows	  ions	  and	  organic	  osmolytes	  that	  are	  released	  from	  the	  cell	  and	  results	  
in	  RVD.	  
1.4	  Factors	  Influencing	  Cell	  Volume	  	  
In	  humans,	  exercise	  or	  even	  exposure	  to	  increased	  ambient	  temperature	  can	  cause	  
many	  challenges	  to	  thermal	  homeostasis,	  and	  ultimately	  fluid	  homeostasis.	  	  When	  challenged,	  
the	  human	  body	  will	  attempt	  to	  cool	  itself	  through	  radiant	  and	  conductive	  heat	  loss	  
(perspiration	  and	  dry	  heat	  exchange);	  however,	  as	  ambient	  temperature	  increases	  there	  is	  a	  
greater	  reliance	  on	  radiation	  and	  perspiration	  due	  to	  ineffective	  conductive	  and	  convective	  
cooling	  [24].	  	  Therefore,	  during	  exercise	  (especially	  in	  hot/humid	  environments),	  the	  body	  loses	  
a	  significant	  amount	  of	  water,	  which	  has	  variable	  consequences	  for	  the	  different	  water	  
compartments	  in	  the	  body.	  	  It	  is	  well	  documented	  that	  plasma	  osmolarity	  increases	  during	  
hypohydration	  due	  to	  the	  initial	  decrease	  in	  plasma	  volume	  [15,	  70].	  	  In	  order	  to	  preserve	  
plasma	  volume,	  fluid	  shifts	  from	  the	  ICF	  to	  the	  hyper-­‐osmotic	  ECF	  [24].	  	  In	  1976,	  Costill	  et	  al.	  
documented	  the	  proportion	  of	  water	  lost	  from	  the	  various	  compartments	  at	  different	  levels	  of	  
dehydration.	  	  Increased	  levels	  of	  whole	  body	  water	  loss	  (dehydration)	  resulted	  in	  
proportionately	  greater	  fluid	  loss	  from	  the	  ICF	  (Figure	  1).	  	  This	  represented	  one	  of	  the	  first	  in	  
vivo	  human	  studies	  to	  clearly	  demonstrate	  that	  whole	  body	  hydration	  status	  and	  body	  
temperature	  could	  significantly	  influence	  cell	  volume.	  	  
	  
	  






Figure	  1:	  Proportion	  of	  water	  loss	  by	  compartments	  at	  different	  levels	  of	  
dehydration	  (Adapted	  from	  Costill	  1976)	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Malnutrition,	  diseases	  and	  infections	  can	  also	  alter	  influence	  cell	  volume.	  	  In	  1979,	  
Barac-­‐Nieto	  et	  al.	  reported	  that	  severely	  under-­‐nourished	  males	  exhibited	  extracellular	  
expansion	  and	  intracellular	  water	  shrinkage	  [6].	  	  In	  addition,	  other	  hypercatabolic	  states	  such	  as	  
severe	  burns,	  physical	  injuries,	  liver	  carcinomas	  etc.	  are	  accompanied	  by	  a	  decrease	  in	  muscle	  
cell	  volume	  [42].	  	  In	  summary,	  exercise,	  temperature	  and	  perhaps	  other	  disease	  states	  influence	  
cell	  volume,	  typically	  causing	  cell	  volume	  to	  decrease.	  	  These	  external	  factors	  can	  trigger	  RVI	  
activation	  where	  an	  influx	  of	  ions	  and	  organic	  osmolytes	  attempting	  to	  increase	  intracellular	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2.	  Overview	  of	  Carbohydrate	  Metabolism	  	  
2.1	  Cell	  Volume	  Influences	  Metabolism	  	  
In	  1994,	  Haussinger	  described	  the	  Cell	  Swelling	  Theory	  in	  rat	  hepatocytes.	  	  When	  
perfused	  with	  glutamine,	  hepatoctyes	  swelled	  for	  the	  duration	  of	  the	  perfusion	  [31].	  	  Haussinger	  
et	  al.	  speculated	  that	  Na+	  entered	  the	  cell	  via	  the	  glutamine/Na+	  co-­‐transport,	  thereby	  creating	  a	  
hypo-­‐osmotic	  environment	  thus	  resulting	  in	  cell	  swelling	  [62].	  The	  authors	  also	  discovered	  that	  
protein	  metabolism	  was	  influenced	  by	  cell	  volume,	  as	  a	  15%	  increase	  in	  cell	  volume	  inhibited	  
proteolysis	  by	  25%	  [62].	  	  Other	  measurements	  demonstrated	  that	  cell	  swelling	  decreased	  
glycogenolysis	  and	  glycolysis,	  while	  increasing	  glycogen	  synthesis,	  lactate	  uptake	  and	  acetyl-­‐CoA	  
carboxylase	  activity;	  while	  the	  opposite	  was	  true	  for	  cell	  shrinkage.	  	  This	  led	  the	  authors	  to	  
believe	  that	  cell	  swelling	  was	  an	  anabolic	  signal	  (to	  decrease	  cell	  energy	  production)	  whereas	  
cell	  shrinkage	  was	  a	  catabolic	  signal	  (to	  increase	  the	  cell	  energy	  production).	  	  Since	  the	  original	  
findings	  by	  Haussinger,	  many	  authors	  have	  observed	  similar	  results	  in	  various	  models	  [2,	  42].	  	  
More	  recently,	  our	  laboratory	  has	  investigated	  the	  relevance	  of	  this	  theory	  in	  intact	  skeletal	  
muscle.	  	  Ansio-­‐osmotic	  environments	  have	  been	  previously	  documented	  to	  alter	  both	  physical	  
and	  metabolic	  characteristics	  in	  skeletal	  muscle	  [2,	  19].	  	  	  
Antolic	  et	  al.	  established	  an	  in-­‐vitro	  skeletal	  muscle	  model	  to	  study	  acute	  alterations	  in	  
resting	  cell	  volume	  using	  isolated	  whole	  rat	  muscle	  (EDL	  and	  soleus).	  	  The	  rat	  muscles	  were	  
incubated	  in	  a	  tissue	  bath	  where	  the	  medium	  was	  manipulated	  with	  mannitol	  to	  create	  three	  
extracellular	  environments:	  an	  iso-­‐osmotic	  environment	  (ISO;	  290	  ±10	  mmol/kg),	  a	  hyper-­‐
osmotic	  environment	  (HYPER;	  400	  ±10	  mmol/kg)	  and	  a	  hypo-­‐osmotic	  environment	  (HYPO;	  190	  
±10	  mmol/kg).	  	  A	  significant	  increase	  and	  decrease	  in	  water	  content	  and	  cross-­‐sectional	  area	  
was	  quantitatively	  reported	  in	  HYPO	  and	  HYPER	  conditions,	  respectively,	  when	  compared	  to	  the	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ISO	  condition	  [2].	  	  Furthermore,	  high	  energy	  phosphate	  compounds	  (ATP,	  PCr)	  were	  found	  to	  
decrease	  while	  lactate	  content	  increased	  4-­‐fold	  under	  the	  influence	  of	  hyper-­‐osmotic	  stress	  in	  
EDL	  muscle	  [2].	  	  These	  metabolic	  changes	  support	  Haussinger’s	  hypothesis	  in	  which	  hyper-­‐
osmotic	  stress	  induces	  a	  catabolic	  response	  in	  skeletal	  muscle,	  resulting	  in	  increased	  flux	  
through	  glycolysis	  and	  glycogenolysis	  (and	  thus	  an	  increased	  demand	  for	  glucose)	  [2].	  	  In	  2007,	  
Farlinger	  followed	  up	  Antolic’s	  experiments	  with	  the	  purpose	  of	  understanding	  the	  influence	  of	  
resting	  cell	  volume	  alterations	  on	  glucose	  metabolism,	  specifically	  glucose	  uptake	  (unpublished	  
thesis	  work)	  [19].	  	  To	  remain	  consistent,	  Farlinger	  duplicated	  the	  protocol	  described	  by	  Antolic	  
et	  al.,	  with	  the	  addition	  of	  3H	  labelled	  2-­‐deoxyglucose	  to	  Medium-­‐199	  to	  quantitatively	  measure	  
glucose	  uptake.	  	  	  The	  major	  finding	  was	  that	  glucose	  uptake	  was	  increased	  in	  HYPER	  
environments	  compared	  to	  ISO	  and	  HYPO.	  	  In	  addition,	  the	  HYPER	  condition	  produced	  increased	  
intramuscular	  concentrations	  of	  unphosphorylated	  glucose	  and	  lactate	  (~2-­‐fold	  compared	  to	  
ISO),	  while	  muscle	  glycogen	  content	  declined	  compared	  to	  HYPO	  and	  ISO	  conditions	  in	  EDL	  
muscle	  (unpublished	  thesis	  work)	  [19].	  	  These	  data	  are	  consistent	  with	  Haussinger’s	  hypothesis,	  
in	  which	  hyper-­‐osmotic	  stress	  induces	  a	  catabolic	  environment	  and	  is	  accompanied	  by	  an	  
increase	  in	  glucose	  uptake.	  	  The	  increase	  in	  glucose	  uptake	  may	  be	  a	  mechanism	  to	  restore	  cell	  
volume	  and	  provide	  supplementary	  energy	  required	  for	  RVI.	  
RVI	  is	  primarily	  achieved	  through	  a	  rise	  in	  ion	  concentration	  via	  increased	  activity	  of	  the	  
NKCC	  and	  Na+/K+	  ATPase.	  	  However,	  increasing	  particle	  concentration	  (and	  therefore	  increasing	  
intracellular	  osmolality)	  can	  also	  be	  achieved	  through	  increased	  glucose	  uptake	  into	  the	  cell.	  	  
Furthermore,	  mechanisms	  for	  RVI	  require	  energy,	  and	  therefore	  increase	  ATP	  turnover.	  	  
Homeostatic	  mechanisms	  will	  trigger	  ATP	  producing	  pathways,	  namely	  glycolysis	  and	  
glycogenolysis,	  which	  will	  also	  increase	  particle	  concentration	  (1	  glucose	  	  2	  pyruvate).	  	  An	  
increased	  flux	  through	  glycolysis	  requires	  additional	  glucose	  as	  a	  substrate;	  this	  is	  accomplished	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through	  the	  breakdown	  of	  stored	  glycogen	  and	  increasing	  glucose	  uptake.	  	  Therefore,	  increasing	  
glucose	  uptake	  seems	  to	  be	  an	  efficient	  strategy	  for	  cells	  to	  counteract	  acute	  decreases	  in	  cell	  
volume.	  	  However,	  the	  exact	  signaling	  mechanisms	  responsible	  for	  GLUT4	  translocation	  and	  
activation	  due	  to	  hyper-­‐osmotic	  stress	  in	  whole	  skeletal	  muscle	  remain	  unknown.	  	  	  
	   In	  2009,	  Apostol	  et	  al.	  Suggested	  that	  there	  was	  an	  uncontrolled	  Ca2+	  release	  in	  skeletal	  
muscle	  under	  hyper-­‐osmotic	  stress	  [5].	  	  Termed	  calcium	  “sparks”,	  spontaneous	  calcium	  release	  
from	  the	  sarcoplasmic	  reticulum	  (SR)	  was	  observed	  in	  whole	  intact	  skeletal	  muscle	  during	  rest	  or	  
at	  low	  activation	  levels.	  	  In	  normal	  excitation-­‐contraction	  coupling	  mechanisms,	  a	  wave	  of	  
depolarization	  travels	  down	  the	  transverse-­‐tubules	  (T-­‐tubules)	  triggering	  the	  activation	  of	  
dihydropyridine	  receptors	  (DHPR)	  located	  in	  the	  T-­‐tubule	  membrane.	  	  The	  voltage	  -­‐sensing	  
DHPR	  uses	  a	  mechanical	  link	  to	  open	  the	  ryanodine	  receptors	  (RyR)	  located	  in	  the	  SR	  
membrane.	  	  This	  allows	  for	  calcium	  to	  flow	  down	  its	  concentration	  gradient	  and	  into	  the	  cytosol.	  	  
Wang	  et	  al.	  proposed	  a	  mechanism	  in	  which	  hyper-­‐osmotic	  stress	  impairs	  the	  ability	  of	  DHPR	  to	  
maintain	  RyR’s	  in	  a	  “closed”	  position,	  resulting	  in	  calcium	  leaks	  or	  sparks	  from	  the	  SR	  [5,	  81].	  	  
Apostol	  et	  al.	  were	  able	  to	  support	  Wang’s	  hypothesis	  through	  a	  spatial-­‐temporal	  analysis	  of	  
intracellular	  calcium	  signals	  in	  response	  to	  hyperosmotic	  stress	  [5].	  	  These	  findings	  are	  an	  
important	  step	  to	  uncovering	  a	  possible	  link	  between	  calcium	  signaling,	  osmotic	  stress	  and	  
glucose	  uptake.	  	  Important	  signaling	  intermediates,	  AS160	  and	  protein	  kinase	  C	  (PKC)	  are	  
hypothesized	  to	  be	  active	  under	  osmotic	  stress	  and	  both	  proteins	  possess	  calcium	  binding	  
domains	  which	  may	  play	  a	  role	  in	  regulating	  protein	  activity	  and	  possibly	  glucose	  uptake	  under	  
hyper-­‐osmotic	  conditions.	  	  	  
2.2	  Glucose	  Homeostasis	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Generally,	  only	  four	  grams	  of	  glucose	  is	  circulating	  within	  the	  blood	  stream	  of	  a	  70kg	  
person	  at	  any	  moment,	  however	  slight	  deviations	  in	  blood	  glucose	  can	  result	  in	  metabolic	  
dysfunction,	  neuroglycopenia,	  seizure	  or	  even	  death	  [82].	  	  Major	  sources	  of	  blood	  glucose	  
include	  that	  endogenously	  produced	  by	  the	  liver	  and	  that	  exogenously	  consumed	  through	  the	  
diet.	  	  The	  human	  body	  has	  established	  a	  complex	  control	  system	  to	  protect	  and	  maintain	  blood	  
glucose	  levels	  between	  5-­‐6	  mmolL-­‐1.	  	  There	  are	  two	  characteristics	  that	  demonstrate	  the	  
importance	  and	  complexity	  of	  whole-­‐body	  glucose	  control.	  	  Firstly,	  several	  redundancies	  exist	  in	  
the	  many	  layers	  of	  glucoregulatory	  response.	  	  Glucagon	  and	  insulin	  are	  the	  chief	  hormones	  
responsible	  for	  maintaining	  blood	  glucose,	  however	  many	  other	  hormones,	  including	  
catecholamines,	  cortisol	  and	  growth	  hormone	  all	  act	  as	  a	  safety	  net	  to	  further	  prevent	  
deviations	  in	  glucose	  homeostasis	  [82].	  	  Secondly,	  there	  is	  a	  distribution	  of	  control.	  When	  the	  
body	  is	  challenged	  with	  the	  consumption	  of	  a	  large	  exogenous	  glucose	  load,	  the	  range	  of	  control	  
is	  not	  reliant	  on	  a	  single	  organ	  or	  system.	  	  Glucose	  removal	  (from	  circulation)	  occurs	  in	  two	  main	  
tissues;	  skeletal	  muscle	  and	  adipose	  tissue.	  In	  fact,	  skeletal	  muscle	  is	  responsible	  for	  up	  to	  75%	  
of	  glucose	  uptake	  in	  humans	  [7].	  	  
Despite	  the	  attempts	  to	  maintain	  glucose	  homeostasis,	  many	  conditions	  threaten	  whole	  
body	  glucose	  homeostasis,	  and	  perhaps	  the	  most	  common	  is	  diabetes	  mellitus.	  	  Type	  II	  diabetes	  
is	  a	  rapidly	  growing	  disorder	  that	  is	  estimated	  to	  reach	  a	  global	  prevalence	  of	  300	  million	  by	  the	  
year	  2025	  [18].	  	  It	  is	  characterized	  by	  the	  inability	  to	  remove	  glucose	  from	  the	  blood	  resulting	  
from	  dysfunctional	  insulin	  signaling	  mechanisms	  (insulin	  resistance)	  in	  skeletal	  muscle	  and	  
adipose	  tissue.	  	  It	  is	  well	  established	  that	  insulin	  and	  muscle	  contraction	  are	  two	  primary	  
stimulators	  of	  responsible	  for	  glucose	  uptake	  in	  skeletal	  muscle.	  	  Skeletal	  muscle	  is	  the	  primary	  
and	  most	  abundant	  organ	  for	  glucose	  uptake,	  and	  therefore	  plays	  an	  important	  role	  in	  glucose	  
homeostasis.	  	  The	  principle	  glucose	  transporter	  in	  human	  skeletal	  muscle	  is	  glucose	  transporter	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4	  (GLUT4).	  	  GLUT4	  is	  one	  of	  a	  family	  of	  12	  facilitated	  monosaccharide	  transporters	  (GLUT	  1-­‐12)	  
[33].	  	  Other	  monosaccharide	  transporters	  display	  different	  characteristics	  in	  terms	  of	  tissue	  
expression	  and	  substrate	  specificity.	  	  For	  example,	  GLUT1	  is	  widely	  expressed	  in	  all	  tissues	  with	  a	  
low	  capacity	  for	  glucose	  transport,	  while	  GLUT	  5	  and	  11	  are	  fructose	  transporters	  [33].	  	  
Nevertheless,	  GLUT4	  is	  the	  chief	  transporter	  in	  skeletal	  muscle,	  accounting	  for	  approximately	  
60-­‐70%	  of	  total	  glucose	  uptake	  in	  unstimulated	  (insulin)	  isolated	  skeletal	  muscle	  [64].	  	  	  
Individuals	  with	  diabetes	  lack	  the	  ability	  to	  take	  up	  blood	  glucose	  due	  to	  impaired	  insulin	  
signaling	  mechanisms.	  	  It	  is	  hypothesized	  that	  insulin,	  contraction	  and	  osmotic	  stress,	  stimulate	  
GLUT4	  translocation	  through	  independent	  signaling	  mechanisms.	  	  Signaling	  mechanisms	  via	  
insulin	  and	  contraction	  have	  received	  significantly	  more	  attention	  in	  the	  literature	  and	  the	  
signaling	  mechanisms	  seem	  to	  be	  relatively	  well	  understood.	  	  In	  contrast,	  the	  signaling	  
mechanisms	  involved	  in	  osmotically	  stimulated	  glucose	  uptake	  have	  received	  very	  little	  
attention	  and	  require	  further	  research.	  Therefore,	  a	  greater	  understanding	  of	  all	  signalling	  
processes	  involved	  in	  glucose	  uptake,	  including	  osmotic	  stress,	  could	  potentially	  have	  
implications	  for	  the	  management	  of	  type	  II	  diabetes.	  Delineation	  of	  all	  glucose	  uptake	  
stimulatory	  pathways	  could	  potentially	  lead	  to	  new	  therapeutic	  targets,	  and	  pharmacological	  
interventions	  that	  could	  facilitate	  better	  glycemic	  control	  in	  the	  diabetic	  population.	  
2.3	  GLUT4	  translocation	  
It	  is	  important	  to	  understand	  the	  process	  of	  GLUT4	  translocation	  to	  identify	  points	  of	  
integration	  by	  stimulators	  and	  possibly	  signaling	  proteins.	  	  Insulin	  is	  the	  most	  well	  known	  of	  the	  
stimulators	  and	  will	  therefore	  represent	  the	  majority	  of	  information	  in	  this	  section.	  	  However,	  
GLUT4	  recycling	  seems	  to	  respond	  similarly	  to	  both	  contraction	  and	  hyper-­‐osmotic	  stress	  [36,	  
60].	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GLUT4	  cycles	  to	  and	  from	  the	  sarcolemma	  through	  exocytosis	  and	  endocytosis.	  	  In	  basal	  
(unstimulated)	  conditions,	  the	  distribution	  favours	  the	  endocytotic	  arm,	  sequestering	  GLUT4	  in	  
its	  intracellular	  compartments.	  	  Microscopy	  has	  localized	  intracellular	  compartments	  into	  a	  
perinuclear	  region	  and	  a	  few	  distinct	  regions	  throughout	  the	  cytosol	  [18].	  	  Newly	  endocytosed	  
GLUT4	  merge	  with	  each	  other	  to	  form	  sorting	  endosomal	  compartments.	  	  Figure	  2,	  illustrates	  
the	  many	  fates	  of	  a	  GLUT4	  vesicle	  as	  it	  enters	  the	  cell.	  	  Contents	  of	  the	  sorting	  endosomal	  
compartments	  appear	  to	  dissociate	  into	  endosomal	  recycling	  compartment	  or	  mature	  into	  later	  
endosomes	  and	  lysosomes	  [33,	  47].	  	  Downstream	  compartments	  in	  the	  cytosol	  have	  yet	  to	  be	  
fully	  characterized,	  however	  the	  end	  product	  is	  known	  as	  GLUT4	  storage	  vesicles	  [18].	  	  Figure	  2	  
indicates	  various	  points	  of	  GLUT4	  recycling	  that	  may	  be	  regulated	  by	  insulin	  stimulation.	  	  Dotted	  
arrows	  indicate	  hypotheses	  that	  have	  yet	  to	  be	  verified	  through	  definitive	  scientific	  
experiments.	  	  It	  has	  been	  well	  established	  that	  insulin	  signaling	  rapidly	  increases	  GLUT4	  
recycling	  to	  favour	  the	  exocytotic	  arm,	  with	  minimal	  change	  to	  the	  endocytotic	  arm	  [18,	  77].	  	  
This	  results	  in	  a	  shift	  in	  steady-­‐state	  distribution,	  favouring	  translocation	  towards	  the	  plasma	  














Figure	  2:	  GLUT4	  continuously	  recycles	  to	  (exocytosis)	  and	  from	  (endocytosis)	  the	  sarcolemma	  
of	  muscle	  cells.	  	  Newly	  endocytosed	  GLUT4	  transporters	  are	  initially	  sequestered	  into	  sorting	  
endosomes	  (SE)	  and	  are	  either	  shuttled	  towards	  endosomal	  recycling	  compartments	  (ERC)	  or	  
gradually	  mature	  to	  later	  endosomes	  (LE)	  and	  lysosomes	  (LY).	  	  The	  trans-­‐Gogli	  network	  (TGN)	  
is	  hypothesized	  to	  interact	  with	  ERC	  to	  generate	  glucose	  storage	  vesicles	  (GSV)	  allowing	  
GLUT4	  translocation	  to	  the	  plasma	  membrane.	  	  Insulin	  can	  also	  influence	  various	  steps	  within	  
GLUT4	  recycling.	  	  Solid	  arrows	  indicate	  known	  actions,	  whereas	  dashed	  arrows	  illustrate	  
current	  hypothesises	  (Adapted	  from	  Huang	  2007).	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Conversely,	  muscle	  contraction	  and	  energy	  deprivation	  have	  been	  shown	  to	  reduce	  GLUT4	  
endocytosis	  thereby	  increasing	  GLUT4	  on	  the	  membrane	  surface	  [39].	  
Rudich	  and	  colleagues	  have	  proposed	  two	  mechanisms	  to	  describe	  enhanced	  GLUT4	  
exocytosis	  in	  L6	  muscle	  culture:	  the	  “Push”	  and	  “Pull”	  mechanisms	  [64].	  	  The	  “pull”	  refers	  to	  
actin	  filament	  remodelling	  upon	  stimulation.	  	  Actin	  remodelling	  can	  be	  thought	  of	  as	  building	  
scaffolding	  for	  GLUT4	  vesicles	  to	  travel	  on.	  	  As	  early	  as	  three	  minutes	  after	  insulin	  stimulation,	  
actin	  begins	  to	  form	  mesh-­‐like	  structures	  causing	  ruffles	  and	  ridges	  allowing	  GLUT4	  vesicles	  to	  
tether	  or	  attach	  and	  “pull”	  themselves	  towards	  the	  cell	  surface	  [64].	  	  	  Currently,	  it	  is	  debated	  as	  
to	  whether	  actin	  remodelling	  is	  essential	  for	  all	  types	  of	  stimuli	  [64].	  	  The	  “push”	  mechanism	  
involves	  the	  acceleration	  of	  GLUT4	  recycling	  within	  the	  endosomal	  compartments.	  	  At	  steady-­‐
state,	  GLUT4	  pools	  are	  found	  to	  co-­‐localize	  with	  the	  endosomal	  recycling	  compartments	  and	  
golgi	  organs.	  	  From	  here,	  GLUT4	  is	  thought	  to	  exit	  the	  endosomal	  recycling	  compartment’s	  and	  
begin	  translocation	  towards	  the	  cell	  membrane	  as	  glucose	  storage	  vesicle	  (Figure	  2).	  	  Foster	  et	  
al.	  were	  able	  to	  measure	  the	  transit	  time	  (defined	  as	  the	  time	  between	  the	  arrival	  and	  exit	  of	  
GLUT4	  in	  the	  endosomal	  recycling	  compartments)	  under	  insulin	  stimulation	  in	  myoblasts	  [20].	  	  
Results	  showed	  that	  insulin	  reduced	  the	  transit	  time	  from	  20	  minutes	  to	  10	  minutes,	  ultimately	  
forming	  the	  “push”	  hypothesis	  [20].	  	  	  
The	  endocytotic	  arm	  of	  GLUT4	  translocation	  has	  received	  much	  less	  attention	  in	  the	  
literature,	  however,	  there	  have	  been	  several	  mechanisms	  identified	  for	  the	  internalization	  of	  
GLUT4	  under	  various	  stimuli	  and	  in	  various	  tissue.	  	  Antonescu	  et	  al.	  determined	  two	  major	  
routes	  for	  GLUT4	  to	  be	  internalized	  in	  myoblasts	  and	  myotubes	  under	  insulin	  and	  hypertonic	  
stimulation:	  a	  clathrin/dynamin-­‐dependant	  route	  and	  a	  cholesterol/dynamin-­‐dependent	  route	  
[3].	  	  Clathrin-­‐mediated	  endocytosis	  is	  initiated	  by	  various	  light	  and	  heavy	  chain	  clathrin	  proteins	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assembling	  in	  a	  shallow	  invagination	  at	  the	  surface,	  creating	  a	  clathrin	  coated	  pit.	  	  The	  clathrin	  
coated	  pit	  gradually	  deepens	  and	  envelops	  the	  GLUT4	  vesicles,	  a	  process	  facilitated	  by	  dynamin,	  
transferrin	  and	  several	  other	  proteins	  [4,	  47].	  	  Once	  the	  membrane	  is	  completely	  enclosed,	  the	  
clathrin	  coated	  GLUT4	  vesicle	  is	  internalized	  as	  sorting	  endosomes	  and	  mature	  into	  later	  
endosomes	  and	  endosomal	  recycling	  compartments.	  	  	  	  
Upon	  various	  stimulations,	  it	  is	  hypothesized	  that	  a	  GLUT4	  vesicle	  undergoes	  several	  
regulated	  steps	  for	  glucose	  trafficking.	  	  GLUT4	  vesicles	  have	  been	  documented	  to	  tether,	  dock	  
and	  fuse	  with	  the	  plasma	  membrane	  prior	  to	  glucose	  uptake	  [33,	  39].	  	  During	  the	  tethering	  
phase,	  recent	  research	  suggests	  the	  involvement	  of	  α-­‐actin-­‐4,	  a	  protein	  that	  can	  bind	  GLUT4	  to	  
actin	  filaments	  [39].	  	  Remember,	  actin	  remodelling	  is	  the	  basis	  of	  Rudich	  et	  al.	  “pull”	  mechanism	  
for	  enhancing	  GLUT4	  exocytosis;	  therefore	  α-­‐actin-­‐4	  is	  an	  important	  protein	  to	  allow	  GLUT4	  to	  
interact	  with	  actin	  remodelling.	  	  Syntaxin	  4	  and	  its	  vesicle	  associated	  membrane	  protein-­‐2	  
(VAMP2)	  are	  members	  of	  a	  family	  of	  soluble	  nitrogen	  ethylmaleimide	  sensitive	  factor	  (NSF)	  
attachment	  proteins	  (SNARE)	  that	  are	  functionally	  required	  for	  the	  majority	  (~70%)	  of	  insulin-­‐
stimulated	  glucose	  uptake	  [64].	  	  SNAREs	  can	  be	  divided	  into	  two	  categories,	  vesicle	  (v-­‐SNARE)	  
and	  target	  (t-­‐SNARE)	  SNAREs.	  Simply,	  v-­‐SNAREs	  are	  incorporated	  into	  the	  membrane	  of	  a	  
transporting	  vesicle	  while	  t-­‐SNAREs	  are	  bound	  onto	  the	  membrane	  of	  target	  tissues.	  	  v-­‐SNAREs,	  
Syntaxin	  4	  and	  VAMP2,	  seems	  to	  be	  specific	  to	  a	  specialized	  subpopulation	  of	  GLUT4	  vesicles.	  	  
More	  specifically,	  it	  is	  thought	  that	  VAMP2	  is	  specific	  to	  insulin-­‐stimulated	  “pools”	  of	  GLUT4	  
[64].	  	  Interestingly,	  VAMP2	  cleaving	  toxins	  (tetanus	  toxin;	  TeTx)	  do	  not	  affect	  GLUT4	  trafficking	  
in	  response	  to	  a	  hypertonic	  sucrose	  stimuli.	  	  This	  suggests	  that	  insulin	  and	  osmolality	  stimulate	  
glucose	  uptake	  through	  diverse	  mechanisms	  and	  non-­‐similar	  pools	  of	  GLUT4’s.	  The	  tethering,	  
docking	  and	  fusion	  phase	  are	  not	  considered	  secondary	  responses	  to	  GLUT4	  stimulation.	  	  In	  fact,	  
they	  are	  part	  of	  the	  primary	  response	  that	  may	  receive	  direct	  signals	  from	  the	  insulin	  receptor	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substrate	  (IRS).	  	  The	  exact	  mechanisms	  of	  the	  tether/dock/fuse	  phases	  are	  still	  currently	  
debated.	  	  
	  	  Recent	  research	  has	  shown	  that	  increased	  GLUT4	  translocation	  alone	  does	  not	  
necessarily	  equate	  to	  increased	  glucose	  uptake.	  	  In	  2001,	  Somwar,	  Klip	  and	  colleges	  observed	  a	  
consistent	  discrepancy	  between	  the	  magnitude	  of	  stimulation,	  the	  rate	  of	  glucose	  uptake	  and	  
the	  rate	  of	  GLUT4	  translocation	  [73].	  	  Literature	  has	  shown	  that	  low	  concentrations	  of	  
wortmannin	  (<10mM)	  inhibited	  glucose	  uptake	  without	  disrupting	  the	  timing	  and	  number	  of	  
GLUT1’s	  and	  GLUT4’s	  translocated	  to	  the	  membrane	  [73].	  	  The	  authors	  suggested	  graded	  levels	  
of	  GLUT4	  activity	  may	  account	  for	  the	  discrepancy	  between	  GLUT4	  translocation	  and	  glucose	  
uptake.	  Using	  insulin	  stimulation,	  Klip	  et	  al.	  determined	  that	  p38	  mitogen-­‐activated	  protein	  
kinase	  (MAPK;	  a	  downstream	  target	  of	  the	  insulin)	  can	  intrinsically	  activate	  GLUT4	  protein	  
preceding	  GLUT4	  translocation	  in	  L6	  myotubes	  [50,	  73].	  	  Two	  possible	  mechanisms	  have	  been	  
proposed	  for	  regulating	  GLUT4	  activity:	  GLUT4	  phosphorylation	  and/or	  a	  ligand	  binding	  
mechanism	  [50].	  	  GLUT4	  contains	  one	  site	  for	  phosphorylation;	  in	  basal	  conditions,	  there	  is	  a	  
larger	  proportion	  of	  phosphorylated	  than	  unphosphorylated	  GLUT4	  [50].	  	  Moreover,	  the	  
phosphorylated	  state	  of	  GLUT4	  is	  inversely	  proportional	  to	  glucose	  uptake	  [50].	  	  Taken	  together,	  
this	  may	  suggest	  a	  downstream	  phosphatase	  action	  by	  known	  stimulators.	  	  The	  ligand	  binding	  
mechanism	  presents	  two	  possibilities,	  the	  binding	  of	  an	  activator	  or	  the	  release	  of	  an	  inhibitor	  
upon	  stimulation.	  	  Currently,	  the	  literature	  endorses	  the	  latter	  option	  in	  cell	  culture,	  as	  the	  
cytosolic	  C-­‐terminus	  of	  GLUT4	  is	  more	  accessible	  to	  antibodies	  after	  insulin	  stimulation	  than	  in	  
its	  basal	  state	  [50].	  	  	  
GLUT4	  recycling	  is	  heavily	  regulated	  and	  is	  a	  critical	  factor	  in	  the	  rate	  of	  glucose	  uptake	  
in	  skeletal	  muscle.	  	  Stimulators	  (i.e.	  insulin,	  contraction	  and	  osmotic	  stress)	  of	  glucose	  uptake	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seem	  to	  have	  multiple	  regulatory	  inputs	  in	  the	  GLUT4	  recycling	  pathway.	  	  Stimulators	  can	  
enhance	  the	  activity	  of	  exocytosis	  or	  even	  decrease	  the	  activity	  of	  endocytosis.	  	  Moreover,	  
GLUT4	  activation	  can	  be	  regulated	  apart	  from	  GLUT4	  translocation,	  however	  the	  majority	  of	  the	  
current	  literature	  has	  been	  investigated	  through	  insulin.	  	  Limited	  research	  is	  available	  to	  verify	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3.	  Signaling	  Proteins	  Implicated	  in	  Glucose	  Uptake	  	  
	   This	  section	  represents	  a	  brief	  introduction	  into	  some	  of	  the	  common	  signaling	  cascades	  
and	  proteins	  that	  have	  been	  described	  to	  have	  an	  association	  with	  glucose	  uptake.	  	  The	  
following	  proteins	  are	  common	  to	  insulin	  and	  contraction	  stimulated	  glucose	  uptake	  and	  may	  be	  
involved	  in	  hyper-­‐osmotically	  stimulated	  glucose	  uptake.	  	  Complete	  descriptions	  of	  the	  detailed	  
signaling	  pathways	  of	  glucose	  uptake	  will	  be	  provided	  in	  section	  4.	  
3.1	  Akt/PKB	  
Three	  (1,2	  and	  3)	  mammalian	  isoforms	  of	  Akt/protein	  kinase	  B	  (PKB)	  have	  been	  
identified	  and	  are	  all	  stimulated	  by	  insulin	  via	  PI3-­‐K	  [77,	  80].	  	  Akt1	  and	  2	  are	  expressed	  in	  
adipose	  tissue	  and	  skeletal	  muscle	  and	  Akt3	  is	  also	  present	  in	  L6	  and	  3T3-­‐L1	  cell	  culture	  tissues	  
[77].	  	  Interestingly,	  Akt2	  knockout	  mice	  display	  severely	  impaired	  glucose	  uptake,	  while	  Akt1	  
knockouts	  do	  not	  display	  any	  obvious	  insulin	  resistance	  [83].	  	  Thus	  far,	  Akt2	  is	  known	  to	  be	  
responsible	  for	  metabolic	  actions	  in	  the	  body,	  while	  Akt1	  is	  thought	  to	  facilitate	  growth-­‐
promoting	  signals	  and	  has	  little	  metabolic	  consequence.	  	  It	  is	  hypothesized	  that	  the	  enzyme	  is	  
phosphorylated	  on	  Thr308/309	  of	  its	  activation	  loop	  by	  PDK1	  (phosphotidylinositol	  dependent	  
kinase	  1)	  [77].	  	  	  Akt	  also	  contains	  a	  second	  phosphorylation	  site,	  Ser473/474,	  however;	  its	  role	  is	  
not	  clear.	  	  It	  has	  been	  speculated	  that	  serine	  phosphorylation	  precedes	  Thr308/309	  
phosphorylation	  and	  that	  Akt	  may	  require	  dual	  phosphorylation	  to	  be	  activated	  [77].	  	  Akt	  is	  
proposed	  to	  have	  multiple	  regulatory	  outputs	  to	  promote	  glucose	  uptake,	  rather	  than	  relaying	  a	  
signal	  down	  a	  solitarily	  cascade.	  	  In	  fact,	  Akt	  is	  known	  to	  interact	  with	  over	  35	  various	  substrates	  
involved	  in	  various	  survival	  and	  apoptotic	  processes	  [18].	  	  In	  regards	  to	  glucose	  uptake,	  the	  
more	  relevant	  actions	  of	  Akt	  include	  both	  the	  acceleration	  of	  endosomal	  transit	  of	  GLUT4,	  and	  
regulation	  of	  vesicle	  fusion	  between	  SNARE	  complexes	  and	  the	  plasma	  membrane	  [77].	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3.2	  AS160/TBC1D4	  
	   AS160,	  also	  known	  as	  TBC1D4,	  is	  an	  Akt	  substrate	  that	  was	  first	  successfully	  identified	  in	  
2002	  [37].	  	  Although	  it	  was	  originally	  thought	  to	  be	  an	  exclusive	  substrate	  for	  Akt,	  it	  now	  
appears	  that	  other	  kinases,	  like	  AMPK,	  are	  capable	  of	  phosphorylating	  and	  deactivating	  AS160	  
[9].	  	  AS160	  is	  a	  Rab-­‐GAP	  (GTPase	  activating	  protein)	  that	  is	  considered	  the	  link	  between	  Akt	  and	  
GLUT4	  translocation.	  	  At	  rest,	  AS160	  is	  highly	  active	  suppressing	  Rab	  proteins	  found	  on	  glucose	  
storage	  vesicles.	  	  Upon	  stimulation,	  AS160	  releases	  its	  inhibition	  on	  glucose	  storage	  vesicles	  -­‐
bound	  Rabs,	  allowing	  glucose	  storage	  vesicles	  to	  be	  loaded	  with	  GTP	  and	  transport	  GLUT4	  to	  the	  
cell	  surface	  [13].	  	  AS160	  appears	  to	  possess	  at	  least	  eight	  different	  phosphorylation	  sites,	  
however,	  the	  roles	  of	  these	  different	  sites	  have	  yet	  to	  be	  definitively	  identified	  [13,	  59,	  67].	  	  
Sano	  et	  al.	  have	  identified	  phosphorylation	  sites	  at	  Ser318,	  Ser341,	  Ser570,	  Ser751,	  Ser588	  and	  Thr642	  
in	  mouse	  AS160	  [67]	  and	  the	  phosphorylation	  of	  these	  various	  sites	  appears	  to	  depend	  on	  the	  
type	  of	  stimulus	  [13].	  	  For	  example,	  insulin	  stimulated	  activation	  of	  Rab	  proteins	  have	  been	  
observed	  to	  be	  mediated	  through	  phosphorylation	  of	  Thr642	  site,	  while	  pharmacological	  
stimulation	  of	  AMPK	  has	  been	  demonstrated	  to	  increase	  Ser237	  phosphorylation	  [59,	  66].	  	  	  
Interestingly,	  mutations	  at	  four	  of	  the	  various	  phosphorylation	  sites	  (including	  Ser588	  and	  Thr642)	  
have	  been	  observed	  to	  inhibit	  insulin	  stimulated	  GLUT4	  translocation	  [59,	  67].	  	  Furthermore,	  	  
over	  expression	  of	  a	  mutated	  form	  of	  AS160	  (AS160-­‐4P)	  has	  lead	  to	  a	  significant	  decline	  in	  both	  
insulin	  (~30%)	  and	  contraction	  (~40%)	  stimulated	  glucose	  uptake	  in	  skeletal	  muscle	  [41,	  66].	  	  
Therefore,	  it	  appears	  that	  AS160	  phosphorylation	  at	  some	  of	  its	  phosphorylation	  sites	  decreases	  
AS160	  activity	  which	  then	  allows	  for	  increased	  GLUT4	  translocation.	  	  However,	  further	  work	  is	  
required	  to	  determine	  the	  role	  of	  all	  of	  the	  possible	  phosphorylation	  sites	  on	  AS160.	  
The	  human	  genome	  possess	  over	  50	  Rabs	  and	  Rab-­‐GAPs,	  reflecting	  the	  specificity	  
required	  for	  such	  an	  interaction	  [66].	  	  Over	  a	  dozen	  different	  Rab	  proteins	  have	  been	  found	  to	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be	  associated	  with	  GLUT4	  vesicles,	  but	  the	  key	  players	  appear	  to	  be	  Rab	  2A,	  -­‐8A,	  -­‐8B,	  -­‐10,	  1-­‐1	  
and	  -­‐14,	  conversely	  their	  specific	  functions	  have	  yet	  to	  be	  fully	  understood	  [34,	  66].	  	  
Interestingly,	  AS160	  contains	  a	  region	  in	  a	  Rab-­‐GAP	  domain	  (amino	  acids	  834-­‐857)	  that	  is	  about	  
58%	  identical	  to	  a	  calmodulin-­‐binding	  domain	  (CBD)	  within	  Drosophilia	  protein	  Pollux	  [41].	  	  Both	  
human	  and	  Drosophilia	  peptide	  sequences	  contain	  key	  residues	  for	  calmodulin	  /	  calcium	  
association.	  	  This	  association	  could	  serve	  as	  a	  potential	  mechanistic	  link	  between	  calcium	  and	  
glucose	  transport	  involving	  AS160	  and	  possibly	  calmodulin.	  
3.3	  AMPK	  
	   Adenosine-­‐5’-­‐monophosphate	  protein	  kinase	  (AMPK)	  is	  a	  hetrotrimeric	  protein	  
composed	  of	  a	  catalytic	  α	  subunit	  and	  two	  regulatory	  subunits,	  β	  and	  γ	  [52].	  	  Each	  subunit	  has	  2	  
or	  more	  isoforms.	  	  α1	  and	  α2	  are	  functionally	  considered	  the	  most	  important	  isoforms,	  where	  
α1	  is	  widely	  expressed	  in	  almost	  all	  tissue	  and	  α2	  is	  the	  predominately	  found	  in	  the	  liver,	  heart	  
and	  skeletal	  muscle.	  	  In	  skeletal	  muscle,	  AMPK	  acts	  as	  a	  sensor	  for	  energy	  status	  within	  the	  cell	  
and	  is	  allosterically	  regulated	  by	  AMP/ATP	  and	  Cr/PCr	  ratios.	  	  Allosteric	  activation	  (by	  AMP)	  is	  
required	  to	  allow	  phosphorylation	  at	  Thr172	  by	  other	  upstream	  kinases	  (LKB	  and	  CaMK),	  leading	  
to	  the	  activation	  of	  AMPK	  [52].	  	  Moreover,	  AMP	  binding	  to	  the	  α2	  causes	  a	  conformational	  
change	  to	  protect	  Thr172	  from	  dephosphorylation	  [78].	  	  Activation	  of	  AMPK	  activity	  increases	  as	  
AMP	  levels	  increase	  during	  exercise	  and/or	  metabolic	  stress.	  	  Examples	  of	  metabolic	  stress	  
include	  osmotic	  stress,	  hypoxia,	  ischemia,	  thermal	  shock,	  inhibitors	  of	  glycolysis	  and	  
mitochondrial	  uncouplers	  [52].	  	  Therefore,	  it	  is	  logical	  that	  activation	  of	  AMPK	  stimulates	  ATP-­‐
producing	  pathways	  (glycolysis,	  glycogenolysis,	  fatty	  acid	  oxidation),	  while	  also	  suppressing	  ATP-­‐
consuming	  pathways	  (glycogen	  synthesis)	  [32,	  52].	  	  
When	  considering	  osmotic	  stress,	  AMPK	  could	  be	  a	  potential	  candidate	  for	  activation	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based	  on	  the	  metabolic	  influences	  of	  hyper-­‐osmotic	  stress.	  	  HYPER	  extracellular	  environments	  
lead	  to	  decreases	  in	  cell	  volume,	  decrease	  in	  energy	  status	  and	  an	  overall	  catabolic	  state	  within	  
cells	  [2].	  	  Activation	  of	  AMPK	  would	  theoretically	  increase	  the	  activity	  of	  ATP	  generating	  
pathways	  in	  order	  to	  meet	  the	  increased	  energy	  demands	  required	  to	  cope	  with	  the	  osmotic	  
stress.	  	  Once	  again,	  taking	  up	  glucose	  not	  only	  contributes	  to	  RVI	  through	  increasing	  omsolality,	  
it	  also	  provides	  available	  substrate	  for	  glycolysis.	  	  Therefore,	  it	  would	  be	  logical	  that	  AMPK	  could	  
play	  a	  role	  in	  regulating	  osmotically	  induced	  glucose	  uptake	  [32,	  52,	  54].	  
3.4	  ERK	  MAPK	  
	   All	  eukaryotic	  cells	  exhibit	  multiple	  mitogen	  activated	  protein	  kinase	  (MAPK)	  pathways	  
that	  regulate	  a	  wide	  variety	  of	  cellular	  activities	  that	  range	  from	  mitosis	  to	  cell	  apoptosis.	  	  To	  
date,	  five	  distinct	  groups	  of	  MAPK	  have	  been	  characterized	  in	  mammals:	  extracellular	  signal-­‐
related	  kinases	  1	  and	  2	  (ERK1/2);	  c-­‐Jun	  amino-­‐terminal	  kinases	  (JNK)	  1,2	  and	  3;	  p38;	  ERK	  3/4	  and	  
ERK5	  [63].	  	  Each	  group	  of	  MAPKs	  belong	  to	  a	  family	  of	  three	  evolutionary	  conserved	  kinase	  
sequences:	  a	  MAPK,	  a	  MAPK	  kinase	  (MAPKK)	  and	  a	  MAPKK	  kinase	  (MAPKKK).	  	  Figure	  3,	  
illustrates	  the	  family	  of	  cascades	  for	  each	  of	  the	  MAPK	  groups.	  	  Generally,	  MAPKs	  are	  responsive	  
to	  a	  diverse	  set	  of	  stimuli,	  however	  not	  all	  MAPKs	  respond	  to	  each	  stimulus	  to	  the	  same	  degree.	  	  
ERK1/2	  may	  have	  a	  possible	  role	  in	  hyper	  osmotic	  induced	  glucose	  uptake	  signalling	  as	  it	  has	  
been	  shown	  to	  responsed	  to	  a	  diverse	  range	  of	  extracellular	  stimuli	  including	  mitogens,	  growth	  
































Figure	  3:	  Family	  of	  extracellular	  related	  kinases	  (Adapted	  from	  Roux	  2004)	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phosphorylation	  of	  Thr202	  and	  Tyr204	  while	  ERK2	  catalytic	  activity	  is	  achieved	  when	  dually	  
phosphorylated	  at	  Thr185	  and	  Tyr187	  [25].	  	  Activation	  of	  ERK1/2	  upstream	  kinases	  (Raf	  proteins)	  
are	  not	  fully	  understood,	  however,	  it	  is	  known	  that	  multiple	  phosphorylation	  events	  of	  Raf	  
proteins	  at	  the	  plasma	  membrane	  are	  required	  for	  activation	  [63].	  	  	  In	  2002,	  Sajan	  et	  al.	  
proposed	  that	  a	  non-­‐receptor	  tyrosine	  kinase,	  proline-­‐rich	  tyrosine	  kinase-­‐2	  (PYK-­‐2)	  is	  
responsible	  for	  activating	  Raf	  and	  other	  MAPKKK	  in	  the	  ERK	  family.	  	  Using	  a	  series	  of	  inhibitors	  in	  
3T3-­‐L1	  cells	  and	  L6	  myotubes,	  Sajan	  et	  al	  suggested	  a	  pathway	  where	  PYK-­‐2	  activates	  Raf	  
proteins	  which	  subsequently	  activates	  ERK1/2.	  This	  in	  turn	  increases	  aPKC	  activation	  and	  
eventually	  results	  in	  increased	  GLUT4	  translocation	  [65].	  	  They	  also	  demonstrated	  that	  PI3-­‐K	  and	  
PDK	  activation	  did	  not	  influence	  sorbitol	  induced-­‐PKC	  activation.	  	  Based	  on	  these	  observations,	  
it	  is	  plausible	  that	  that	  hyper-­‐osmotic	  stress	  could	  lead	  to	  phosphorylation	  and	  activation	  of	  
ERK1/2,	  resulting	  in	  an	  increase	  in	  glucose	  uptake	  in	  the	  absence	  of	  PI3-­‐K	  and	  other	  insulin-­‐
signaling	  proteins.	  	  Therefore,	  future	  research	  should	  investigate	  the	  possible	  role	  of	  this	  protein	  
in	  hyperosmotic	  induced	  glucose	  uptake.	  	  
3.5	  Protein	  Kinase	  C	  
	   The	  protein	  kinase	  C	  (PKC)	  family	  of	  serine/threonine	  proteins	  is	  responsible	  for	  many	  
cellular	  functions	  including	  cell	  growth,	  proliferation	  and	  apoptosis.	  	  This	  family	  is	  subdivided	  
into	  three	  major	  classes:	  conventional	  (cPKC),	  novel	  (nPKC)	  and	  atypical	  (aPKC).	  	  These	  
distinctions	  were	  established	  based	  on	  the	  protein	  composition	  and	  ability	  to	  bind	  calcium	  and	  
lipids.	  cPKC	  comprise	  the	  α,	  βI,	  βII	  and	  γ,	  while	  nPKC	  includes	  δ,	  ε,	  η	  and	  θ	  isotypes	  and	  aPKC	  
consist	  of	  the	  ζ	  and	  ι/λ	  isotypes.	  cPKCs	  are	  composed	  of	  N-­‐terminus	  regions	  consisting	  of	  C1	  and	  
C2	  binding	  domains.	  	  The	  C1	  domain	  is	  responsible	  for	  binding	  second	  messenger	  diacylglycerols	  
(DAGs)	  while	  the	  C2	  domain	  binds	  calcium	  as	  a	  second	  messenger.	  	  nPKCs	  have	  a	  functional	  C1	  
domain,	  but	  a	  C2	  variant	  that	  does	  not	  bind	  calcium,	  making	  them	  calcium-­‐insensitive.	  	  Similarly,	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aPKC	  does	  not	  have	  a	  C2	  binding	  site	  and	  a	  C1	  domain	  that	  does	  not	  bind	  DAG,	  making	  these	  
isotypes	  both	  calcium	  and	  DAG	  insensitive	  [10,	  26].	  	  	  
PKCα	  is	  considered	  the	  dominant	  isoform	  of	  the	  cPKCs.	  	  PKCα	  is	  synthesized	  near	  the	  
membrane	  in	  the	  cytoplasm	  where	  it	  is	  unphosphorylated	  and	  inactive.	  PKCα	  is	  activated	  by	  a	  
two-­‐step	  mechanism;	  first,	  it	  gains	  catalytic	  potential	  via	  the	  phosphorylation	  of	  in	  its	  activation	  
loop	  (Thr497),	  and	  this	  in	  turn	  autophosphorylates	  two	  additional	  motifs:	  Thr638	  and	  Ser657.	  	  After	  
becoming	  catalytically	  competent,	  the	  protein	  is	  released	  into	  the	  cytoplasm	  primed	  for	  phase	  
two	  of	  activation.	  	  Full	  activation	  requires	  the	  binding	  of	  diacylglycerol	  to	  the	  C1	  domain,	  or	  the	  
binding	  of	  calcium	  and	  phosphatidylserine	  to	  the	  C2	  domain.	  PKCα	  	  is	  down-­‐regulated	  by	  
phosphatases	  and	  desensitizing	  agents	  such	  as	  heat	  shock	  protein	  70	  [10].	  
In	  summary,	  cPKC	  activation	  is	  partially	  facilitated	  by	  calcium,	  while	  calcium	  has	  been	  
reported	  to	  partially	  induce	  glucose	  uptake	  [38,	  54],	  and	  hyper-­‐osmotic	  stress	  has	  been	  found	  to	  
produce	  calcium	  sparks.	  	  Collectively,	  these	  separate	  observations	  can	  be	  interpreted	  to	  suggest	  
that	  hyper-­‐osmotically	  induced	  calcium	  release	  may	  lead	  to	  an	  increase	  in	  glucose	  uptake	  via	  
cPKC	  [5].	  	  Clearly,	  further	  research	  is	  warranted	  to	  better	  understand	  the	  interaction	  of	  these	  
various	  signaling	  processes.	  
3.6	  Time	  Course	  for	  Signaling	  Cascades	  
Due	  to	  the	  transient	  nature	  of	  cell	  signaling	  and	  the	  multiple	  steps	  involved	  in	  signaling	  
processes,	  phosphorylation	  and	  dephosphorylation	  of	  various	  proteins	  likely	  occurs	  at	  varying	  
time	  points.	  	  There	  has	  been	  limited	  work	  investigating	  the	  specific	  time	  course	  of	  signaling	  with	  
osmotic	  stress.	  	  In	  2007,	  Thong	  et	  al.	  used	  CHO-­‐IR	  cell	  culture	  to	  determine	  the	  phosphorylation	  
levels	  of	  AS160	  in	  response	  to	  osmotic	  shock	  [76].	  	  CHO-­‐IR	  cells	  were	  exposed	  to	  0.45	  mM	  
sucrose	  for	  30	  minutes,	  and	  phosphorylation	  of	  AS160	  was	  significantly	  higher	  when	  compared	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to	  basal	  levels.	  	  Similarly,	  Sano	  et	  al.	  incubated	  3T3-­‐L1	  cell	  culture	  in	  160nmol/L	  insulin	  for	  30	  
minutes	  [67].	  	  Results	  were	  similar	  to	  that	  of	  Thong,	  in	  which	  AS160	  phosphorylation	  was	  
significantly	  higher	  at	  30	  minutes	  compared	  to	  basal	  levels.	  	  Taken	  together,	  both	  studies	  
demonstrate	  that	  AS160	  phosphorylation	  was	  detectable	  within	  30	  minutes	  of	  stimulation.	  	  	  
Chen	  et	  al.	  used	  3T3-­‐L1	  cell	  culture	  to	  determine	  the	  effects	  of	  osmotic	  shock	  on	  insulin	  
signaling	  proteins,	  mainly,	  Akt	  [11].	  	  Osmotic	  shock	  was	  induced	  by	  incubating	  the	  cell	  culture	  in	  
600mM	  of	  sorbitol	  for	  30	  minutes.	  	  The	  authors	  were	  successful	  in	  eliciting	  the	  hypothesized	  
results	  for	  Akt	  and	  the	  insulin	  signaling	  cascade.	  	  In	  addition,	  Bruss	  et	  al.	  used	  rat	  epitrochlearis	  
to	  determine	  the	  effects	  of	  120nmol/L	  insulin	  on	  Akt	  phosphorylation	  [9].	  	  Akt	  phosphorylation	  
was	  significantly	  increased	  (from	  basal	  levels)	  within	  10	  minutes	  of	  stimulation	  and	  remained	  
elevated	  for	  the	  entire	  60	  minute	  incubation.	  	  Thus,	  it	  appears	  that	  phosphorylation	  of	  Akt	  
occurs	  rapidly	  with	  both	  osmotic	  shock	  and	  insulin	  stimulation,	  and	  is	  likely	  detectable	  within	  30	  
minutes	  of	  stimulation.	  	  	  
Hayashi	  et	  al.	  hypothesized	  that	  AMPK	  was	  the	  central	  mediator	  of	  insulin-­‐independent	  
glucose	  transport	  during	  osmotic	  stress	  [32].	  	  Rat	  epitrochlearis	  muscles	  were	  incubated	  in	  
120mmol/L	  sorbitol	  (~120	  mmol/kg)	  for	  40	  minutes.	  	  AMPK	  activity	  was	  significantly	  higher	  at	  40	  
minutes	  compared	  to	  basal,	  unstimulated	  controls.	  	  Furthermore,	  Williamson	  examined	  the	  
phosphorylation	  time	  course	  for	  AMPK	  in	  C1C12	  cell	  culture	  under	  2mM	  AICAR	  stimulation	  [84].	  	  
Cells	  were	  incubated	  for	  15,	  30	  and	  60	  minutes	  and	  AMPK	  was	  elevated	  at	  all	  time	  points	  
compared	  to	  basal	  unstimulated	  controls.	  	  These	  two	  studies,	  along	  with	  other	  studies	  done	  by	  
Patel	  [54]	  and	  Fryer	  [21]	  suggest	  that	  AMPK	  phosphorylation	  is	  also	  rapid	  and	  likely	  occurs	  
within	  15	  minutes	  of	  stimulation	  and	  likely	  remains	  phosphorylated	  beyond	  60	  minutes	  of	  
stimulation.	  	  	  
Rat	  adipocytes	  were	  used	  by	  Sajan	  et	  al.	  to	  investigate	  ERK	  activity	  under	  osmotic	  stress	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[65].	  	  Cells	  were	  incubated	  in	  300mM	  of	  sorbitol	  for	  30	  minutes.	  	  ERK	  activity	  was	  significantly	  
higher	  than	  non-­‐stimulated	  controls	  at	  15	  minutes	  of	  incubation	  and	  was	  sustained	  to	  30	  
minutes.	  	  Moreover,	  Leng	  et	  al.	  used	  rat	  EDL	  muscle	  to	  determine	  the	  effects	  of	  120nmol/L	  
insulin	  on	  ERK	  MAPK	  phosphorylation	  [44].	  	  A	  time	  course	  was	  published	  between	  1	  minute	  and	  
40	  minutes.	  	  ERK	  phosphorylation	  seemed	  to	  peak	  at	  20	  minutes	  (6	  fold	  above	  basal	  levels),	  and	  
remained	  elevated	  at	  40	  minutes	  (5	  fold	  above	  basal).	  	  Together,	  these	  studies	  suggest	  that	  ERK	  
phosphorylation	  also	  occurs	  rapidly,	  and	  is	  likely	  maintained	  beyond	  40	  minutes	  of	  stimulation.	  
In	  summary,	  there	  has	  been	  limited	  investigation	  of	  the	  time	  course	  of	  osmotic	  induced	  
activation	  of	  glucose	  signaling	  cascades.	  	  Based	  on	  the	  limited	  information	  it	  would	  appear	  that	  
AS160,	  Akt,	  AMPK	  and	  ERK	  all	  show	  increased	  levels	  of	  phosphorylation/activation	  within	  30	  
minutes	  of	  exposure	  to	  osmotic	  stress.	  	  However,	  it	  should	  be	  noted	  that	  various	  models	  were	  
used	  to	  establish	  the	  described	  time	  lines	  and	  as	  such	  the	  timelines	  may	  not	  be	  the	  same	  for	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4.0	  Stimulators/Regulators	  of	  Cellular	  Glucose	  Uptake	  
4.1	  Introduction	  
Glucose	  uptake	  in	  skeletal	  muscle	  is	  a	  tightly	  regulated	  process	  necessary	  to	  maintain	  
whole	  body	  glucose	  homeostasis.	  	  Under	  basal,	  unstimulated	  conditions,	  the	  majority	  of	  GLUT4	  
vesicles	  are	  sequestered	  in	  intracellular	  compartments.	  	  Various	  stimulators	  such	  as	  insulin,	  
contraction,	  osmotic	  stress,	  hypoxia	  and	  dinitrophenol	  (DNP;	  a	  mitochondria	  uncoupler)	  have	  
been	  shown	  to	  redistribute	  GLUT4	  towards	  the	  plasma	  membrane	  thereby	  increasing	  glucose	  
uptake	  [18,	  45,	  54,	  76,	  77].	  	  Most	  of	  our	  understanding	  of	  these	  mechanisms	  come	  from	  cell	  
culture	  and	  adipose	  tissue	  models;	  the	  role	  of	  GLUT4	  cycling	  in	  whole	  skeletal	  muscle	  remains	  to	  
be	  fully	  confirmed	  [18].	  	  By	  far	  the	  most	  studied	  stimulator	  of	  glucose	  uptake	  is	  the	  insulin-­‐
signaling	  cascade.	  	  Contraction	  has	  also	  gained	  much	  attention	  as	  an	  insulin-­‐independent	  
stimulator	  and	  is	  very	  attractive	  signaling	  pathway	  that	  seems	  to	  circumvent	  insulin	  resistance.	  	  
Osmotic	  stress	  is	  a	  less	  common	  stimulator	  than	  the	  previous	  two,	  however	  it	  may	  present	  a	  
third	  signaling	  pathway,	  independent	  of	  insulin	  and	  contraction.	  	  Hypoxia	  and	  mitochondrial	  
uncoupling	  will	  not	  be	  reviewed	  in	  this	  investigation.	  	  	  
4.2	  Insulin	  Stimulation	  	  
Insulin-­‐induced	  GLUT4	  translocation	  (Figure	  4)	  and	  activation	  is	  the	  primary	  mechanism	  
in	  which	  glucose	  is	  removed	  from	  the	  blood	  and	  taken	  up	  into	  the	  tissues.	  	  This	  has	  been	  
demonstrated	  in	  cell	  culture,	  adipose	  tissue	  and	  skeletal	  muscle	  [11,	  18-­‐20].	  	  Elevations	  in	  blood	  
glucose	  will	  trigger	  the	  release	  of	  insulin	  from	  the	  pancreas	  into	  the	  blood	  stream.	  	  Insulin	  binds	  
to	  the	  extracellular	  α-­‐subunit	  of	  the	  insulin	  receptor	  (IR),	  found	  on	  the	  surface	  of	  adipocytes	  and	  
skeletal	  muscle	  cells;	  this	  in	  turn	  results	  in	  a	  conformational	  change	  of	  the	  IR.	  	  This	  physical	  
change	  causes	  multi-­‐site	  autophosphorylation	  of	  the	  tyrosine	  residues	  on	  the	  β-­‐subunit,	  leading	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to	  increased	  tyrosine	  kinase	  activity.	  	  Consequently,	  the	  insulin-­‐receptor	  substrate	  (IRS)	  binds	  to	  
the	  IR	  through	  phosphotyrosine-­‐	  binding	  (PTB)	  sites,	  thereby	  creating	  a	  high	  affinity	  binding	  site	  
for	  effector	  proteins	  containing	  Src	  homology	  2	  (SH2)	  domains	  [55,	  77].	  	  The	  chief	  SH2	  
containing	  protein	  is	  the	  p85	  regulatory	  subunit	  of	  type	  1A	  phosphatidyl	  inositol	  3-­‐kinase	  (PI3-­‐
K).	  	  Interaction	  of	  the	  p85	  subunit	  with	  IRS-­‐1	  causes	  activation	  of	  the	  p110	  catalytic	  subunit	  of	  
PI3-­‐K.	  	  The	  role	  of	  PI3-­‐K	  has	  been	  demonstrated	  to	  be	  essential	  from	  experiments	  utilizing	  the	  
PI3-­‐K	  inhibitor,	  wortmannin	  [32,	  77].	  	  Wortmannin	  has	  been	  shown,	  and	  used	  by	  many	  scientist,	  
to	  lengthen	  insulin-­‐stimulated	  GLUT4	  endosomal	  transit	  time	  and	  inhibit	  actin	  remodeling	  
required	  for	  GLUT4	  translocation	  [77].	  	  From	  here,	  the	  activated	  PI3-­‐K	  continues	  to	  migrate	  
towards	  the	  plasma	  membrane	  where	  it	  phosphorylates	  phosphatidyl	  inositol	  (3,4)	  diphosphate	  
[PI(3,4)P2]	  and	  converts	  to	  phosphatidylinositol	  3,4,5-­‐triphosphate	  [PI(3,4,5)P3].	  	  The	  activation	  
of	  PIP3	  recruits	  Akt	  to	  the	  plasma	  membrane	  though	  the	  activation	  of	  PIP3-­‐containing	  effector	  
protein	  phosphatidylinositol-­‐dependant	  kinase-­‐1	  (PDK1)	  [77,	  83].	  	  PDK1	  will	  then	  phosphorylate	  
and	  activate	  Akt.	  	  Akt	  is	  known	  to	  control	  many	  common	  cellular	  processes	  which	  are	  vital	  to	  cell	  
survival	  and	  more	  specifically	  glucose	  metabolism.	  	  	  	  	  
The	  next	  step	  in	  the	  insulin-­‐signaling	  cascade	  involves	  a	  recently	  discovered	  protein	  
known	  as	  AS160.	  	  Akt	  activation	  is	  known	  to	  inhibit	  the	  Rab	  GAP	  activity	  thereby	  resulting	  in	  the	  
conversion	  of	  Rab-­‐GDP	  to	  Rab-­‐GTP.	  	  GLUT4	  vesicles	  loaded	  with	  GTP	  are	  able	  to	  mobilize	  
towards	  the	  plasma	  membrane	  and	  increase	  glucose	  transport	  [76,	  77].	  	  AS160	  appears	  to	  be	  
the	  last	  signaling	  protein	  involved	  in	  the	  cascade	  before	  GLUT4	  translocation.	  	  Therefore,	  AS160	  
represents	  the	  definitive	  signal	  that	  leads	  to	  the	  translocation	  of	  GLUT4,	  and	  as	  such	  it	  is	  
important	  to	  understand	  its	  role	  under	  various	  forms	  of	  stimulation	  such	  as	  osmotic	  stress.	  	  	  
It	  is	  also	  important	  to	  note	  that	  the	  insulin	  pathway	  bifurcates	  at	  several	  points	  along	  
the	  cascade.	  	  From	  the	  most	  proximal	  end,	  signals	  from	  IRS-­‐1	  protein	  divide	  into	  a	  PI3-­‐K	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independent,	  yet	  parallel	  pathway	  [28,	  39,	  77].	  This	  pathway	  involves	  the	  c-­‐Cbl	  associated	  
protein	  (CAP),	  Cbl	  and	  the	  GTPase	  TC10	  and	  could	  possibly	  regulate	  GLUT4	  translocation	  in	  
muscle.	  	  However,	  the	  validity	  and	  function	  of	  the	  pathway	  remains	  debated	  and	  has	  only	  been	  
documented	  in	  adipose	  tissue	  [18,	  55].	  	  In	  addition,	  PDK1	  is	  known	  to	  interact	  with	  a	  second	  
downstream	  target	  other	  than	  Akt,	  called	  atypical	  protein	  kinase	  C	  (aPKC).	  	  The	  aPKC	  pathway	  is	  
considered	  an	  important	  cascade	  for	  activating	  motor	  proteins	  such	  as	  kinesins,	  which	  
contribute	  to	  GLUT4	  vesicles	  migration	  to	  the	  sarcolemma	  [34,	  68].	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Figure	  4:	  	  A	  schematic	  representation	  of	  the	  insulin	  signaling	  cascade	  in	  skeletal	  
muscle.	  	  Insulin	  receptor	  substrate	  (IRS),	  phosphatidyl	  inostiol	  3-­‐Kinase	  (PI3-­‐K),	  
phosphatidyl	  inostiol	  diphosphate	  (PIP2),	  phosphatidyl	  inostiol	  triphosphate	  	  
(PIP3),	  phosphatidylinositol-­‐dependant	  kinase	  (PDK),	  	  protein	  kinase	  C	  (PKC),	  Akt	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4.3	  Contraction	  	  
Muscle	  contraction	  is	  another	  potent	  stimulator	  of	  glucose	  uptake	  for	  both	  healthy	  
individuals	  and	  individuals	  with	  diabetes	  [68].	  	  Glucose	  uptake	  during	  skeletal	  muscle	  
contraction	  has	  been	  observed	  numerous	  times	  in	  the	  absence	  of	  insulin	  [17,	  36,	  41,	  52].	  	  	  	  
Moreover,	  PI3-­‐K	  inhibitor,	  wortmannin,	  has	  been	  shown	  to	  have	  no	  effect	  on	  contraction-­‐
induced	  uptake	  [17,	  36,	  68].	  	  Interestingly,	  the	  influence	  of	  insulin	  and	  contraction	  on	  glucose	  
transport	  are	  additive,	  and	  research	  has	  provided	  compelling	  evidence	  that	  the	  signaling	  
mechanisms	  for	  insulin	  and	  contraction	  are	  partially	  independent	  and	  divergent.	  	  In	  fact,	  it	  is	  
hypothesized	  that	  insulin	  and	  contraction	  stimulated	  signaling	  are	  initiated	  differently	  leading	  to	  
independent	  proximal	  pathways,	  however	  the	  downstream	  targets	  may	  converge.	  	  Ultimately,	  
the	  contraction	  mediated	  signaling	  cascade	  has	  gained	  much	  attention	  as	  it	  is	  a	  very	  attractive	  
pathway	  to	  target	  as	  an	  alternative	  to	  possibly	  circumvent	  the	  deficiencies	  that	  occur	  with	  
insulin	  resistance	  and	  type	  II	  diabetes.	  	  	  	  
	   Currently,	  there	  are	  two	  suggested	  mechanisms	  to	  explain	  contraction	  mediated	  glucose	  
uptake.	  	  The	  first	  is	  based	  on	  the	  metabolic	  and	  energetic	  stresses	  placed	  on	  the	  cell	  during	  
muscle	  contraction.	  	  The	  second	  suggests	  Ca2+,	  as	  a	  second	  messenger,	  initiates	  the	  
translocation	  of	  GLUT4	  towards	  the	  plasma	  membrane.	  	  	  
	   By	  far	  the	  most	  popular	  protein-­‐kinase	  associated	  with	  metabolic/energetic	  stress	  and	  
glucose	  uptake	  is	  AMPK.	  	  Over	  the	  past	  decade,	  extensive	  research	  has	  been	  conducted	  to	  relate	  
AMPK	  and	  contraction-­‐induced	  glucose	  transport.	  	  One	  of	  the	  most	  utilized	  techniques	  to	  study	  
this	  protein	  is	  with	  5-­‐aminoimidazole-­‐4-­‐carboxamide-­‐riboside	  (AICAR),	  a	  pharmacological	  agent	  
that	  can	  directly	  activate	  AMPK.	  	  Many	  scientists	  have	  documented	  a	  strong	  relationship	  
between	  increased	  AMPK	  activity,	  glucose	  transport	  and	  muscle	  contraction	  in	  all	  tissue	  types	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[21,	  32,	  36,	  52,	  78].	  	  	  
	   The	  exact	  signaling	  mechanisms	  involving	  AMPK	  and	  glucose	  transport	  have	  yet	  to	  be	  
fully	  understood.	  	  Recent	  findings	  in	  cell	  culture	  propose	  tumor	  suppressor	  kinase,	  LBK1,	  as	  the	  
major	  upstream	  regulator	  of	  AMPK	  [71].	  	  Some	  convincing	  work	  by	  Thong	  et	  al.	  used	  a	  muscle	  
specific	  LKB1	  knockout	  (KO)	  mouse	  model	  to	  support	  the	  role	  of	  AMPK	  in	  mediating	  glucose	  
uptake	  with	  contraction	  [76].	  	  In	  their	  study,	  they	  reported	  reduced	  AMPK	  activation	  by	  AICAR	  
and	  muscle	  stimulation	  in	  EDL	  from	  LKB1	  KO’s	  [76].	  	  Therefore,	  LKB1	  seems	  to	  be	  an	  essential	  
upstream	  catalyst	  for	  AMPK	  activation,	  but	  whether	  it	  is	  the	  only	  kinase	  responsible	  for	  AMPK	  
activation	  is	  still	  being	  debated.	  	  	  	  
The	  contraction-­‐stimulated	  pathway	  is	  thought	  to	  converge	  with	  the	  classic	  insulin	  
cascade	  downstream	  of	  AMPK	  and	  Akt.	  	  Recently,	  separate	  labs	  have	  independently	  
demonstrated	  that	  AS160	  may	  be	  a	  possible	  point	  of	  convergence,	  as	  AS160	  was	  found	  to	  be	  
phosphorylated	  during	  both	  insulin	  and	  contraction	  induced	  stimulation	  of	  glucose	  uptake	  
(Figure	  5)	  [9,	  16,	  36].	  	  Phosphorylation	  of	  AS160	  and	  AICAR-­‐induced	  glucose	  transport	  was	  
completely	  abolished	  in	  skeletal	  muscle	  from	  AMPKα2	  knockout	  mice	  [78],	  suggesting	  the	  
AS160	  is	  a	  likely	  downstream	  target	  of	  AMPK.	  	  Similarly,	  inhibition	  of	  Akt	  and	  AS160	  
phosphorylation	  is	  known	  to	  reduce	  insulin	  mediated	  GLUT4	  translocation	  [9,	  76].	  	  AS160	  
represents	  a	  possible	  point	  of	  convergence	  as	  it	  appears	  to	  be	  involved	  in	  both	  insulin	  and	  
contraction	  stimulation	  of	  glucose	  uptake.	  	  It	  has	  also	  been	  suggested	  to	  be	  the	  final	  step	  before	  
GLUT4	  translocation;	  however,	  additional	  research	  is	  required	  to	  address	  this	  hypothesis	  
adequately.	  	  	  
	   Another	  mechanism	  that	  has	  been	  suggested	  to	  possibly	  mediate	  contraction	  induced	  
glucose	  uptake	  involves	  the	  released	  of	  Ca2+	  from	  the	  sarcoplasmic	  reticulum	  (SR).	  	  Alpha-­‐motor	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neuron	  stimulation	  of	  skeletal	  muscle	  leads	  to	  intracellular	  spikes	  in	  Ca2+	  which	  results	  in	  actin	  
and	  myosin	  interaction,	  and	  ultimately	  force	  production	  in	  skeletal	  muscle.	  	  Caffeine	  is	  a	  
pharmacological	  agent	  used	  in	  literature	  to	  initiate	  the	  release	  of	  Ca2+	  without	  depolarization	  of	  
the	  T-­‐tubules	  or	  energy	  depletion	  [36,	  87].	  	  The	  underlying	  mechanism	  of	  Ca2+	  induced	  glucose	  
uptake	  is	  unknown,	  however,	  it	  is	  unlikely	  that	  Ca2+	  directly	  initiates	  the	  GLUT4	  transport	  
system,	  since	  Ca2+	  is	  almost	  immediately	  sequestered	  back	  into	  the	  SR,	  while	  GLUT4	  transport	  is	  
comparatively	  elevated	  for	  a	  prolonged	  period	  of	  time	  [36].	  	  Alternatively,	  Ca2+	  could	  act	  as	  a	  
second	  messenger	  for	  other	  proteins.	  	  Two	  groups	  proteins	  have	  been	  identified	  in	  this	  context:	  
the	  CaMK	  family	  consisting	  of	  CaMK	  I,	  II	  and	  III	  and	  a	  family	  known	  as	  the	  PKC	  family	  [36,	  68].	  	  
Through	  an	  unknown	  mechanism,	  CaMK	  is	  hypothesized	  to	  facilitate	  Ca2+	  stimulation	  of	  glucose	  
uptake	  by	  enhancing	  GLUT4	  translocation	  to	  the	  plasma	  membrane	  of	  skeletal	  muscle	  [68].	  	  
Wright	  et	  al.	  reported	  a	  synergistic	  effect	  between	  AMPK,	  AICAR,	  CaMK	  and	  caffeine	  on	  glucose	  
uptake	  [86].	  	  Introduction	  of	  KN62	  (a	  specific	  inhibitor	  of	  CaMK)	  inhibited	  glucose	  transport	  
stimulated	  by	  caffeine	  by	  ~66%,	  while	  inhibiting	  contraction-­‐stimulated	  glucose	  uptake	  by	  
approximately	  50%	  [86].	  	  This	  contradicted	  previous	  literature	  which	  reported	  that	  CaMK	  and	  
AMPK	  stimulated	  glucose	  uptake	  through	  independent	  signaling	  pathways.	  	  Recently,	  Jessen	  et	  
al.	  proposed	  the	  concept	  of	  CaMK	  kinase	  (CaMKK)	  being	  an	  upstream	  signaler	  of	  AMPK,	  
suggesting	  muscle	  contraction	  can	  activate	  AMPK	  through	  both	  Ca2+	  and	  AMP/ATP	  ratios	  [35].	  	  
Figure	  6	  illustrates	  a	  proposed	  signaling	  pathway	  where	  calcium	  could	  potentially	  regulate	  
glucose	  uptake	  in	  skeletal	  muscle,	  however	  the	  mechanism	  is	  still	  highly	  debated	  [68].	  
Atypical	  and	  conventional	  PKCs	  are	  less	  studied	  than	  CaMK,	  however,	  some	  studies	  have	  
shown	  muscle	  contraction	  alone	  activates	  the	  PKCs	  [36].	  	  In	  addition,	  inhibition	  of	  aPKC	  (using	  
polymoxin	  B)	  has	  simultaneously	  diminished	  contraction-­‐induced	  glucose	  uptake.	  	  These	  results,	  
however,	  should	  be	  interpreted	  with	  caution,	  since	  polymoxin	  B	  is	  not	  a	  specific	  inhibitor	  of	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aPKC	  and	  may	  influence	  contractile	  properties	  of	  skeletal	  muscle	  and/or	  possibly	  influence	  other	  
kinases	  [36].	  	   In	  summary,	  the	  current	  literature	  has	  provided	  convincing	  evidence	  that	  
contraction	  mediated	  glucose	  uptake	  converges	  with	  components	  of	  the	  classic	  insulin	  signaling	  
cascade.	  AS160	  may	  be	  the	  point	  of	  convergence	  as	  it	  influences	  both	  contraction	  and	  insulin	  
stimulation.	  	  AMPK	  is	  generally	  acknowledged	  to	  be	  at	  least	  partially	  involved	  with	  contraction	  
stimulated	  glucose	  transport,	  due	  to	  energy	  stresses	  on	  the	  cell.	  	  Calcium	  released	  during	  
muscle	  contraction	  may	  also	  stimulate	  glucose	  transport	  through	  CaMK	  and	  PKC,	  however	  
further	  research	  is	  required.	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Figure	  5:	  A	  schematic	  representation	  of	  the	  contraction	  stimulated	  signaling	  cascade	  in	  
skeletal	  muscle.	  	  Atypical	  protein	  kinase	  C	  (aPKC),	  conventional	  protein	  kinase	  C	  (cPKC),	  
Akt	  substrate	  of	  160	  kDa	  (AS160),	  calmodulin	  kinase	  kinase	  (CaMKK),	  AMP-­‐activated	  
protein	  kinase	  (AMPK),	  Extracellular	  related	  kinase	  (ERK).	  	  Adapted	  from	  Sakamoto	  et	  al	  
2008.	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4.4	  Hyper-­‐Osmolality	  	  
	   In	  isolated	  whole	  skeletal	  muscle,	  osmolality	  has	  only	  been	  recently	  identified	  as	  a	  
stimulator	  for	  increasing	  glucose	  uptake	  (unpublished	  thesis	  work)	  [19].	  	  The	  majority	  of	  existing	  
literature	  suggesting	  osmolality	  as	  a	  stimulator	  has	  been	  documented	  in	  cell	  culture	  and	  adipose	  
tissue	  [11,	  45,	  65].	  	  Recent	  findings	  suggest	  hyper-­‐osmotic	  stress	  may	  increase	  GLUT4	  content	  at	  
the	  plasma	  membrane	  from	  various	  intracellular	  “pools”	  [19].	  	  	  
Li	  et	  al.	  reported	  that	  hyper-­‐osmotic	  stress	  induced	  GLUT4	  translocation	  from	  a	  “pool”	  
other	  than	  the	  insulin	  pool	  in	  L6	  myoblasts	  [45].	  	  This	  was	  evident	  when	  hyper-­‐osmolality	  was	  
insensitive	  to	  TeTx	  cleavage	  of	  VAMP2.	  	  Recall	  that	  VAMP2,	  a	  v-­‐SNARE	  is	  functionally	  required	  
for	  the	  majority	  (~70%)	  of	  insulin-­‐stimulated	  glucose	  uptake	  (see	  GLUT4	  recycling).	  	  Therefore,	  it	  
is	  possible	  that	  osmotically	  induced	  GLUT4	  translocation	  draws	  from	  another	  pool,	  or	  another	  
mechanism	  is	  utilized	  by	  hyper-­‐osmolality	  to	  maintain	  GLUT4	  at	  the	  plasma	  membrane.	  	  In	  2000,	  
Randhawa	  et	  al.	  reported	  that	  hyper-­‐osmotic	  stress	  recruited	  GLUT4	  using	  a	  TeTx	  insensitive,	  v-­‐
SNARE,	  T1-­‐VAMP	  [60].	  	  In	  this	  investigation,	  myoblasts	  were	  transiently	  infected	  with	  small	  
interfering	  RNA	  for	  VAMP1	  (T1-­‐VAMP	  siRNA).	  This	  intervention	  lead	  to	  a	  robust	  reduction	  in	  the	  
concentration	  of	  membrane-­‐bound	  GLUT4	  vesicles	  in	  response	  to	  hyper-­‐tonicity,	  however,	  only	  
a	  partial	  reduction	  was	  observed	  during	  insulin	  stimulation	  [60].	  	  	  	  The	  authors	  then	  concluded	  
that	  insulin	  and	  hyper-­‐tonicity	  recruit	  GLUT4	  from	  distinct	  pools	  that	  require	  VAMP2	  and	  T1-­‐
VAMP,	  respectively	  [28,	  45,	  60].	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Figure	  6:	  Proposed	  signaling	  cascade	  for	  calcium	  activated	  proteins	  on	  increasing	  
glucose	  uptake	  (Adapted	  from	  Santos	  2008)	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In	  cell	  culture,	  Li	  et	  al.	  reported	  that	  hyper-­‐osmolarity	  increased	  GLUT4	  concentration	  at	  
the	  cell	  membrane	  by	  abolishing	  GLUT4	  internalization	  [45].	  	  Interestingly,	  K+	  depletion	  is	  one	  
technique	  known	  to	  prevent	  GLUT4	  endocytosis	  possibly	  in	  a	  manner	  similar	  to	  what	  has	  been	  
observed	  with	  hyper	  osmotic	  stress.	  	  K+	  depletion	  interferes	  with	  clathrin	  lattices	  at	  the	  plasma	  
membrane	  thereby	  inhibiting	  clathrin	  mediated	  endocytosis	  [29].	  	  Therefore,	  the	  concentration	  
of	  surface	  GLUT4	  should	  be	  similar	  when	  comparing	  hyper-­‐osmotic	  stress	  with	  K+	  depletion	  [29,	  
45].	  	  	  	  Li	  et	  al.	  were	  able	  to	  compare	  the	  two	  processes	  by	  first	  measuring	  GLUT4myc	  traffic	  in	  a	  
60	  minute	  incubation	  period	  in	  a	  hyper-­‐osmotic	  environment.	  	  During	  the	  60	  minutes	  GLUT4myc	  
was	  maintained	  on	  the	  cell	  surface	  while	  K+	  concentrations	  diminished.	  	  The	  myotubes	  were	  
then	  removed	  from	  the	  hyper-­‐osmotic	  environment	  and	  placed	  in	  a	  K+	  free,	  iso-­‐osmotic	  buffer	  
for	  30	  minutes.	  	  The	  authors	  reported	  that	  GLUT4myc	  remained	  on	  the	  surface	  despite	  the	  iso-­‐
osmotic	  environment.	  	  A	  comparative	  experiment	  was	  also	  performed	  and	  found	  that	  removal	  
from	  the	  hyper-­‐osmotic	  environment	  into	  a	  K+	  containing	  medium	  significantly	  restored	  
GLUT4myc	  internalization	  [45].	  	  These	  results	  strongly	  suggest	  that	  hyper-­‐osmolality	  and	  K+	  
depletion	  can	  increase	  GLUT4	  accumulation	  at	  the	  cell	  surface.	  	  	  
Osmotic	  stress	  can	  also	  stimulate	  a	  rise	  in	  glucose	  uptake	  through	  increased	  activation	  
of	  the	  exocytotic	  arm.	  	  It	  is	  hypothesized	  that	  this	  mechanism	  is	  largely	  independent	  of	  IRS1	  and	  
PI3-­‐K,	  due	  to	  insensitivity	  to	  wortmannin	  in	  both	  adipocytes	  and	  muscle	  cell	  culture	  [28].	  	  The	  
mechanisms	  regulating	  the	  response	  to	  osmotic	  stress	  in	  skeletal	  muscle	  have	  yet	  to	  be	  fully	  
understood,	  however,	  osmotic	  stress	  and	  insulin	  are	  hypothesized	  to	  stimulate	  GLUT4	  
exocytosis	  through	  diverse	  signaling	  pathways	  in	  all	  tissue	  types	  [11,	  45,	  60,	  65].	  	  In	  fact,	  it	  has	  
been	  documented	  in	  cell	  culture	  that	  insulin	  and	  hyper-­‐osmotic	  stress	  produce	  partially	  additive	  
gains	  in	  glucose	  uptake	  [45].	  	  However,	  the	  order	  of	  stimulation	  appears	  to	  have	  a	  profound	  
effect	  on	  the	  resulting	  glucose	  uptake.	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Li	  et	  al.	  demonstrated	  that	  insulin	  treatment	  followed	  by	  osmotic	  stress	  increased	  
sarcolemmal	  GLUT4	  concentrations	  by	  three-­‐fold	  compare	  to	  basal	  levels.	  	  Conversely,	  when	  
insulin	  treatment	  follows	  osmotic	  stress,	  only	  a	  two-­‐fold	  increase	  is	  seen	  in	  membrane	  GLUT4	  
concentrations	  [45].	  	  These	  results	  support	  a	  previously	  reported	  concept	  in	  which	  hyper-­‐
osmolality	  leads	  to	  cellular	  insulin	  resistance	  [11,	  28,	  45].	  	  Using	  3T3-­‐L1	  cell	  culture,	  Chen	  et	  al.	  
have	  documented	  that	  osmotic	  shock	  inhibited	  insulin	  signaling	  by	  maintaining	  Akt	  in	  its	  
dephosphorylated	  state,	  while	  increasing	  serine	  phosphorylation	  on	  IRS-­‐1	  [11,	  28].	  	  During	  
insulin	  stimulation,	  IRS-­‐1	  is	  phosphorylated	  on	  its	  tyrosine	  residues,	  leading	  to	  its	  activation.	  	  
Serine	  phosphorylation	  is	  known	  to	  inhibit	  IRS-­‐1	  function,	  therefore	  preventing	  insulin-­‐
stimulated	  glucose	  uptake	  [28].	  	  Therefore,	  osmotic	  stress	  may	  lead	  to	  decreases	  in	  insulin	  
stimulated	  glucose	  uptake	  through	  inhibition	  of	  IRS-­‐1	  and	  Akt.	  
Further	  work	  has	  investigated	  the	  interaction	  of	  osmotic	  stress	  with	  other	  components	  
of	  the	  insulin	  signaling	  pathway.	  	  Thong	  et	  al.	  used	  L6	  cell	  culture	  with	  point	  mutations	  at	  AS160	  
(RK-­‐AS160;	  GAP	  activating	  protein	  is	  inactive)	  to	  investigate	  the	  relationship	  between	  insulin	  and	  
osmotically	  induced	  glucose	  uptake.	  	  It	  was	  reported	  that	  insulin	  and	  osmotically	  induced	  GLUT4	  
translocation	  were	  not	  affected	  by	  the	  point	  mutations	  [76].	  	  This	  suggests	  that	  AS160	  is	  not	  
essential	  in	  insulin	  and	  osmotically	  induced	  GLUT4	  translocation.	  	  Within	  the	  same	  study,	  Thong	  
et	  al.	  examined	  AS160	  phosphorylation	  in	  cultured	  Chinese	  hamster	  ovary	  cells	  with	  over	  
expressed	  insulin	  receptors	  (CHO-­‐IR)	  under	  hyper-­‐osmolar	  sucrose	  stimulation.	  	  The	  authors	  
reported	  a	  significant	  increase	  in	  AS160	  phosphorylation	  following	  a	  30	  minutes	  hyper-­‐osmotic	  
perturbation	  (0.45M	  sucrose)	  [76].	  	  Combined,	  these	  results	  possibly	  suggest	  that	  the	  
involvement	  of	  AS160	  in	  osmotically	  induced	  glucose	  transport	  may	  be	  tissue	  dependent.	  
Another	  possibility	  is	  that	  AS160	  phosphorylation	  is	  active	  under	  hyper-­‐osmotic	  stress	  but	  may	  
not	  be	  essential	  for	  GLUT4	  translocation.	  	  	  All	  in	  all,	  the	  current	  literature	  suggests	  that	  osmotic	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stress	  stimulates	  glucose	  uptake	  independently	  of	  IRS-­‐1,	  PI3-­‐K	  and	  Akt	  in	  adipocytes	  and	  muscle	  
cell	  culture;	  while	  the	  possible	  involvement	  of	  AS160	  remains	  unclear.	  	  Figure	  7	  illustrates	  
possible	  signaling	  mechanisms	  that	  are	  proposed	  to	  stimulate	  or	  suppress	  GLUT4	  translocation	  
with	  osmotic	  stress.	  
In	  much	  of	  the	  current	  literature,	  hyper-­‐osmotic	  conditions	  are	  induced	  through	  the	  
addition	  of	  a	  pharmaceutical	  sugar	  alcohol	  agent,	  sorbitol,	  to	  the	  media.	  	  It	  has	  been	  
demonstrated	  that	  muscle	  cells	  in	  culture,	  treated	  with	  sorbitol	  (hyper-­‐osmotic	  condition;	  
600mmol/L),	  results	  in	  the	  activation	  of	  AMPK	  [22].	  	  In	  turn,	  sorbitol	  induced	  activation	  of	  AMPK	  
is	  thought	  to	  stimulate	  glucose	  uptake.	  	  This	  was	  further	  supported	  when	  over	  expression	  of	  a	  
dominant-­‐negative	  form	  of	  AMPK	  inhibited	  sorbitol	  induced	  glucose	  uptake	  [21,	  28].	  	  Recall	  that	  
AMPK	  is	  a	  very	  common	  signaling	  protein	  involved	  when	  the	  energy	  status	  of	  the	  cell	  is	  
compromised.	  	  During	  hyper-­‐osmotic	  stress,	  RVI	  increases	  the	  energy	  demand	  of	  the	  cell	  and	  it	  
is	  hypothesized	  that	  AMPK	  would	  be	  active	  under	  such	  stresses	  in	  skeletal	  muscle.	  	  However,	  
limited	  literature	  exists	  on	  the	  role	  of	  AMPK	  in	  glucose	  uptake.	  
Signaling	  downstream	  of	  AMPK	  is	  still	  unclear	  (in	  cell	  culture	  and	  whole	  muscle)	  and	  two	  
different	  pathways	  have	  been	  proposed.	  	  Fryer	  and	  Jessen	  have	  both	  suggested	  an	  important	  
role	  for	  nitric	  oxide	  (NO)	  and	  nitric	  oxide	  synthase	  (NOS)	  in	  sorbitol	  induced	  glucose	  uptake	  [22,	  
36].	  	  Theoretically,	  the	  activation	  of	  AMPK	  phosphorylates	  NOS	  thereby	  increasing	  NO	  
production.	  	  Subsequently,	  NO	  activates	  the	  soluble	  form	  of	  guanylate	  cyclase,	  producing	  the	  
second	  messenger	  cyclic	  guanosine	  monophosphate	  (cGMP).	  	  The	  exact	  mechanisms	  
downstream	  of	  cGMP	  are	  largely	  unknown	  and	  require	  further	  research,	  however;	  the	  end	  
result	  is	  thought	  to	  be	  increased	  GLUT4	  translocation	  to	  the	  plasma	  membrane	  [22,	  48].	  	  Using	  
H-­‐2b	  cell	  lines,	  Fryer	  et	  al.	  successfully	  demonstrated	  that	  inhibition	  of	  either	  NOS	  or	  guanylate	  	  




Figure	  7:	  	  Illustrates	  the	  proposed	  pathways	  of	  signaling	  stimulators.	  	  Double	  
circled	  proteins	  (AS160,	  AMPK,	  cPKC,	  ERK)	  are	  hypothesized	  to	  be	  
phosphorylated	  under	  hyper-­‐osmotic	  stress.	  	  Proteins	  in	  a	  dashed	  circle	  (Akt)	  
are	  hypothesized	  to	  be	  less	  phosphorylated	  under	  hyper-­‐osmotic	  stress.	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cyclase	  significantly	  reduced	  glucose	  uptake	  stimulated	  by	  either	  AICAR	  or	  hyper-­‐osmotic	  stress	  
(600mmol/L	  of	  sorbitol)	  [22].	  	  
Another	  mechanism	  proposed	  to	  be	  downstream	  of	  AMPK	  during	  osmotically	  induced	  
glucose	  uptake	  in	  adipocytes	  involves	  the	  activation	  of	  extracellular	  related	  kinase	  (ERK)	  [65].	  	  
Sajan	  et	  al.	  suggest	  that	  the	  activation	  of	  AMPK	  promotes	  the	  activation	  of	  non-­‐receptor	  
proline-­‐rich	  tyrosine	  kinase-­‐2	  (PYK-­‐2)	  leading	  to	  the	  activation	  of	  the	  RAS/ERK	  pathway	  [28,	  65].	  
The	  ERK	  pathway	  theoretically	  activates	  phospholipase	  D	  (PLD)	  leading	  to	  the	  stimulation	  of	  
aPKC,	  resulting	  in	  increased	  glucose	  uptake	  [28,	  65].	  	  Indirectly,	  ERK	  activation	  has	  been	  
observed	  in	  skeletal	  muscle	  with	  hyper-­‐osmotic	  stress	  [88].	  	  Hyper-­‐osmotic	  stress	  normally	  leads	  
to	  the	  activation	  of	  the	  NKCC,	  however	  when	  they	  introduced	  an	  inhibitor	  of	  the	  ERK	  pathway,	  
the	  activation	  of	  the	  NKCC	  was	  reduced,	  suggesting	  that	  hyper-­‐osmotic	  stress	  leads	  to	  activation	  
of	  the	  ERK	  pathway	  in	  muscle	  cell	  culture.	  	  Taken	  together	  is	  possible	  that	  the	  ERK	  pathway	  
could	  be	  involved	  in	  osmotic	  stress	  induced	  glucose	  uptake,	  however,	  to	  date	  there	  has	  been	  no	  
research	  investigating	  this	  possibility	  in	  skeletal	  muscle.	  	  	  	  	  
It	  has	  been	  suggested	  that	  mitochondrial	  uncoupling	  can	  also	  activate	  cPKC	  (via	  
increased	  cytoplasmic	  calcium	  concentrations)	  and	  result	  in	  rapid	  glucose	  uptake	  in	  L6	  cell	  
culture	  giving	  further	  support	  of	  the	  involvement	  of	  calcium	  as	  a	  second	  messenger	  [38].	  	  
Mitochondrial	  uncoupling,	  via	  DNP,	  provokes	  a	  rise	  in	  intracellular	  calcium,	  subsequently	  
activating	  cPKC	  through	  its	  calcium	  regulatory	  domain	  in	  muscle	  cells	  [38].	  	  Therefore,	  during	  
this	  investigation,	  cPKC	  is	  hypothesized	  to	  be	  involved	  in	  a	  signaling	  cascade	  responsible	  for	  
stimulating	  glucose	  uptake.	  	  Khayat	  et	  al.	  reported	  that	  chelation	  of	  calcium	  inhibits	  78%	  of	  DNP	  
induced	  glucose	  uptake	  [38].	  	  The	  mechanism	  responsible	  is	  wortmannin	  insensitive,	  therefore	  it	  
is	  also	  independent	  from	  the	  insulin	  cascade.	  	  Furthermore,	  treatment	  to	  inhibit	  cPKC	  activation,	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decreased	  DNP	  stimulated	  glucose	  uptake	  by	  50%,	  and	  did	  not	  affect	  insulin	  stimulated	  glucose	  
uptake	  [38].	  	  Taken	  together,	  cPKC	  activation	  is	  likely	  to	  be	  partially	  responsible	  for	  observed	  
increases	  in	  glucose	  uptake	  under	  what	  appears	  to	  be	  calcium	  mediated	  DNP	  stimulation.	  	  As	  
mentioned	  previously,	  hyper-­‐osmotic	  stress	  has	  recently	  been	  observed	  to	  cause	  uncontrolled	  
calcium	  sparks	  in	  skeletal	  muscle	  cells	  [5,	  81].	  	  When	  combined	  with	  Khayat’s	  research,	  this	  
presents	  the	  possibility	  that	  osmotically	  stimulated	  calcium	  sparks	  could	  also	  activate	  cPKC,	  
which	  turn	  could	  increases	  glucose	  uptake.	  	  	  This	  concept	  is	  supported	  by	  observations	  made	  in	  
L6	  cell	  culture,	  where	  calcium	  chelation	  and	  cPKC	  inhibition	  significantly	  reduced	  cell	  surface	  
GLUT4	  content,	  but	  had	  no	  effect	  on	  AMPK	  activity	  [54].	  	  	  	  	  	  
Research	  has	  also	  shown	  hyper-­‐osmotic	  stress	  to	  increase	  the	  activity	  of	  the	  exocytosis	  
of	  GLUT4.	  	  Exocytosis	  in	  cell	  culture	  seems	  to	  be	  largely	  dependent	  on	  AMPK,	  ERK,	  cPKC	  and	  
NOS	  during	  hyper-­‐osmotic	  stress,	  while	  activation	  of	  Akt,	  IRS1	  and	  PI3-­‐K	  are	  thought	  to	  be	  
independent	  of	  osmotically	  induced	  glucose	  uptake.	  	  AS160’s	  involvement	  in	  osmotically	  
stimulated	  glucose	  uptake	  is	  largely	  unknown	  in	  all	  tissues.	  	  The	  vast	  majority	  of	  research	  done	  
to	  date,	  has	  been	  reported	  with	  either	  adipocytes	  or	  muscle	  cell	  culture.	  	  As	  such,	  the	  
involvement	  of	  AMPK,	  ERK,	  cPKC,	  AS160	  and	  Akt	  are	  not	  well	  understood	  in	  whole,	  intact	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5.	  Statement	  of	  the	  Problem	  
5.1	  Statement	  of	  the	  Problem	  
	   Currently,	  it	  is	  accepted	  that	  skeletal	  muscle	  glucose	  metabolism	  is	  altered	  in	  response	  
to	  aniso-­‐osmotic	  environments	  [19].	  	  Glucose	  uptake	  is	  significantly	  increased	  in	  muscles	  
exposed	  to	  hyper-­‐osmotic	  stress	  when	  compared	  to	  muscles	  exposed	  to	  iso-­‐osmotic	  conditions	  
and	  hypo-­‐osmotic	  stress	  [19].	  	  The	  signaling	  mechanisms	  responsible	  for	  increased	  glucose	  
uptake	  under	  hyper-­‐osmotic	  stress	  are	  not	  fully	  understood.	  	  Akt,	  AMPK	  and	  ERK	  are	  common	  
proteins	  involved	  in	  several	  essential	  cellular	  processes	  including	  insulin	  mediated	  glucose	  
uptake	  (Akt),	  cell	  proliferation	  (Akt,	  Erk),	  contraction	  mediated	  glucose	  uptake	  (AMPK)	  and	  
energy	  regulation	  (AMPK).	  	  cPKC	  is	  hypothesized	  to	  be	  activated	  by	  free	  cytoplasmic	  calcium	  and	  
appears	  to	  contribute	  to	  GLUT4	  translocation	  to	  the	  cell	  surface	  [76].	  	  Lastly,	  the	  
phosphorylation	  of	  AS160	  is	  directly	  involved	  with	  both	  insulin	  and	  contraction	  mediated	  
glucose	  uptake,	  therefore	  its	  role	  in	  osmotically	  glucose	  uptake	  warrants	  investigation.	  	  Osmotic	  
stress	  is	  a	  complicated	  metabolic	  stress	  for	  skeletal	  muscle,	  and	  as	  such	  multiple	  signalling	  
cascades	  appear	  to	  be	  involved.	  	  Akt,	  Erk,	  AMPK,	  cPKC	  and	  AS160	  have	  all	  been	  observed	  to	  
have	  a	  potential	  role	  in	  the	  signalling	  responses	  to	  osmotic	  stress	  in	  various	  cell	  types,	  yet	  there	  
has	  very	  limited	  characterization	  of	  these	  signalling	  processes	  during	  osmotic	  stress	  in	  whole	  
skeletal	  muscle	  tissue.	  	  	  
5.2	  Purpose	  
	   AMPK,	  Akt,	  AS160,	  cPKC	  and	  ERK	  MAPK	  are	  common	  proteins	  in	  the	  insulin	  and	  
contraction	  signaling	  pathways,	  however	  their	  involvement	  in	  hyper	  osmotically	  induced	  glucose	  
uptake	  remains	  unclear	  in	  intact	  whole	  muscle	  tissue.	  The	  purpose	  of	  this	  investigation	  is	  to	  
investigate	  the	  phosphorylation	  states	  of	  these	  signaling	  proteins	  during	  1	  hour	  of	  hyper-­‐
osmotic	  stress	  in	  isolated	  rat	  skeletal	  (EDL)	  muscle.	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5.3	  Hypothesis	  	  
	   It	  is	  hypothesized	  that	  under	  hyper-­‐osmotic	  stress,	  AMPK,	  cPKC	  and	  ERK	  will	  be	  
relatively	  more	  active	  at	  the	  earlier	  time	  points	  when	  compared	  to	  muscles	  in	  an	  iso-­‐osmotic	  
environment	  at	  the	  same	  time	  points.	  	  The	  active	  forms	  of	  AMPK,	  cPKC	  and	  ERK	  are	  equivalent	  
to	  the	  phosphorylated	  form	  of	  the	  proteins.	  	  In	  accordance	  with	  previous	  literature,	  Akt	  and	  
AS160	  are	  expected	  to	  be	  found	  in	  their	  non-­‐active	  state.	  	  Therefore,	  it	  is	  hypothesized	  that	  the	  
phosphorylation	  state	  of	  Akt	  under	  hyper-­‐osmotic	  stress	  will	  be	  similar	  when	  compared	  to	  the	  
iso-­‐osmotic	  environment.	  	  On	  the	  other	  hand,	  decreasing	  AS160	  activity	  is	  achieved	  through	  the	  
phosphorylation	  of	  the	  protein,	  therefore	  it	  is	  hypothesized	  that	  under	  hyper-­‐osmotic	  stress,	  
AS160	  phosphorylation	  will	  be	  increased	  as	  compare	  to	  muscles	  in	  an	  iso-­‐osmotic	  environment	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6.	  Methodology	  	  
6.1	  Animals	  
	   A	  total	  of	  thirty-­‐three	  male	  Long	  Evan	  rats	  (Charles	  River	  Laboratories,	  St.	  Constant,	  QC)	  
were	  used	  for	  this	  investigation.	  Young	  rats	  (30.7	  ±	  3.7	  days	  old;	  128.6	  ±	  21.7g)	  were	  used	  to	  
ensure	  shorter	  diffusion	  distances	  within	  the	  incubated	  muscles	  due	  to	  the	  smaller	  muscle	  size	  
in	  the	  animals.	  	  All	  animals	  were	  housed	  within	  Brock	  University’s	  Animal	  Care	  Facility	  with	  4-­‐6	  
rats	  per	  cage.	  	  All	  animals	  had	  ad	  libitum	  access	  to	  both	  food	  and	  water	  (5012	  rat	  diet,	  PMI	  
Nutrition	  Inc.	  Brentwood,	  MO)	  prior	  to	  experiments.	  	  Furthermore,	  the	  animals	  operated	  on	  a	  
12:12	  hour	  light-­‐dark	  cycle	  at	  a	  constant	  ambient	  temperature	  of	  22°C.	  	  All	  procedures	  were	  
approved	  by	  the	  Brock	  University	  Animal	  Care	  and	  Use	  Committee	  (ACUC)	  and	  conformed	  to	  the	  
Canadian	  Council	  on	  Animal	  Care	  (CCAC)	  guidelines.	  
6.2	  Osmotic	  Conditions	  
	   The	  model	  used	  in	  this	  study	  had	  been	  previously	  validated	  by	  Antolic	  et	  al	  [2].	  	  Briefly,	  
isolated	  whole	  rat	  muscle	  were	  incubated	  in	  a	  tissue	  bath	  and	  submerged	  in	  a	  medium	  (Sigma	  
medium	  199	  Sigma	  Aldrich	  St.	  Louis	  MO,	  USA;	  M4530;	  Appendix	  I)	  designed	  to	  preserve	  
physiological	  conditions	  of	  ECF.	  	  The	  incubation	  medium	  was	  continually	  perfused	  with	  a	  gas	  
mixture	  of	  95%-­‐O2-­‐5%-­‐CO2	  and	  temperature	  was	  maintained	  at	  30	  ±2°C.	  	  Within	  the	  bath,	  each	  
muscle	  was	  resting	  under	  1	  gram	  of	  tension.	  	  Based	  on	  previous	  literature,	  8mM	  of	  extracellular	  
glucose	  induces	  half	  maximal	  rate	  of	  glucose	  uptake	  in	  rat	  skeletal	  muscle	  [56,	  85].	  	  Thus	  to	  
achieve	  optimal	  rate	  of	  glucose	  uptake,	  D-­‐glucose	  (Sigma	  Aldrich	  St.	  Louis,	  MO,	  USA;	  G-­‐8270)	  
was	  added	  to	  elevate	  the	  glucose	  concentration	  of	  the	  Sigma	  medium	  (ECF)	  from	  5mM	  to	  8mM.	  	  
The	  medium	  was	  further	  manipulated	  with	  mannitol	  (Sigma-­‐Aldrich	  St.	  Louis,	  MO,	  USA;	  M-­‐9546;	  
Appendix	  II)	  to	  create	  two	  extracellular	  environments:	  an	  iso-­‐osmotic	  environment	  (ISO;	  290	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±10	  mmol/kg),	  and	  a	  hyper-­‐osmotic	  environment	  (HYPER;	  400	  ±10	  mmol/kg).	  	  Osmolality	  of	  
each	  solution	  was	  validated	  using	  a	  VAPRO	  pressure	  osmometer	  (VAPRO5520,	  Westcor,	  Logan,	  
UT).	  	  	  	  
6.3	  Muscle	  Extraction	  
Prior	  to	  the	  surgical	  procedure,	  rats	  were	  anaesthetized	  with	  sodium	  pentobarbital	  
(55mg/kg)	  via	  interperoneal	  (IP)	  injection.	  	  Once	  the	  animal	  became	  unresponsive	  to	  physical	  
stimuli	  muscle	  extraction	  began	  by	  removing	  the	  skin	  from	  the	  distal	  hindlimb.	  	  A	  small	  incision	  
between	  the	  lateral	  patella	  to	  the	  lateral	  malleolus	  was	  made	  to	  separate	  the	  fascia	  of	  the	  
superficial	  muscle	  groups,	  thereby	  exposing	  the	  deeper	  muscles	  of	  the	  hindlimb.	  	  Once	  the	  EDL	  
was	  identified,	  sutures	  (4-­‐0	  Silk)	  were	  fastened	  at	  each	  tendon	  in	  situ,	  and	  the	  muscles	  were	  
then	  excised.	  	  Sutures	  were	  used	  to	  secure	  muscles	  to	  the	  organ	  bath	  (Radnoti	  Glass	  Technology	  
Inc.,	  Monrovia,	  CA)	  containing	  approximately	  15	  ml	  of	  the	  Sigma	  media.	  	  The	  EDL	  was	  hung	  from	  
a	  force	  transducer	  (Grass	  Telefactor,	  West	  Warwick,	  RI)	  and	  randomly	  placed	  in	  one	  of	  two	  
conditions:	  ISO	  and	  HYPER	  (Figure	  9).	  	  Within	  the	  ISO	  and	  HYPER	  groups,	  muscles	  were	  
incubated	  for	  30,	  45	  or	  60	  minutes	  (n=10	  per	  group).	  	  Following	  incubations,	  each	  muscle	  was	  
flash	  frozen	  in	  liquid	  nitrogen	  and	  stored	  at	  -­‐80°C	  for	  subsequent	  analysis	  (Figure	  9).	  A	  group	  of	  
five	  non-­‐incubated	  muscles	  (NON)	  were	  excised	  and	  immediately	  flash	  frozen	  in	  liquid	  nitrogen	  
and	  stored	  at	  -­‐80°C	  and	  later	  used	  for	  metabolite	  analysis.	  	  EDL	  muscles	  were	  strategically	  
excised	  when	  rats	  were	  approximately	  29-­‐30	  days	  old.	  	  This	  coincided	  with	  body	  masses	  of	  
~110-­‐140g	  and	  this	  served	  two	  purposes.	  	  Firstly,	  at	  about	  30	  days	  old,	  muscle	  fibre	  types	  were	  
fully	  matured	  and	  differentiation	  between	  slow	  and	  fast	  twitch	  muscle	  was	  ensured	  [14].	  
	  
	  








Figure	  8:	  A	  breakdown	  of	  the	  experimental	  groups,	  
N	  =	  single	  EDL	  muscle.	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6.4	  Metabolite	  Analysis	  
Adenosine	  triphosphate	  (ATP)	  and	  phosphocreatine	  (PCr)	  were	  measured	  to	  verify	  the	  
viability	  of	  the	  muscle	  incubations.	  	  Small	  pieces	  of	  muscles	  from	  three	  samples	  per	  time	  group	  
were	  randomly	  selected	  for	  metabolite	  analysis.	  	  Approximately	  half	  of	  each	  muscle	  sample	  was	  
chipped	  off	  and	  lyophilized	  for	  ~18	  hours.	  	  Each	  sample	  was	  then	  powdered	  and	  any	  visible	  
connective	  tissue	  or	  blood	  was	  removed.	  	  Metabolites	  were	  then	  extracted	  using	  0.5M	  
perchloric	  acid	  and	  later	  neutralized	  with	  potassium	  bicarbonate.	  	  Enzymes	  such	  as	  G-­‐6-­‐P	  
dehydrogenase,	  HK	  and	  creatine	  kinase	  were	  added	  to	  samples	  along	  with	  excess	  substrates	  to	  
create	  environments	  where	  ATP	  and	  PCr	  were	  limiting	  substrates.	  	  ATP	  and	  PCr	  concentrations	  
were	  indirectly	  measured	  through	  fluorescence	  of	  nicotinamide	  adenine	  dinucleotide	  phosphate	  
(NADPH).	  	  Fluorometric	  techniques	  originated	  from	  Harris	  et	  al.	  [30],	  were	  modified	  by	  Green	  et	  
al.	  [27]	  and	  further	  adapted	  in	  our	  lab	  by	  Antolic	  et	  al.	  [2].	  	  Detailed	  methods	  can	  be	  found	  in	  
Appendix	  III.	  	  	  	  
6.5	  Protein	  Quantification:	  Western	  Blotting	  	  
Frozen	  muscles	  were	  homogenized	  by	  hand	  in	  an	  ice-­‐cold	  lysis	  buffer	  (~14	  µl⋅mg-­‐1	  wet	  
wt);	  250mM	  sucrose;	  100mM	  KCl;	  5mM	  EDTA;	  pH	  6.8)	  along	  with	  a	  protease	  and	  phosphatase	  
inhibitor	  solution	  (Roche	  Diagnostics,	  Mannheim,	  Germany).	  	  Once	  homogenized,	  samples	  were	  
centrifuged	  at	  1200g	  for	  10	  minutes	  at	  4°C.	  	  Total	  protein	  concentration	  of	  the	  supernatant	  was	  
determined	  by	  Bradford	  assay	  (Bio-­‐Rad	  Laboratories,	  CA,	  USA).	  	  All	  samples	  were	  diluted	  to	  a	  
standard	  concentration	  of	  1	  µg⋅µl-­‐1	  with	  a	  Laemmli	  buffer	  containing	  β-­‐mercaptoethanol.	  	  
Samples	  were	  then	  denatured	  in	  boiling	  water	  for	  5	  minutes	  and	  immediately	  cooled	  in	  crushed	  
ice	  for	  an	  additional	  5	  minutes.	  	  Proteins	  were	  separated	  using	  sodium	  dodecyl	  sulphate	  
polyacrylamide	  gel	  electrophoresis	  (SDS-­‐PAGE)	  on	  an	  8-­‐10%	  gradient	  gel	  for	  90	  minutes	  at	  120V.	  	  
Subsequently,	  the	  proteins	  were	  transferred	  on	  to	  either	  polyvinylidene	  fluoride	  (PVDF;	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Millipore	  Bedford,	  MA,	  USA;	  IPVH00010;	  Pore	  size:	  0.45µm)	  or	  nitrocellulose	  (Bio-­‐Rad	  
Laboratories,	  CA,	  USA;	  162-­‐0115;	  Pore	  size:	  0.45µm)	  membranes	  at	  100V	  for	  90	  minutes.	  
Membranes	  were	  blocked	  in	  either	  BSA	  (bovine	  serum	  albumin)	  solution	  or	  milk-­‐TBST	  (tris-­‐
buffered	  saline	  with	  0.1%	  Tween-­‐20;	  Sigma	  Aldrich,	  St	  Louis,	  MO,	  USA)	  solution	  at	  room	  
temperature	  for	  60	  minutes.	  	  The	  membranes	  were	  then	  washed	  5	  times	  for	  5	  minutes	  each	  to	  
ensure	  a	  low	  background	  and	  clean	  signal.	  	  Each	  membrane	  was	  cut	  just	  above	  42	  kDa	  and	  
treated	  as	  two	  different	  membranes.	  	  The	  bottom	  half	  was	  used	  to	  blot	  for	  actin	  (the	  
housekeeping	  protein	  used	  to	  normalize	  within	  membrane	  variance	  and	  the	  denominator	  when	  
comparing	  treatment)	  and	  the	  top	  half	  was	  used	  to	  blot	  for	  the	  protein	  of	  interest.	  	  Primary	  
antibodies	  were	  incubated	  (in	  various	  concentrations;	  see	  Appendix	  V)	  with	  either	  a	  5%	  BSA	  or	  
milk-­‐TBST	  solution	  and	  agitated	  overnight	  at	  4°C.	  	  Following	  another	  5x5	  minute	  wash,	  
membranes	  were	  incubated	  in	  either	  an	  anti-­‐rabbit	  or	  anti-­‐mouse	  IgG	  horseradish	  peroxidase-­‐
conjugated	  secondary	  antibody	  (Cell	  Signaling,	  Danvers,	  MA	  USA;	  7074)	  in	  room	  temperature	  for	  
60	  minutes.	  	  Lastly,	  membranes	  were	  visualized	  by	  Chemiluminescent	  Substrate	  (Alpha	  
Innotech,	  San	  Leandro,	  CA;	  60-­‐12596-­‐00)	  and	  quantified	  using	  “Image	  J”	  software	  	  (National	  
Institute	  of	  Mental	  Health,	  Bethesda,	  MD).	  	  Relative	  phophorylation	  was	  presented	  as	  a	  ratio	  of	  
actin,	  and	  relative	  to	  ISO	  at	  30	  minutes	  for	  each	  membrane.	  	  Detailed	  Western	  Blotting	  
Protocols	  can	  be	  found	  in	  appendix	  V.	  	  	  	  	  
6.6	  Antibodies	  
Antibodies	  were	  purchased	  from	  the	  following	  sources	  (catalogue	  number	  in	  
parenthesis):	  phospho-­‐AMPK	  alpha	  (4188),	  Cell	  Signaling	  [Danvers,	  MA];	  phospho-­‐Akt	  [Thr208]	  
(2965),	  phospho-­‐p44/42	  MAPK	  [ERK1/2][Thr202/Tyr204](4370),	  Cell	  Signaling	  [Danvers,	  MA];	  
phospho-­‐AS160	  [pT642]	  (33-­‐1071G),	  Invitrogen/Biosource	  [Carlsbad,	  CA];	  phospho-­‐PKCα	  (06-­‐
822),	  Millipore	  [Billerica,	  MA]	  and	  anti-­‐actin	  (612656),	  BD	  Transduction	  Laboratories	  [Franklin	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Lakes,	  NJ].	  	  Secondary	  anti-­‐rabbit	  IGg,	  HRP-­‐linked	  (7074)	  was	  also	  purchased	  from	  Cell	  Signaling	  
[Danvers,	  MA].	  	  Secondary	  anti-­‐Mouse	  HRP-­‐linked	  (A-­‐4416)	  was	  purchased	  from	  Sigma	  Aldrich	  
[St.	  Louis,	  MO].	  	  	  	  
6.7	  Statistical	  Analysis	  
	   A	  two-­‐way	  analysis	  of	  variance	  (ANOVA)	  was	  utilized	  to	  determine	  phosphorylation	  
differences	  and	  metabolic	  concentrations.	  	  Osmotic	  condition	  (HYPER	  and	  ISO)	  and	  incubation	  
times	  (30,	  45	  and	  60	  minutes)	  were	  treated	  as	  independent	  variables.	  	  If	  the	  two-­‐way	  ANOVA	  
showed	  any	  significance	  (p<0.05),	  a	  Tukey	  HSD	  post-­‐hoc	  analysis	  was	  conducted	  to	  evaluate	  the	  
significance	  of	  pair	  wise	  differences.	  	  All	  statistical	  analyses	  were	  conducted	  using	  SigmaStat	  3.1	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7.	  Results	  	  
7.1	  General	  Observations	  
	   Rat	  weights	  and	  ages	  were	  not	  significantly	  different	  across	  all	  experimental	  groups.	  	  	  
7.2	  Metabolites	  
	  
PCr	  was	  significantly	  lower	  in	  HYPER	  compared	  to	  ISO	  group	  (main	  effect;	  Table	  2).	  	  PCr	  
in	  NON	  was	  not	  significantly	  different	  from	  ISO	  and	  HYPER.	  	  ATP	  concentrations	  within	  the	  EDL	  
muscles	  were	  not	  different	  among	  any	  of	  the	  three	  groups.	  	  
	  
Conditions	   	   [ATP]	   [PCr]	  
	  
ISO	  
30	   28.50	  ±	  15.4	   84.28	  ±	  30.0	  
45	   31.93	  ±	  4.6	   107.87	  ±	  5.2	  
60	   32.57	  ±	  6.1	   95.27	  ±	  28.2	  
	  
HYPER†	  
30	   31.09	  ±	  4.7	   52.75	  ± 	  10.8	  
45	   28.43	  ±	  4.2	   65.11	  ± 	  6.4	  
60	   29.81	  ±	  4.9	   86.64	  ± 	  30.4	  




Note:	  	  All	  values	  are	  derived	  from	  random	  EDL	  samples	  from	  each	  condition	  and	  are	  
expressed	  in	  mmolkg-­‐1	  dry	  wt.	  (mean	  ±	  SD)	  N=3	  for	  ISO	  and	  HYPER	  conditions.	  N=5	  
for	  NON	  conditions.	  	  ATP	  =	  adenosine	  triphosphate,	  PCr	  =	  phosphocreatine,	  ISO	  30	  =	  
iso-­‐osmotic	  condition	  incubated	  for	  30	  minutes.	  	  HYPER	  30	  =	  hyper-­‐osmotic	  
condition	  incubated	  for	  30	  minutes.	  	  NON	  =	  non-­‐incubated	  controls.	  †	  Significantly	  
different	  (p<0.05)	  from	  ISO	  (main	  effect).	  	  Bolding	  indicates	  the	  significance	  (†)	  
corresponds	  with	  those	  values.	  	  	  	  
Experimental	  Groups	   Whole	  Rat	  Weight	  (g)	   Rat	  Age	  (Days)	  
HYPER	   131.1	  ±	  20.6	   31.0	  ±	  3.8	  
ISO	   130.2	  ±	  20.7	   31.1	  ±	  3.7	  
NON	   109.9	  ±	  8.4	   27.2	  ±	  1.6	  
	  Note:	  	  All	  values	  are	  expressed	  as	  means	  ±	  SD.	  	  N	  =10	  for	  HYPER	  and	  ISO	  groups.	  	  N=5	  for	  
NON	  group.	  	  HYPER	  =	  Hype-­‐osmolality;	  ISO	  	  =	  Iso-­‐osmolality;	  NON	  =	  non-­‐incubated	  	  
Table	  1:	  Average	  Rat	  Weights	  
Table	  2:	  High	  Energy	  Phosphate	  Metabolite	  Concentrations	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7.3	  Time	  Course	  of	  Signaling	  Proteins	  	  
	   A	  preliminary	  pilot	  study	  was	  also	  conducted	  in	  our	  laboratory	  to	  investigate	  the	  time	  
course	  of	  phosphorylation	  states	  during	  hyper-­‐osmotic	  stimulation.	  	  	  	  The	  pilot	  study	  analyzed	  
the	  phosphorylation	  states	  of	  Akt,	  AMPK,	  AS160	  and	  ERK	  at	  15,	  30,	  45	  and	  60	  minutes	  of	  hyper-­‐
osmotic	  stress.	  Each	  lane	  was	  normalized	  to	  actin	  to	  control	  for	  loading	  variation.	  	  The	  results	  of	  
this	  limited	  pilot	  study	  demonstrated	  that	  Akt	  and	  AMPK	  seemed	  to	  reach	  peak	  phosphorylation	  
by	  30	  minutes,	  which	  was	  maintained	  through	  45	  minutes,	  and	  was	  followed	  by	  a	  rapid	  decline	  
by	  60	  minutes	  (Figure	  8).	  	  Correspondingly,	  ERK	  and	  AS160	  phosphorylation	  increased	  drastically	  
from	  15	  minutes	  and	  reached	  peak	  phosphorylation	  at	  45	  minutes	  (Figure	  8).	  Interestingly,	  
these	  pilot	  results	  suggested	  that	  Akt	  and	  AMPK	  may	  be	  involved	  near	  the	  proximal	  end	  of	  the	  
cascade	  while	  ERK	  and	  AS160	  are	  distal	  to	  Akt	  and	  AMPK.	  	  The	  results	  from	  this	  limited	  pilot	  
study	  supported	  what	  was	  found	  in	  the	  literature,	  that	  phosphorylation	  differences	  should	  be	  
detectable	  for	  all	  four	  proteins	  between	  30	  and	  60	  minutes	  of	  incubation	  with	  hyper-­‐osmotic	  
stress.	  	  Interestingly,	  previous	  work	  in	  our	  lab	  has	  also	  demonstrated	  significant	  increases	  in	  
glucose	  uptake	  with	  hyper-­‐osmotic	  stress	  during	  the	  same	  time	  frame	  (30	  to	  60	  minutes)	  
(unpublished	  thesis	  work)	  [19].	  	  Therefore,	  for	  this	  study	  we	  chose	  to	  investigate	  the	  
phosphorylation	  status	  of	  a	  number	  of	  signalling	  pathways	  potentially	  implicated	  in	  regulating	  

















Figure	  9:	  Results	  from	  a	  preliminary	  pilot	  study	  to	  determine	  an	  appropriate	  time	  
course	  to	  detect	  differences	  in	  phosphorylation	  in	  AMPK,	  Akt,	  ERK,	  and	  AS160.	  	  AMPK	  =	  
Adenosine	  monophosphate	  protein	  kinase,	  ERK	  =	  extracellular	  related	  kinase,	  AS160	  =	  
Akt	  substrate	  of	  160kDa.	  	  N=1	  per	  time	  point.	  
	   57	  
7.4	  Signaling	  Proteins	  	  
AS160	  showed	  a	  1.7	  fold	  increase	  in	  phosphorylation	  under	  HYPER	  stress	  when	  
compared	  to	  ISO	  condition	  at	  30	  minutes	  (p<0.01,	  Figure	  10).	  	  Interestingly,	  there	  was	  also	  a	  
trend	  for	  a	  main	  effect	  for	  condition	  (p=0.053),	  such	  that	  there	  was	  an	  increase	  in	  
phosphorylation	  for	  AS160	  in	  HYPER	  as	  compared	  to	  ISO.	  	  A	  main	  effect	  for	  time	  was	  also	  









Figure	  10:	  Phosphorylated	  AS160.	  	  Values	  are	  expressed	  as	  means	  ±	  SD.	  
N=9-­‐10	  per	  condition.	  	  HYPER	  =	  Hyper-­‐osmolality;	  ISO	  =	  Iso-­‐osmolality.	  	  *	  
Significant	  interaction	  difference	  (p<0.01).	  	  	  Phosphorylation	  at	  45	  minutes	  
was	  significantly	  higher	  than	  phosphorylation	  at	  60	  minutes	  (main	  effect;	  
p<0.01)	  	  









Phosphorylation	  of	  cPKC	  was	  significantly	  lower	  in	  HYPER	  compared	  to	  ISO	  at	  60	  
minutes	  of	  incubation	  (p<0.01,	  Figure	  11).	  	  A	  significant	  main	  effect	  for	  time	  was	  also	  found	  for	  
cPKC;	  phosphorylation	  at	  30	  minutes	  and	  45	  minutes	  were	  significantly	  higher	  than	  at	  60	  
minutes	  (p<0.001).	  	  
	  
	  
Figure	  11:	  Phosphorylated	  PKCα .	  	  Values	  are	  expressed	  as	  means	  ±	  SD.	  N=9-­‐10	  per	  
condition.	  	  HYPER	  =	  Hyper-­‐osmolality;	  ISO	  =	  Iso-­‐osmolality.	  	  *	  Significant	  interaction	  
difference	  (p<0.001).	  	  Phosphorylation	  at	  60	  minutes	  was	  significantly	  lower	  than	  
phosphorylation	  at	  30	  (Δ)	  and	  45	  minutes	  (✝)	  	  (p<0.001)	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No	  significant	  interactions	  were	  found	  for	  ERK	  phosphorylation	  across	  all	  time	  points	  
and	  conditions	  (Figure	  12).	  	  There	  was	  however,	  a	  significant	  main	  effect	  for	  time	  alone.	  	  
Phosphorylation	  at	  30	  minutes	  was	  significantly	  higher	  than	  45	  minutes	  when	  condition	  was	  not	  




















Akt	  phosphorylation	  (Figure	  13)	  demonstrated	  a	  slight	  trend	  for	  a	  main	  effect	  for	  
condition	  (p=0.075).	  	  Phosphorylation	  of	  HYPER	  trended	  higher	  than	  ISO	  when	  time	  was	  not	  
considered.	  	  	  	  No	  differences	  were	  revealed	  for	  AMPK	  across	  all	  time	  points	  and	  conditions	  




Figure	  12:	  Phosphorylated	  ERK.	  	  Values	  are	  expressed	  as	  means	  ±	  SD.	  N=7-­‐8	  per	  
condition.	  	  HYPER	  =	  Hyper-­‐osmolality;	  ISO	  =	  Iso-­‐osmolality.	  Phosphorylation	  at	  30	  
minutes	  was	  significantly	  higher	  than	  phosphorylation	  at	  45	  minutes	  (✝	  main	  
effect;	  p<0.05)	  
	  








	   Figure	  13:	  Phosphorylated	  Akt.	  	  Values	  are	  expressed	  as	  means	  ±	  SD.	  N=10	  
per	  condition.	  	  HYPER	  =	  Hyper-­‐osmolality;	  ISO	  =	  Iso-­‐osmolality.	  	  	  
	  








	   Lastly,	  expression	  of	  total	  Akt,	  AMPK,	  AS160	  and	  ERK	  were	  determined	  in	  a	  pilot	  study	  
(data	  not	  shown)	  conducted	  in	  our	  lab.	  	  Results	  demonstrated	  that	  total	  protein	  content	  did	  not	  
change	  over	  the	  entire	  osmotic	  perturbation	  of	  60	  minutes	  for	  any	  of	  the	  proteins	  and	  any	  of	  









Figure	  14:	  Phosphorylated	  AMPK.	  	  Values	  are	  expressed	  as	  means	  ±	  SD.	  
N=7-­‐8	  per	  condition.	  	  HYPER	  =	  Hyper-­‐osmolality;	  ISO	  =	  Iso-­‐osmolality.	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8.	  Discussion	  
The	  main	  finding	  of	  the	  current	  study	  was	  that	  AS160	  phosphorylation	  was	  increased	  
during	  the	  30	  and	  60	  minutes	  of	  hyper	  osmotic	  stress	  as	  compared	  to	  iso-­‐osmotic	  conditions.	  	  
Additionally,	  no	  changes	  in	  the	  phosphorylation	  states	  of;	  Akt,	  ERK,	  AMPK	  and	  cPKC	  were	  
observed	  with	  hyper	  osmotic	  stress	  as	  compared	  to	  iso-­‐osmotic	  control	  conditions.	  	  Finally,	  
hyper-­‐osmotic	  stress	  resulted	  in	  a	  significant	  decline	  in	  PCr,	  but	  no	  change	  in	  ATP.	  
8.1	  Metabolites	  
	   Metabolites	  were	  measured	  in	  all	  the	  experimental	  groups	  to	  ensure	  the	  viability	  of	  the	  
incubated	  muscles.	  	  Specifically,	  ATP	  and	  PCr	  content	  were	  measured	  from	  three	  random	  
samples	  from	  each	  of	  ISO	  and	  HYPER	  groups,	  as	  well	  as	  five	  non-­‐incubated	  (NON)	  muscles.	  	  
Theoretically,	  the	  NON	  group	  represented	  the	  high	  energy	  phosphagen	  content	  of	  muscle	  in	  
vivo,	  and	  the	  ISO	  group	  should	  have	  yielded	  a	  similar	  phosphagen	  content.	  	  In	  the	  current	  study,	  
values	  were	  not	  significantly	  different	  between	  the	  NON	  and	  ISO	  groups,	  indicating	  the	  
incubated	  muscles	  were	  viable	  and	  adequate	  oxygen	  diffused	  into	  the	  muscles	  during	  the	  
incubations	  (Table	  2).	  	  Furthermore,	  resting	  concentrations	  of	  ATP	  and	  PCr	  in	  skeletal	  muscle	  
were	  ~25	  mmol/kg	  and	  79	  mmol/kg	  of	  dry	  weight,	  respectively,	  and	  were	  similar	  to	  previously	  
reported	  values	  obtained	  using	  a	  similar	  model	  [1,	  57].	  	  The	  NON	  and	  ISO	  groups	  in	  the	  current	  
study	  matched	  the	  theoretical	  resting	  concentrations	  of	  both	  ATP	  and	  PCr.	  	  Lastly,	  PCr	  
concentrations	  in	  the	  HYPER	  group	  were	  found	  to	  be	  significantly	  lower	  than	  the	  ISO	  group	  
(Table	  2).	  	  Such	  declines	  in	  PCr	  concentrations	  are	  common	  during	  HYPER,	  and	  have	  been	  
attributed	  to	  increases	  in	  ATP	  turnover	  in	  response	  to	  the	  osmotic	  stress	  [2,	  19,	  51].	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8.2	  Glucose	  Signaling	  Summary	  
Figure	  15	  illustrates	  a	  hypothesized	  signaling	  scheme	  as	  a	  result	  of	  the	  current	  
observations.	  	  AS160	  is	  still	  hypothesized	  to	  be	  the	  convergence	  point	  for	  many	  stimulators	  and	  
is	  directly	  responsible	  for	  GLUT4	  translocation.	  	  It	  is	  encircled	  in	  a	  double	  oval,	  indicates	  that	  it	  is	  
involved	  in	  osmotically	  stimulated	  glucose	  uptake	  after	  30	  minutes	  of	  stimulation.	  	  All	  the	  
proteins	  encircled	  with	  a	  dashed	  oval,	  indicate	  that	  they	  appear	  not	  to	  be	  involved	  in	  
osmotically	  stimulated	  glucose	  uptake	  after	  30	  minutes	  of	  hyper-­‐osmotic	  stimulation	  in	  isolated	  
muscle.	  	  Those	  proteins	  in	  a	  dotted	  oval	  indicate	  other	  possible	  proteins	  involved,	  but	  require	  
further	  research.	  	  
The	  insulin	  signaling	  cascade	  is	  dependent	  on	  Akt,	  which	  was	  found	  to	  be	  inactive	  during	  
hyper-­‐osmotic	  stress	  after	  30	  minutes.	  	  Contraction	  is	  thought	  to	  stimulate	  glucose	  uptake	  
through	  two	  mechanisms,	  energy	  depletion	  and	  calcium	  release.	  	  AMPK	  and	  ERK	  are	  involved	  in	  
the	  energy	  depletion	  pathway	  and	  are	  not	  involved	  in	  osmotically	  stimulated	  glucose	  uptake	  
between	  30	  and	  60	  minutes.	  	  cPKC	  may	  be	  involved	  in	  the	  calcium	  stimulated	  pathway	  and	  
results	  show	  that	  it	  may	  not	  be	  involved	  with	  osmotically	  stimulated	  glucose	  uptake	  after	  30	  
minutes	  of	  hyper-­‐osmotic	  stress.	  	  Hyper-­‐osmotic	  stress	  seems	  to	  phosphorylate	  AS160	  similar	  to	  
insulin	  and	  contraction.	  	  During	  insulin	  and	  contraction	  stimulated	  glucose	  uptake,	  AS160	  is	  
phosphorylated	  between	  30	  and	  60	  minutes	  under	  the	  appropriate	  stimulation	  [9,	  74].	  	  This	  may	  
indicate	  that	  the	  signaling	  mechanisms	  of	  the	  three	  stimulators	  begin	  on	  divergent	  pathways,	  
but	  eventually	  converge	  to	  the	  same	  point.	  	  Further	  research	  is	  required	  to	  explore	  other	  
proteins	  actively	  involved	  in	  signaling	  glucose	  uptake	  under	  hyper-­‐osmotic	  stress.	  	  In	  addition,	  
further	  research	  is	  required	  to	  clarify	  the	  signaling	  related	  events	  involving	  Akt,	  AMPK,	  ERK,	  
cPKC	  and	  AS160	  prior	  to	  30	  minutes	  of	  incubation	  of	  skeletal	  muscle	  in	  a	  hyper-­‐osmotic	  
environment.	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8.3	  AS160	  
The	  most	  important	  finding	  of	  the	  current	  investigation	  was	  that	  phosphorylation	  of	  
AS160	  was	  significantly	  higher	  in	  the	  HYPER	  condition	  compared	  to	  the	  ISO	  condition	  at	  30	  
minutes.	  	  Recall	  that	  phosphorylation	  of	  AS160	  transforms	  AS160	  to	  become	  less	  active	  
therefore	  releasing	  the	  inhibition	  on	  downstream	  Rab	  targets	  ultimately	  leading	  to	  increase	  
GLUT4	  translocation	  and	  glucose	  uptake.	  	  Therefore	  the	  current	  finding	  advances	  the	  possibility	  
that	  AS160	  may	  be	  a	  key	  signaling	  protein	  in	  osmotically	  induced	  glucose	  uptake.	  	  
Thong	  et	  al.	  in	  2007	  have	  been	  the	  only	  group	  to	  date	  that	  has	  investigated	  AS160	  
phosphorylation	  with	  hyper-­‐osmotic	  stress	  and	  mixed	  results	  were	  reported	  [76].	  	  Thong	  
reported	  that	  in	  CHO-­‐IR	  cell	  culture,	  but	  not	  L6	  muscle	  cell	  culture,	  that	  AS160	  phosphorylation	  
was	  required	  for	  osmotically	  induced	  glucose	  uptake	  [76].	  	  Results	  from	  the	  present	  study	  
suggest	  that	  AS160	  is	  phosphorylated	  under	  hyper-­‐osmotic	  stress	  in	  whole	  skeletal	  muscle	  and	  
may	  contribute	  to	  the	  increase	  in	  glucose	  uptake.	  	  
It	  is	  worthy	  to	  note	  that	  AS160	  is	  hypothesized	  to	  be	  one	  of	  the	  last	  proteins	  involved	  in	  
the	  osmotic	  signaling	  cascade.	  	  Somewhere	  between	  30	  minutes	  and	  45	  minutes,	  
phosphorylation	  seems	  to	  return	  to	  basal	  levels.	  	  The	  pilot	  study	  mentioned	  above,	  suggested	  
that	  AS160	  phosphorylation	  reaches	  phosphorylation	  at	  45	  minutes,	  and	  more	  importantly,	  
after	  Akt	  and	  AMPK.	  	  The	  current	  data	  does	  not	  rule	  out	  other	  possible	  signaling	  cascades	  that	  
could	  also	  influence	  AS160.	  	  Future	  work	  should	  focus	  on	  determining	  how	  rapidly	  
phosphorylation	  of	  AS160	  occurs	  and	  if	  varying	  degrees	  of	  osmotic	  stress	  alter	  this	  response.	  	  
8.4	  cPKC	  
Our	  cPKC	  data	  suggests	  two	  possible	  situations,	  one	  being	  that	  peak	  phosphorylation	  
states	  occur	  before	  30	  minutes	  (Figure	  11),	  or	  that	  cPKC	  is	  not	  involved.	  	  At	  60	  minutes,	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phosphorylation	  was	  significantly	  lower	  in	  HYPER	  compared	  to	  ISO.	  	  The	  reason	  for	  this	  
phenomenon	  is	  unknown.	  	  cPKC	  was	  included	  in	  this	  investigation	  to	  evaluate	  the	  hypothesis	  
that	  calcium	  sparks	  may	  provide	  a	  signal	  that	  contributes	  to	  the	  increases	  in	  glucose	  uptake	  [68]	  
that	  are	  observed	  with	  osmotic	  stress.	  	  Calcium	  sparks	  are	  transient	  events	  and	  the	  peak	  of	  cPKC	  
phosphorylation	  may	  have	  occurred	  prior	  to	  our	  earliest	  time	  point,	  therefore	  eluding	  our	  ability	  
to	  detect	  cPKC	  phosphorylation.	  	  In	  fact,	  research	  by	  Bartlett	  et	  al.	  has	  suggested	  that	  cPKC	  
responses	  mimic	  the	  oscillatory	  patterns	  of	  calcium	  [8],	  and	  if	  this	  is	  true,	  phosphorylation	  of	  
cPKC	  could	  be	  intermittent	  or	  transitory.	  	  Lastly,	  cPKCα	  is	  only	  one	  isoform	  of	  the	  conventional	  
PKCs,	  and	  perhaps	  other	  isoforms	  such	  as	  the	  β	  and/or	  γ	  isoforms	  work	  in	  concert	  with	  PKCα	  to	  
produce	  a	  more	  substantial	  signal.	  	  In	  addition,	  the	  PKC	  family	  is	  regulated	  by	  many	  spatial	  
factors,	  such	  as	  DAGs	  and	  heat	  shock	  proteins,	  and	  as	  such,	  phosphorylation	  of	  the	  protein	  may	  
not	  tell	  the	  full	  story	  of	  its	  true	  activity	  [26].	  	  Therefore,	  a	  more	  in-­‐depth	  examination	  of	  other	  
PKC	  isoforms	  and	  other	  regulatory	  factors	  is	  necessary	  to	  better	  understand	  the	  possible	  role	  of	  
PKC	  in	  osmotically	  induced	  glucose	  uptake.	  	  	  
8.5	  AMPK	  
	   In	  the	  current	  study,	  no	  difference	  in	  phosphorylation	  of	  AMPK	  was	  observed	  between	  
conditions	  across	  all	  time	  points	  (Figure	  14),	  even	  despite	  a	  decline	  in	  PCr	  as	  expected	  in	  HYPER.	  	  
The	  role	  of	  AMPK	  in	  osmotically	  induced	  glucose	  uptake	  in	  both	  muscle	  cell	  culture	  [32,	  54,	  76]	  
and	  adipose	  cell	  culture	  [21]	  has	  been	  previously	  been	  investigated;	  however	  results	  have	  been	  
very	  inconclusive.	  	  Fryer	  suggested	  that	  AMPK	  is	  essential	  for	  hyper-­‐osmotic	  induced	  glucose	  
uptake	  in	  C1C12	  cell	  culture	  [21,	  32].	  	  Similarly,	  Hayashi	  reported	  AMPK	  was	  also	  essential	  for	  
sorbitol	  induced	  glucose	  uptake	  in	  isolated	  rat	  epitrochlearis	  muscle	  [32].	  	  However,	  Patel	  and	  
Thong	  have	  independently	  reported	  that	  AMPK	  was	  not	  required	  for	  glucose	  uptake	  under	  
hyper-­‐osmotic	  stress	  in	  L6	  muscle	  culture	  [54,	  76].	  	  In	  addition,	  Fujii	  et	  al.	  used	  an	  AMPK	  knock	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out	  (KO)	  mouse	  model	  to	  investigate	  AMPK’s	  role	  in	  glucose	  uptake	  [23]	  and	  found	  AMPK	  was	  
not	  essential	  for	  glucose	  transport.	  	  Fujii	  and	  Hayashi	  have	  been	  the	  only	  two	  groups	  to	  use	  
whole	  skeletal	  muscle,	  however	  their	  results	  require	  clarification	  due	  to	  conflicting	  results	  and	  
the	  KO	  model	  used.	  	  Research	  involving	  KO	  animals	  always	  carries	  the	  possibility	  of	  
unknown/unwanted	  side	  effects	  or	  compensations	  in	  physiological	  function	  and	  control.	  	  	  
The	  current	  study	  provides	  support	  to	  the	  observations	  of	  Patel	  and	  Thong’s,	  where	  
they	  observed	  that	  AMPK	  was	  not	  involved	  in	  osmotically	  induced	  glucose	  uptake	  in	  whole	  
skeletal	  muscle	  under	  physiological	  hyper	  osmotic	  stress	  after	  30	  minutes.	  	  These	  results	  
contrast	  both	  Fryer	  and	  Hayashi	  findings	  [21,	  22,	  32].	  	  Differences	  from	  Fryer’s	  results	  could	  be	  
attributed	  to	  the	  differences	  in	  models	  used,	  as	  characteristics	  between	  whole	  skeletal	  muscle	  
and	  C1C12	  cell	  culture	  are	  not	  always	  consistent.	  	  	  	  Furthermore,	  Hayashi’s	  observations	  might	  
be	  partially	  related	  to	  the	  fuel	  status	  of	  their	  sorbitol-­‐treated	  cells	  in	  culture.	  	  Hayashi	  reported	  
intramuscular	  concentrations	  of	  ATP,	  PCr	  and	  glycogen	  that	  were	  significantly	  lower	  with	  the	  
sorbitol	  treated	  cells	  as	  compared	  to	  control	  cells	  [32],	  suggesting	  a	  more	  marked	  energy	  
compromise.	  	  In	  contrast,	  in	  the	  current	  study	  and	  other	  studies	  previously	  done	  in	  our	  
laboratory,	  ATP	  concentrations	  were	  maintained	  across	  all	  conditions	  [19,	  51].	  	  The	  osmolality	  of	  
the	  HYPER	  condition	  in	  the	  current	  study	  (400	  mmol/kg)	  was	  specifically	  chosen	  to	  mimic	  
physiological	  osmolalities	  seen	  during	  high	  intensity	  exercise	  [46].	  	  Hayashi’s	  perturbation	  of	  
120mmol/L	  of	  sorbitol	  was	  measured	  in	  our	  lab	  using	  the	  VAPRO	  pressure	  osmometer	  
(VAPRO5520,	  Westcor,	  Logan,	  UT),	  and	  resulted	  in	  an	  average	  osmolality	  of	  123	  mmol/kg,	  which	  
is	  considered	  hypo-­‐osmotic	  under	  normal	  physiological	  conditions.	  	  All	  in	  all,	  the	  drop	  in	  ATP	  and	  
hypo	  rather	  than	  hyper-­‐osmotic	  environment	  demonstrates	  a	  non-­‐viable	  and/or	  drastically	  
different	  incubation	  protocol	  that	  likely	  contributed	  to	  the	  disparate	  AMPK	  activation.	  	  Further	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work	  is	  required	  to	  better	  understand	  the	  role	  of	  AMPK	  in	  osmotically	  stimulated	  glucose	  
uptake.	  	  	  
8.6	  ERK	  
	   Data	  from	  the	  current	  study	  found	  no	  differences	  in	  ERK	  phosphorylation	  between	  ISO	  
and	  HYPER	  conditions	  after	  30	  minutes	  of	  incubation.	  	  This	  is	  in	  contrast	  to	  the	  observations	  of	  
Sajan	  et	  al.,	  who	  found	  increased	  ERK	  phosphorylation	  during	  the	  first	  30	  minutes	  of	  osmotic	  
stress.	  	  It	  is	  possible	  that	  the	  ERK	  signal	  was	  much	  more	  active	  before	  30	  minutes	  compared	  to	  
after	  30	  minutes	  during	  the	  current	  study.	  	  ERK	  has	  been	  previously	  hypothesized	  to	  be	  involved	  
in	  osmotically	  stimulated	  glucose	  uptake	  downstream	  of	  PYK2	  in	  both	  rat	  adipocyte	  and	  L6	  
muscle	  cell	  culture	  [65].	  	  Sajan	  et	  al.	  used	  inhibitors	  in	  the	  various	  tissue	  models	  to	  determine	  
aPKCs	  were	  activated	  downstream	  of	  a	  RAS/RAF/MEK1/PYK2/ERK-­‐dependant	  pathway	  [65].	  	  The	  
observed	  differences	  could	  also	  be	  attributed	  to	  the	  different	  models	  used,	  cell	  culture	  vs.	  
isolated	  muscle.	  	  	  
Chen	  et	  al.	  has	  previously	  reported	  ERK	  to	  be	  activated	  downstream	  of	  AMPK	  during	  
“exercise”	  in	  both	  mouse	  EDL	  and	  L6	  myotubes	  [12].	  	  The	  “exercise”	  effect	  was	  achieved	  by	  
artificially	  stimulating	  AMPK	  using	  AICAR.	  	  Increased	  glucose	  uptake	  and	  activation	  of	  ERK	  and	  
aPKCs	  were	  observed	  with	  AICAR	  stimulation.	  	  However,	  in	  the	  current	  study	  AMPK	  was	  found	  
to	  be	  inactive	  between	  30	  and	  60	  minutes	  of	  incubation,	  it	  is	  not	  surprising	  that	  ERK	  was	  also	  
found	  to	  be	  inactive	  between	  30	  and	  60	  minutes	  based	  on	  the	  reported	  relationship	  of	  these	  
two	  signals.	  	  Conversely,	  ERK	  was	  also	  hypothesized	  to	  be	  phosphorylated	  around	  the	  same	  time	  
point	  as	  AS160,	  if	  not	  slightly	  earlier.	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Figure	  15:	  Mechanism	  for	  hyper-­‐osmotic	  glucose	  uptake.	  Proteins	  within	  a	  double	  oval	  
(AS160)	  may	  be	  involved	  in	  hyper-­‐osmotic	  glucose	  uptake	  between	  30	  and	  60	  minutes.	  	  
Proteins	  encircled	  in	  a	  dashed	  oval	  are	  not	  involved	  with	  hyper-­‐osmotic	  glucose	  uptake	  
between	  30	  and	  60	  minutes	  of	  hyper-­‐osmotic	  stress.	  	  Proteins	  encircled	  by	  a	  dotted	  oval	  are	  
other	  proteins	  that	  have	  not	  been	  studied	  in	  this	  investigation	  but	  warrant	  further	  research	  
to	  clarify	  their	  role	  in	  hyper-­‐osmotic	  glucose	  uptake.	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8.7	  Akt	  
	   Akt	  is	  considered	  the	  centerpiece	  of	  the	  insulin	  signaling	  cascade.	  	  It	  is	  thought	  to	  be	  
directly	  upstream	  of	  AS160	  and	  its	  activation	  would	  provide	  evidence	  of	  any	  upstream	  activation	  
of	  the	  insulin	  signaling	  cascade.	  	  Signaling	  proteins	  such	  as	  PI3-­‐K	  and	  PDK	  are	  associated	  with	  
many	  different	  signaling	  pathways	  and	  lead	  to	  Akt	  activation.	  	  The	  findings	  of	  the	  current	  study	  
supported	  the	  original	  hypothesis	  that	  Akt	  phosphorylation	  would	  be	  similar	  between	  ISO	  and	  
HYPER	  conditions	  at	  all	  time	  points.	  	  Recall	  that	  osmotic	  stress	  was	  thought	  to	  inhibit	  insulin	  
signaling	  via	  inhibition	  of	  Akt	  phosphorylation.	  	  Therefore,	  it	  appears	  unlikely	  that	  upstream	  
kinases	  like	  PI3-­‐K	  and	  PDK	  are	  involved	  in	  osmotically	  stimulated	  glucose	  uptake	  between	  30	  
and	  60	  minutes	  of	  hyper	  osmotic	  incubation.	  	  	  	  	  
8.8	  Conclusions	  	  
	   In	  summary,	  an	  increase	  in	  AS160	  phosphorylation	  was	  observed	  between	  30	  and	  60	  
minutes	  of	  incubation	  as	  compared	  to	  iso-­‐osmotic	  conditions.	  	  Furthermore,	  no	  changes	  in	  the	  
phosphorylation	  states	  of;	  Akt,	  ERK,	  AMPK	  and	  cPKC	  were	  observed	  with	  hyper	  osmotic	  stress	  as	  
compared	  to	  iso-­‐osmotic	  control	  conditions.	  	  This	  suggests	  that	  AS160	  is	  involved	  in	  osmotically	  
stimulated	  glucose	  uptake	  following	  30	  minutes	  of	  osmotic	  stimulation.	  	  	  On	  the	  contrary,	  Akt,	  a	  
major	  signal	  in	  the	  insulin	  stimulated	  pathway	  does	  not	  appear	  to	  be	  involved	  with	  such	  
stimulation.	  	  Furthermore,	  the	  phosphorylation	  state	  of	  signaling	  pathways	  originally	  described	  
to	  be	  involved	  in	  contraction	  stimulated	  or	  stress	  related	  activation	  of	  glucose	  uptake	  (AMPK,	  
ERK	  and	  cPKC)	  remained	  similar	  between	  hyper-­‐osmotic	  and	  iso-­‐osmotic	  conditions	  from	  30	  to	  
60	  minutes	  of	  incubation.	  	  	  	  Future	  research	  should	  attempt	  to	  fully	  elucidate	  the	  time	  frame	  of	  
activation	  (phosphorylation)	  of	  the	  pathways	  implicated	  in	  glucose	  uptake,	  especially	  from	  0	  to	  
30	  minutes	  of	  stimulation,	  to	  develop	  a	  full	  understanding	  of	  the	  mechanisms	  underlying	  hyper-­‐
osmotic	  stress	  induced	  glucose	  uptake.	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8.9	  Future	  Directions	  
	   Glucose	  regulation	  is	  an	  extremely	  complex	  and	  very	  important	  system	  within	  skeletal	  
muscle.	  	  It	  is	  well	  established	  that	  redundant	  signaling	  pathways	  exist	  and	  that	  many	  more	  
proteins	  are	  involved	  than	  the	  few	  studied	  here.	  	  In	  fact,	  most	  of	  the	  proteins	  characterized	  in	  
this	  study	  do	  not	  appear	  to	  be	  involved	  in	  osmotically	  stimulated	  glucose	  uptake	  between	  30	  
and	  60	  minutes	  of	  stimulation.	  Thus,	  an	  obvious	  next	  step	  is	  to	  continue	  to	  profile	  the	  likely	  
signaling	  candidates	  that	  may	  be	  involved.	  	  As	  mentioned	  earlier,	  CaMK	  is	  another	  protein	  that	  
should	  be	  investigated	  to	  explore	  the	  possibility	  that	  calcium	  maybe	  a	  key	  secondary	  messenger	  
in	  regards	  to	  glucose	  uptake	  under	  such	  conditions.	  	  To	  the	  authors	  knowledge,	  no	  literature	  has	  
investigated	  the	  interaction	  of	  osmotic	  stress	  and	  CaMK,	  however,	  a	  number	  of	  articles	  do	  exist	  
that	  demonstrate	  a	  link	  between	  contraction	  stimulated	  glucose	  uptake	  and	  CaMK	  [35,	  86].	  	  
There	  is	  also	  growing	  evidence	  demonstrating	  the	  osmotic	  stress	  leads	  to	  intermittent	  calcium	  
release	  through	  the	  DHPR	  of	  the	  sarcoplasmic	  reticulum	  (REFS).	  	  Such	  increases	  in	  calcium	  could	  
lead	  to	  CaMK	  activation	  and	  may	  provide	  a	  link	  to	  activation	  of	  glucose	  uptake.	  
	   Nitric	  oxide	  synthase	  (NOS)	  is	  another	  signaling	  protein	  that	  may	  be	  involved	  in	  
osmotically	  stimulated	  glucose	  uptake.	  	  Traditionally,	  NOS	  is	  thought	  to	  be	  phosphorylated	  
downstream	  of	  AMPK	  and	  regulate	  GLUT4	  translocation	  through	  increased	  guanylate	  cyclase	  
activity	  (GC)	  [22,	  28].	  	  However,	  we	  did	  not	  observe	  an	  increase	  in	  AMPK	  activation	  following	  30	  
minutes	  of	  hyper-­‐osmotic	  stress,	  however,	  	  there	  hav	  been	  suggestions	  	  that	  	  NOS	  might	  be	  
regulated	  independently	  of	  AMPK	  [49].	  	  Therefore,	  future	  work	  should	  investigate	  if	  it	  is	  possible	  
for	  NOS	  to	  regulate	  osmotically	  induced	  glucose	  uptake	  independent	  of	  AMPK.	  	  	  
	   In	  addition	  to	  exploring	  other	  proteins	  in	  the	  osmotic	  signaling	  cascade,	  it	  would	  be	  very	  
valuable	  to	  fully	  establish	  the	  time	  frame	  for	  signaling	  of	  the	  various	  pathways	  throughout	  a	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period	  of	  osmotic	  stress.	  	  Recommended	  time	  points	  for	  a	  follow-­‐up	  experiment	  should	  include	  
5,	  15	  and	  30	  minutes	  of	  incubations	  in	  both	  ISO	  and	  HYPER	  conditions.	  	  	  	  	  	  
	   Lastly,	  it	  would	  be	  interesting	  to	  consider	  other	  aspects	  of	  GLUT4	  translocation,	  that	  is,	  
GLUT4	  internalization	  and	  GLUT4	  activation.	  	  The	  vast	  majority	  of	  research	  has	  focused	  on	  the	  
exocytotic	  portion	  of	  glucose	  uptake,	  however	  osmotically	  stimulated	  glucose	  uptake	  may	  be	  
achieved	  through	  a	  decrease	  rate	  in	  GLUT4	  internalization.	  	  It	  would	  be	  worth	  researching	  
proteins	  involved	  with	  GLUT4	  internalization,	  such	  as	  clathrin,	  transferrin	  receptors,	  SNARES,	  
VAMPs	  and	  other	  adaptor	  proteins.	  	  GLUT4	  activation	  should	  also	  be	  considered	  as	  GLUT4	  
surface	  content	  does	  not	  necessarily	  imply	  that	  glucose	  is	  taken	  up.	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APPENDIX	  I:	  BREAKDOWN	  OF	  SIGMA	  MEDIA-­‐199	  (#4530)	  
	  
Components	   	   	   M4530	  
Inorganic	  Salts	   	   [1X]	   g•L-­‐1	  
CaCl2·∙2H2O	   	   	   0.265	  
Fe(NO3)3·∙9H2O	  	   	   0.00072	  
MgSO4	  (anhyd)	   	   	   0.9767	  
KCl	   	   	   	   0.4	  
KH2PO4	   	   	   	   -­‐-­‐	  
Na·∙Acetate	  (anhyd)	   	   0.05	  
NaHCO3	   	   2.2	  
NaCl	   	   	   	   6.8	   	  
Na2HPO4	  (anhyd)	   	   -­‐-­‐	  
NaH2PO4	  (anhyd)	   	   0.122	  
Amino	  Acids	  
DL-­‐Alanine	   	   	   0.05	  
L-­‐Arginine·∙HCl	   	   	   0.07	  
DL-­‐Aspartic	  Acid	   	   0.06	  
L-­‐Cysteine·∙HCl·∙H20	   	   0.00011	  
L-­‐Cystine·∙2HCl	   	   	   0.026	  
DL-­‐Glutamic	  Acid	   	   0.1336	  
L-­‐Glutamine	   	   	   0.1	  
Glycine	  	   	   	   0.05	  
L-­‐Histidine·∙HCl·∙H2O	   	   0.02188	  
Hydroxy-­‐L-­‐Proline	   	   0.01	  
Product	  Name	   Medium	  199,	  
With	  Earle s	  salts,	  L-­‐glutamine	  and	  sodium	  bicarbonate,	  liquid,	  sterile-­‐
filtered,	  cell	  culture	  tested	  
Product	  Number	   M4530	  
Product	  Brand	   SIGMA	  
	  	  
TEST	   SPECIFICATION	  
Appearance	  (Turbidity)	   Clear	  
Appearance	  (Form)	   Solution	  
pH	   7.0	  -­‐	  7.6	  
Osmolality	   280	  -­‐	  310	  mOs/kg	  
Cell	  Culture	  Testing	  -­‐	  MTT	   Pass	  
Cell	  Line	   Cell	  Line	  -­‐	  Cell	  Types	  
Key	  Element	  Conc	  -­‐	  ICP	   Pass	  
Amino	  Acid	  Analysis	   Pass	  
Sterility	   Pass	  
Endotoxin	  Level	   <=	  1	  EU/ml	  
Glucose	  Concentration	   0.9	  -­‐	  1.1	  g/l	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DL-­‐Isoleucine	   	   	   0.04	  
DL-­‐Leucine	   	   	   0.12	  
L-­‐Lysine·∙HCl	   	   	   0.07	  
DL-­‐Methionine	   	   	   0.03	  
DL-­‐Phenylalanine	   	   0.05	  
L-­‐Proline	   	   	   0.04	  
DL-­‐Serine	   	   	   0.05	  
DL-­‐Threonine	   	   	   0.06	  
DL-­‐Tryptophan	   	   0.02	  
L-­‐Tyrosine	  2Na·∙2H20	   	   0.05766	  
DL-­‐Valine	   	   	   0.05	  
Vitamins	  
Ascorbic	  Acid·∙Na	   	   0.000056	  
D-­‐Biotin	   	   	   0.00001	  
Calciferol	   	   	   0.0001	  
Choline	  Chloride	   	   0.0005	   	  
Folic	  Acid	   	   	   0.00001	  
Menadione	  (sodium	  bisulfite)	   0.000016	  
myo-­‐Inositol	   	   	   0.00005	  
Niacinamide	   	   	   0.000025	  
Nicotinic	  Acid	   	   	   0.000025	  
p-­‐Amino	  Benzoic	  Acid	   	   0.00005	  
D-­‐Pantothenic	  Acid·∙½Ca	  0.00001	  
Pyridoxal·∙HCl	   	   	   0.000025	  
Pydridoxine·∙HCl	  	   0.000025	  
Retinol	  Acetate	  	   	   0.00014	  
Riboflavin	   	   	   0.00001	  
DL-­‐α-­‐Tocopherol	  Phosphate·∙Na	  0.00001	  
Thiamine·∙HCl	   	   	   0.00001	  
	  
Other	  
Adenine	  Sulfate	  	   0.01	  
Adenosine	  Triphosphate·∙2Na	   0.001	  
Adenosine	  Monophosphate·∙Na	  0.000238	  
Cholesterol	   	   	   0.0002	  
Deoxyribose	   	   	   0.0005	  
Glucose	  	   	   1.0	  
Glutathione	  (reduced)	   	   0.00005	  
Guanine·∙HCl	   	   	   0.0003	  
HEPES	   	   	   	   -­‐-­‐	  
Hypoxanthine	   	   	   0.0003	  
Phenol	  Red·∙Na	   	   	   0.0213	  
Tween	  80	   	   	   0.02	  
Ribose	   	   	   	   0.0005	  
Thymine	   	   	   0.0003	  
Uracil	   	   	   	   0.0003	  
Xanthine·∙Na	   	   	   0.000344	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APPENDIX	  II:	  BREAKDOWN	  OF	  MANNITOL	  (#9546)	  
	  
COPPER	   <0.0005%	  
IRON	   <0.0005%	  
LEAD	   <0.001%	  
MAGNESIUM	   <0.0005%	  
SODIUM	   <0.005%	  
PHOSPHORUS	   <0.0005%	  
ZINC	   <0.0005%	  
POTASSIUM	   <0.005%	  
PURITY	   MINIMUM	  98%	  BY	  GC	  OR	  HPLC	  
Product	  Name	  
D-­‐Mannitol,	  BioXtra	  
Product	  Number	   M9546	  
Product	  Brand	   SIAL	  
CAS	  Number	   69-­‐65-­‐8	  
Molecular	  Weight	   182.17	  
	  	  
TEST	   SPECIFICATION	  
APPEARANCE	   WHITE	  POWDER	  
SOLUBILITY	   COMPLETE	  COLORLESS	  (1M	  IN	  WATER	  AT	  20DEGC)	  
RESIDUE	  UPON	  IGNITION	   <0.01%	  
AMMONIA	  CONTENT	   <0.05%	  
INSOLUBLE	  MATTER	   <0.01%	  
CHLORIDE	  (CL)	   <0.05%	  
SULFATE	  (SO4)	   <0.05%	  
ALUMINUM	   <0.0005%	  
CALCIUM	   <0.0005%	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APPENDIX	  III:	  ATP/PCr	  ASSAY	  PROCEDURE	  
	  	  
I. Reagents	  	  
0.5M	  PCA	   	   21.5mL	  of	  70%	  PCA	  
	   	   	   Bring	  to	  500mL	  with	  dH2O;	  Store	  in	  0-­‐4°C	  for	  1	  month	  
2.3	  M	  KHCO3	  	   2.3g	  KHCO3	  
	   	   	   Add	  10.0mL	  dH2O;	  Make	  Fresh	  Daily	  	  
II. Extraction	  Procedure	  
	  
1. Freeze	  dry	  tissue	  (~12-­‐24	  hours	  to	  ensure	  all	  water	  is	  removed)	  
2. Store	  with	  dry	  rite	  in	  freezer	  until	  powdering	  
3. Tease	  out	  connective	  tissue	  and	  powder	  
4. Place	  in	  pre-­‐weighed	  microcentrifuge	  tube	  and	  weight	  (3-­‐5mg)	  	  
5. Place	  tubes	  in	  an	  ice-­‐bucket	  (make	  sure	  tubes	  remain	  cold)	  
6. Add	  600uL	  of	  pre-­‐cooled	  0.5M	  PCA	  
7. Extract	  for	  10	  minutes,	  vortexing	  several	  times	  	  
8. Centrifuge	  for	  10	  minutes	  at	  15,000G	  (spinning	  helps	  remove	  some	  of	  the	  enzymes	  
that	  can	  influence	  concentration)	  
9. Remove	  540uL	  and	  place	  in	  freezer	  (-­‐20°C)	  for	  10	  minutes	  
10. To	  the	  frozen	  supernatant	  add	  135uL	  of	  2.3M	  KHCO3	  and	  vortex	  until	  liquid	  
(addition	  of	  KHCO3	  to	  a	  frozen	  supernatant	  prevents	  foaming	  over)	  
11. Centrifuge	  for	  10	  minutes,	  0°C	  at	  15,000G.	  	  Remove	  supernatant	  to	  assay	  
metabolites.	  
	  
III. Assay	  Procedure	  (Note:	  run	  everything	  in	  triplicate)	  
	  
1. Prepare	  substrates	  (reagents	  1-­‐5	  in	  section	  IV)	  without	  G-­‐6-­‐P-­‐DH	  enzyme	  and	  bring	  to	  
volume	  	  
2. Prepare	  ATP	  (Solid	  in	  -­‐20)	  and	  PCr	  (aliquots	  found	  in	  -­‐80)	  standards	  
	  
3. Vortex	  each	  concentration	  before	  pipetting	  
a. Fill	  the	  next	  5	  wells	  with	  10.00µL	  of	  varying	  concentrations	  of	  ATP	  
	  
4. Vortex	  each	  concentration	  before	  pipetting	  
a. Fill	  the	  next	  5	  wells	  with	  10.00µL	  of	  varying	  concentrations	  of	  PCr	  
	  
5. Add	  G-­‐6-­‐P-­‐DH	  enzyme	  to	  substrates	  and	  add	  185µL	  of	  this	  buffer	  (pH	  8.1)	  to	  each	  well	  
	  
6. Incubate	  in	  a	  dark	  environment	  for	  20	  minutes,	  set	  up	  the	  fluorometer	  and	  read	  at	  25	  
minutes	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Part	  2:	  	  
1. Mix	  2.5µL	  of	  Hexokinase	  (HK)	  with	  1mL	  of	  buffer.	  Mix	  by	  inversion.	  	  
2. Add	  6µL	  of	  dilute	  HK	  to	  all	  of	  the	  wells	  
3. Incubate	  in	  a	  dark	  environment	  for	  80	  Minutes	  
4. Read	  the	  plate	  (excitation	  setting	  340,	  emission	  setting	  460)	  
5. R2-­‐R1	  =	  reflects	  [ATP]	  in	  extract	  
Part	  3:	  
1. Mix	  ~1.5mg	  of	  phosphocreatine	  kinase	  and	  5mg	  of	  ADP	  into	  5mL	  of	  buffer.	  	  Mix	  by	  
inversion	  
2. Add	  6µL	  of	  dilute	  Creatine	  Kinase	  to	  all	  the	  wells	  
3. Place	  in	  a	  dark	  environment	  for	  120	  Minutes	  	  
4. Read	  the	  plate	  (excitation	  setting	  340,	  emission	  setting	  460)	  
5. R3-­‐R2	  =	  reflects	  [PCr]	  in	  extract	  	  
	   	  





IV. Muscle	  Adenosine	  Triphosphate	  (ATP)	  and	  Phosphocreatine	  (PCr)	  Assay	  	  for	  Plate	  
Reader	  Flourometer	  
	  
P-­‐Creatine	  +	  ADP	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐>	  Creatine	  +	  ATP	  
ATP	  +	  Glucose	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐>	  ADP	  +	  Glucose-­‐6-­‐Phosphate	  	  
Glucose-­‐6-­‐Phosphate	  +	  NADP	  -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐>	  Glucanolactone	  +	  NADPH	  	  
	  
Reagent	   [Stock	  ]	   [Final	  ]	   Volume	  –	  
25mL	  
Volume	  –	  50	  
mL	  
Volume	  –	  100	  
mL	  
1.	  Tris	  (on	  
shelf;	  pH	  8.1)	  
stored	  in	  fridge	  	  
1.00M	   50mM	   1.25mL	   2.5mL	   5.00mL	  
2.	  MgCl2	  (on	  
shelf;	  fresh)	  
(.2033g/mL)	  
1.00M	   1.0mM	   25.00µL	   50.00µL	   100.00µL	  
3.	  D.T.T.	  
(found	  in	  -­‐20)	  	  
aliquots	  -­‐80	  




100.0	  mM	   100.0	  µM	   25.00µL	   50.00µL	   100.00µL	  
5.	  NADP	  
(found	  in	  -­‐20)	  
aliquots	  -­‐80	  
50.0	  mM	   50.0	  µM	   25.00µL	   50.00µL	   100.00µL	  
6.	  G-­‐6-­‐P-­‐DH	  
(liquid	  found	  in	  
+4)	  (Sigma	  G-­‐
5760)	  
2660	  U/mL	   0.02	  U/mL	   1.00	  µL	   2.00	  µL	   4.00	  µL	  
7.	  ATP	  (found	  
in	  -­‐20)	  (Sigma	  A-­‐
7699)	  
Solid	  –	  Refer	  to	  Section	  V	  
8.	  Creatine	  
Kinase	  (found	  
in	  -­‐20)	  (Sigma	  C-­‐
3755)	  
324	  U/mL	  
Note:	  Mix	  reagents	  1-­‐5	  together.	  Bring	  to	  volume	  (23.649mL	  for	  25mL)	  with	  distilled	  water	  and	  
adjust	  pH	  to	  8.1.	  	  Then	  add	  reagent	  6.	  	  Mix	  by	  inversion	  with	  enzymes.	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V.	  Standard	  Curves	  	  	  
ATP	  (Sigma	  A-­‐7699)	  	  	  	  	  	  	  	  
Make	  fresh	  5.51mg	  in	  5	  mL	  dH2O	  
Concentration	  (mM)	   Stock	  (µL)	   dH2O	  (µL)	  
0.05	   25	   975	  
0.1	   50	   950	  
0.2	   100	   900	  
0.3	   150	   850	  
0.4	   200	   800	  
	  
Phosphocreatine	  (Sigma	  P-­‐7936)	  
Stored	  in	  5mM	  aliquots	  in	  the	  -­‐80°C;	  (1.2755	  g/L)	  
Concentration	  (mM)	   Stock	  (µL)	   dH2O	  (µL)	  
0.1	   20	   980	  
0.2	   40	   960	  
0.4	   80	   920	  
0.8	   160	   840	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APPENDIX	  IV:	  WESTERN	  BLOTTING	  
	  
DAY	  1:	  SAMPLE	  PREPARATION	  FOR	  WESTERN	  BLOTTING	  
	  
HOMOGENIZATION	  
1. Set	  centrifuge	  to	  4	  degrees	  C.	  
2. Weigh	  wet	  muscle.	  
3. Add	  muscle	  and	  chilled	  homogenizing	  buffer	  to	  a	  chilled	  glass	  homogenizer	  (on	  ice)	  in	  the	  
following	  proportions	  (try	  to	  keep	  muscle	  weights	  within	  this	  range):	  
Muscle	  Weights	   Homogenization	  Buffer	  
<50	  mg	   700	  µl	  
60	  mg	   850µl	  
70	  mg	   1000	  µl	  
80	  mg	   1150	  µl	  
90	  mg	   1300	  µl	  
100	  mg	   1450	  µl	  
110	  mg	   1600	  µl	  
120	  mg	   1750	  µl	  
130	  mg	   1900	  µl	  
	  
4. Add	  Protease	  Inhibitor	  cocktail	  (Roche	  11836170001;1	  tablet	  per	  10mL	  of	  buffer)	  
5. Add	  Phosphatase	  Inhibitor	  cocktail	  (Roche	  4906845001;1	  tablet	  per	  10mL)	  
6. 100	  passes	  in	  chilled	  buffer	  using	  a	  glass	  pestle	  (on	  ice).	  
7. Rinse	  pestle	  with	  100	  µl	  of	  chilled	  homogenizer	  buffer	  (Solution	  #	  1)	  into	  sample.	  
8. Decant	  into	  1.5	  ml	  eppendorf	  and	  centrifuge	  at	  1200	  x	  g	  for	  10	  min	  
9. Decant	  supernatant	  (SN1)	  and	  store	  in	  an	  eppendorf	  at	  -­‐80	  degress	  C.	  (typically,	  this	  
supernatant	  will	  be	  the	  one	  with	  the	  highest	  protein	  concentration)	  
10. Resuspend	  pellet	  in	  1	  ml	  of	  chilled	  Triton	  X-­‐100	  buffer	  (Solution	  #	  2;	  detergent,	  helps	  
break	  up	  membranes;	  serial	  dilution)	  and	  vortex	  gently	  (also	  helps	  to	  break	  up	  the	  
membranes).	  
11. Centrifuge	  at	  1200	  x	  g	  (1200	  times	  the	  force	  of	  gravity)	  for	  10	  min	  @	  4°C.	  
12. Decant	  supernatant	  (SN2)	  and	  store	  in	  an	  eppendorf	  at	  -­‐80	  degrees	  C.	  
13. Resuspend	  pellet	  in	  1	  ml	  of	  chilled	  wash	  buffer	  (Solution	  #15)	  and	  store	  at	  -­‐80	  degrees	  C.	  
Store	  this	  as	  (Pellet).	  
PROTEIN	  ASSAY	  	  
It	  is	  very	  important	  that	  this	  be	  done	  accurately,	  as	  it	  is	  imperative	  that	  equal	  amounts	  of	  
protein	  are	  loaded	  in	  each	  lane	  for	  the	  electrophoresis.	  
1. A	  standard	  curve	  using	  bovine	  serum	  albumin	  (BSA)	  (Boehringer-­‐Mannheim;	  735-­‐708;	  
stored	  in	  FREEZER)	  is	  run	  with	  each	  new	  microtitre	  plate.	  Each	  point	  on	  the	  calibration	  
curve	  is	  run	  in	  triplicate.	  
2. 	  Start	  with	  a	  1	  mg/ml	  BSA	  protein	  standard	  (Pre-­‐made	  in	  the	  -­‐20	  Freezer).	  	  Label	  7	  
eppendorf	  tubes:	  0.5,	  0.4,	  0.3,	  0.2,	  0.1,	  0.05,	  0.	  Following	  the	  chart	  below,	  dilute	  the	  1	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mg/ml	  stock	  solution	  to	  yield	  desired	  protein	  concentrations.	  	  Final	  volume	  =	  50ul	  
(require	  3	  x	  10ul	  =	  30ul,	  but	  make	  more	  to	  be	  safe)	  
3. Calibration	  curve	  protein	  concentrations:	  
	  
4. Dilute	  each	  of	  the	  muscle	  samples	  10x	  as	  well;	  90	  µl	  ddH2O	  and	  10	  µl	  sample.	  	  
5. VORTEX	  and	  pipette	  into	  the	  wells	  of	  the	  microtitre	  plates	  10	  µl	  of	  the	  newly	  diluted	  BSA	  
in	  triplicate	  to	  establish	  a	  standard	  curve.	  	  	  
6. Vortex	  and	  pipette	  into	  the	  wells	  of	  the	  microtitre	  plates	  10	  µl	  of	  diluted	  sample	  in	  
triplicate.	  
7. Using	  a	  multi-­‐channel	  pipette	  add	  200	  µl	  of	  diluted	  reagent	  (1:4	  dilution	  with	  Bio-­‐Rad	  
Protein	  Assay	  Dye	  Reagent	  Concentrate:	  DH20)	  into	  each	  well.	  
USING	  THE	  FLUOROMETER	  
8. Open	  the	  ‘KC4’	  software.	  
9. Click	  on	  the	  ‘Wizard’	  icon	  and	  select	  ‘Reading	  Parameters’.	  
10. Click	  ‘End	  Point’	  assay,	  make	  sure	  ‘Absorbance’	  is	  also	  checked.	  
11. Wavelength	  should	  be	  set	  to	  595	  nm,	  Intensity	  set	  to	  3,	  and	  Duration	  set	  to	  5.	  
12. Click	  OK.	  
13. 	  Select	  the	  “Read”	  	  
14. Once	  the	  plate	  has	  been	  read,	  click	  on	  ‘Data’	  and	  choose	  Export.	  
15. In	  the	  ‘Plates’	  drop	  down	  menu,	  choose	  595	  nm.	  
16. Copy	  and	  Paste	  to	  Excel	  and	  use	  the	  “Text	  to	  Column”	  (by	  semi	  colon)	  function.	  	  
Article	  I. 	  
DAY	  2:	  GEL	  ELECTROPHORESIS	  AND	  MEMBRANE	  TRANSFER	  
CAST	  GEL	  
Note:	  Gels	  can	  be	  made	  and	  stored	  in	  the	  refrigerator	  (2-­‐8°	  C)	  one	  day	  prior	  to	  gel	  
electrophoresis	  and	  membrane	  transfer.	  	  If	  gels	  are	  to	  be	  made	  in	  advance,	  follow	  the	  procedure	  
below	  until	  step	  3.	  	  After	  completing	  step	  3	  wrap	  the	  gel	  in	  saran	  wrap	  (leaving	  the	  comb	  
inserted	  into	  the	  gel),	  and	  store	  in	  the	  refrigerator.	  
Use	  ProtoGel	  Buffer	  System;	  otherwise	  an	  alternative	  method	  is	  given.	  	  









Volume	  of	  1	  mg/ml	  BSA	  
Standard	  (ul)	  
Volume	  of	  ddH2O	  (ul)	  
0.5	   25	   25	  
0.4	   20	   30	  
0.3	   15	   35	  
0.2	   10	   40	  
0.1	   5	   45	  
0.05	   2.5	   47.5	  
0	   0	   50	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4%	  Stacking	  Gel	  
ddH2O	   9.7ml	   8.02ml	   6.66	  ml	   6.1ml	  
Separating	  buffer	  
(Resolving	  Buffer)	  
5.0ml	   5.0ml	  
	  
	  
5.0	  ml	   -­‐	  
Stacking	  Buffer	   -­‐	   -­‐	   -­‐	   2.5ml	  
ProtoGel	  	  (30%	  
Acrylamide/0.8%	  Bis)	  	  
5.0ml	   6.66ml	   8.02	  ml	   1.33	  ml	  
10%	  AP	  Solution**	  (Solution	  
#9)	  
200µl	   200µl	   200µl	   100µl	  
Temed***	   20µl	   20µl	   20µl	   20µl	  
(i) **Do	  NOT	  add	  AP	  and	  Temed	  until	  immediately	  before	  casting	  the	  gel.	  
***Do	  this	  step	  in	  the	  fumehood.	  
Essentially,	  as	  acrylamide	  increases,	  the	  pore	  size	  decreases	  and	  vice	  versa.	  Large	  pores	  
are	  used	  for	  large	  proteins	  and	  vice	  versa.	  
To	  make	  a	  gel	  of	  X	  percentage,	  follow	  this	  formula:	  	  
	   %	  Gel	  =	  	  (X	  mL	  of	  30%	  Acrylamide/0.8%	  Bis/Total	  Volume)	  *	  0.3*100	  
	   E.g.	  %	  Gel	  =	  (10	  mL	  of	  30%	  Acrylamide/0.8%	  Bis/Total	  Volume)	  *	  0.3*100	  
	   	   	  	  	  	  	  	  =	  10/20*0.3*100	  
	   	   	  	  	  	  	  	  =	  15%	  
	   The	  total	  volume	  should	  remain	  constant	  at	  20	  ml.	  If	  you	  are	  adding	  more	  30%	  	  
Acrylamide/0.8%	  Bis,	  take	  this	  volume	  from	  the	  dH20.	  	  
	  
	  	  
Clean	  1.0	  mm	  spaced	  plates	  with	  70%	  ethanol.	  	  Once	  set	  up,	  pipette	  in	  dH20	  between	  the	  plates	  
and	  let	  stand	  5-­‐10	  min.	  	  If	  the	  water	  level	  drops,	  there	  is	  a	  leak	  in	  the	  bottom	  seal,	  therefore	  set	  
up	  apparati	  again	  and	  re-­‐check	  with	  water.	  	  When	  the	  water	  level	  is	  stable	  after	  5-­‐10	  min,	  then	  
drain	  it,	  wipe	  edges	  with	  Kim-­‐Wipe,	  and	  go	  to	  step	  2.	  
	  
1. Pour	  in	  your	  separating	  gel	  (see	  above	  Table	  for	  making	  this	  solution)	  using	  a	  Pasteur	  
pipette	  until	  the	  gel	  is	  ~1cm	  from	  the	  bottom	  of	  where	  the	  wells	  would	  be.	  It	  is	  ESSENTIAL	  
to	  have	  approx.	  0.5-­‐1	  cm	  of	  stacking	  gel	  on	  top	  of	  the	  separating	  gel	  so	  that	  the	  proteins	  
can	  separate	  before	  moving	  into	  the	  separating	  gel.	  
2. Pour	  slowly	  (from	  the	  middle	  of	  the	  plate)	  to	  prevent	  bubbles	  from	  forming,	  and	  
immediately	  overlay	  with	  dH20	  or	  methanol.	  	  Add	  the	  dH20	  or	  methanol	  slowly	  and	  evenly.	  	  
Allow	  the	  gel	  to	  polymerize	  for	  45min	  at	  RT.	  The	  methanol	  will	  ensure	  that	  the	  gel	  
polymerizes	  evenly	  and	  that	  there	  are	  no	  bubbles.	  	  
CAST	  STACKING	  GEL	  (1	  HOUR)	  
3. Drain	  the	  methanol	  or	  dH20	  from	  top	  of	  gel,	  and	  dry	  edges	  with	  Kim	  wipe.	  	  Place	  the	  comb	  
half	  way	  into	  the	  plates.	  Pour	  in	  stacking	  gel	  (see	  above	  table	  for	  making	  this	  solution)	  
until	  the	  top	  of	  the	  short	  plate,	  and	  then	  push	  the	  comb	  in	  fully.	  	  Allow	  gel	  to	  polymerize	  
for	  30	  min	  to	  an	  hour	  at	  RT.	  
Molecular	  Weight	  Range	  for	  %	  Separating	  Gel	  
>250	  kDa	  =	  4-­‐
5%	  Gel	  	  
250-­‐120	  kDa	  
=	  7.5%	  gel	  
120-­‐40	  kDa	  =	  10%	  
gel	  
40-­‐15	  kda	  =	  13%	  
gel	  
<20	  kda	  =	  15%	  gel	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PREPARE	  SAMPLES	  WHILE	  STACKING	  GEL	  IS	  POLYMERIZING	  
To	  ensure	  consistency	  between	  western	  blots,	  it	  is	  essential	  to	  minimize	  the	  number	  of	  freeze-­‐
thaw	  cycles.	  	  Repeated	  freeze-­‐thaw	  cycles	  will	  affect	  the	  quality	  of	  the	  homogenate,	  thus	  
making	  it	  very	  difficult	  to	  keep	  amount	  of	  protein	  loaded	  consistent.	  	  Refer	  to	  the	  Excel	  
Spreadsheet	  on	  Computer.	  
	  
4. Now	  we	  are	  going	  to	  prepare	  samples	  to	  load	  in	  the	  wells.	  If	  we	  want:	  X	  µg	  of	  muscle	  
protein/lane	  (as	  an	  example,	  we	  want	  40	  ug)	  
5. Volume	  of	  homogenate	  (µl)	  	  =	  40	  µg	  /	  homogenate	  concentration	  (µg/µl)	  
6. Volume	  per	  lane	  on	  a	  10	  lane,	  0.75	  mm	  thick	  gel	  =	  25µl	  (but	  we	  will	  make	  45	  ul).	  	  	  
7. Ratio	  of	  (homogenate	  +	  dilution	  buffer)	  :	  Sample	  Buffer	  is	  ALWAYS	  2:1	  or	  30µl	  :	  15µl.	  
8. Volume	  of	  dilution	  buffer	  =	  30ul	  –	  volume	  of	  muscle	  homogenate.	  	  
9. Follow	  the	  company	  specific	  preparation	  directions	  for	  the	  molecular	  weight	  standard.	  
(BioRad	  Precision	  Plus	  Kaleidoscope	  MW	  Marker	  works	  well).	  
10. Vortex	  gently.	  Poke	  a	  hole	  in	  the	  top	  of	  each	  eppendorf	  with	  a	  needle	  and	  heat	  your	  
samples	  for	  6	  min	  at	  95°C.	  	  Cool	  on	  crushed	  ice	  for	  at	  least	  5	  min.	  	  
11. Flash-­‐spin	  down	  the	  sides	  in	  microcentrifuge	  (20	  seconds	  on	  high	  revolution).	  
Ex:Total	  [protien]	   Amount	  for	  40	  ug	   Dilution	  buffer	   Sample	  buffer	  
(a)	  1.89	  ug/ul	   40ug	  /	  1.89ug/ml	  =	  
21.16	  ul	  
30ul	  –	  21.16ul	  =	  8.84	  
ul	  
15	  ul	  
(b)	  2.39	  ug/ul	   40ug	  /	  2.39	  ug/ul	  =	  
16.74	  ul	  




GEL	  ELECTROPHORESIS	  (1	  HR	  AT	  200V	  OR	  3	  HRS	  AT	  70V)	  
12. CAREFULLY	  remove	  the	  comb	  and	  clean	  out	  each	  well	  using	  thin	  pieces	  of	  filter	  paper.	  
13. Slide	  the	  gel	  cassettes	  into	  electrode	  assembly	  and	  buffer	  chamber	  with	  the	  short	  plate	  
facing	  IN,	  then	  add	  running	  buffer	  (working	  solution)	  to	  the	  inner	  chamber	  until	  it	  
overflows.	  If	  you	  are	  only	  using	  one	  gel,	  be	  sure	  to	  use	  the	  buffer	  dam.	  
14. Load	  appropriate	  volume	  of	  your	  sample	  using	  specialized	  gel-­‐loading	  tips.	  	  
15. Add	  5ul	  of	  Kaleidescope	  (Bio-­‐Rad,	  161-­‐0375)	  	  
16. Top	  up	  both	  chambers	  with	  1	  x	  Tris-­‐Glycine	  Running	  Buffer	  (the	  working	  solution	  –	  see	  
Solution	  #	  10).	  	  Connect	  assembly	  to	  power	  supply	  and	  run	  gels	  at	  120V	  until	  fully	  
migrated	  (~90mins).	  Stop	  the	  current	  when	  the	  blue	  band	  reaches	  the	  bottom	  of	  the	  gel.	  	  
17. While	  the	  proteins	  are	  migrating,	  make	  fresh	  TBST	  and	  Transfer	  Buffer.	  
GEL-­‐MEMBRANE	  TRANSFER	  	  
18. Prior	  to	  use,	  the	  PVFD	  membrane	  (Bio-­‐Rad,	  #162-­‐0184)	  has	  to	  be	  immersed	  in	  methanol	  
for	  10	  seconds	  (to	  open	  the	  pores).	  	  Where	  gloves	  and	  handle	  membrane	  with	  tweezers.	  	  	  
19. Place	  filter	  papers	  (extra	  thick	  blot	  paper,	  7	  x	  8.4	  cm,	  BioRad	  Cat	  #:	  1703966;	  ~6	  per	  gel),	  
the	  gel,	  filter	  pads	  (2	  per	  gel)	  and	  membrane	  in	  Transfer	  Buffer	  (Solution	  #12)	  and	  then	  
allowed	  to	  equilibrate	  in	  transfer	  buffer	  for	  ~10-­‐15	  min.	  (use	  Tupperware	  containers).	  
20. Assembly	  of	  sandwich	  plates:	  	  	  
	   	   	   White	  –	  Filter	  Pad	  –	  3	  Filter	  Papers	  –	  Membrane	  –	  Gel	  –	  	  
	   	   	   	   	   3	  Filter	  Papers	  –	  Filter	  Pad	  -­‐	  Black	  (Back)	  
21. Roll	  out	  each	  layer	  with	  a	  glass	  test	  tube	  to	  eliminate	  air	  bubbles	  
22. Close	  sandwich	  plates	  and	  insert	  into	  transfer	  apparatus.	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23. Place	  the	  safety	  cover	  on	  the	  unit,	  plug	  in	  and	  run	  at	  100	  volts	  for	  90	  minutes	  (limit	  to	  5.5	  
mamps/cm2	  gel).	  
24. Once	  transfer	  is	  complete,	  discard	  filter	  papers	  and	  set	  filter	  pads	  aside.	  
25. Cut	  membrane	  in	  the	  shape	  of	  the	  gel,	  using	  a	  sharp	  knife.	  	  Remember	  to	  make	  an	  extra	  
cut	  on	  the	  corner	  for	  the	  top	  kaleidoscope	  corner.	  	  	  
MEMBRANE	  BLOCKING	  (1	  HOUR	  or	  more)	  
**Blocking	  is	  done	  to	  prevent	  non-­‐specific	  antibody	  binding	  to	  other	  proteins.	  
26. Once	  transfer	  is	  complete,	  carefully	  remove	  membranes	  from	  the	  sandwich	  and	  place	  
FACE-­‐UP	  in	  square	  petri	  dishes.	  	  Wash	  once	  for	  10	  minutes	  in	  TBS	  with	  gentle	  agitation.	  
27. Block	  membrane	  with	  Solution	  #14	  (milk)	  for	  1	  hour	  at	  room	  temperature	  with	  gentle	  
agitation.	  Use	  10mL	  of	  blocking	  solution.	  
28. 	  Wash	  5x5min	  with	  10mL	  of	  TBST	  	  
	  
INCUBATE	  MEMBRANE	  WITH	  PRIMARY	  ANTIBODY	  OVERNIGHT	  
29. Dilute	  the	  primary	  antibody	  in	  a	  recommended/optimized	  ratio	  of	  Ab	  :	  blocking	  solution	  
(see	  Solution	  #14,	  milk).	  	  
30. Apply	  this	  primary	  antibody	  solution	  and	  incubate	  12-­‐24	  hours	  with	  agitation	  in	  fridge.	  
	  
DAY	  3:	  EXPOSE/DEVELOP	  FILM	  AND	  BAND	  DENSITY	  DETERMINATION	  
	  
INCUBATE	  MEMBRANE	  WITH	  SECONDARY	  ANTIBODY	  (1	  hour)	  
31. Make	  fresh	  TBST.	  
32. Pour	  our	  excess	  solution.	  Wash	  with	  fresh	  TBST.	  Wash	  5	  times	  for	  5	  minutes	  each	  in	  TBST	  
with	  gentle	  agitation.	  
33. Use	  enough	  (10-­‐15mL)	  TBST	  to	  cover	  the	  membrane	  each	  time	  
34. For	  AMPK,	  add	  7.5	  ul	  of	  2°Ab	  into	  15	  ml	  of	  milk	  (2°Ab:	  AMPK	  Cell	  Signaling	  Tech.	  #	  ____).	  
Incubate	  for	  1	  hr	  at	  RT	  with	  agitation.	  	  	  
INCUBATE	  MEMBRANE	  WITH	  TAGS	  (~15	  min)	  
35. Wash	  each	  membrane	  5	  times	  each	  (5x5mins),	  with	  enough	  (fresh)	  TBST	  to	  cover	  with	  
gentle	  agitation.	  	  Blot	  the	  membranes	  dry	  and	  place	  into	  a	  clean	  square	  petri	  dish	  for	  
development.	  
Alpha	  Innotech:	  FluoroChem	  5500	  Gel	  Imaging	  System	  
36. For	  the	  Gel	  Dock,	  use	  Chemi	  Glow	  West	  Substrate	  (Fisher,	  Cat.	  #	  CGW-­‐8000).	  	  
37. 	  Dry	  membrane;	  use	  tweezers	  and	  touch	  a	  corner	  to	  kim	  wipe	  and	  empty	  the	  petri	  dish	  
38. Take	  1mL	  from	  each	  bottle	  and	  combine	  in	  the	  petri	  dish/membrane	  	  
39. For	  the	  1st	  membrane	  you	  must	  manually	  “agitate”	  for	  5	  minutes	  
40. For	  the	  2nd	  membrane	  reuse	  the	  2mL	  from	  the	  1st	  membrane	  and	  add	  an	  additional	  2mL	  of	  
Chemi	  Glow	  
41. For	  the	  3rd,	  4th	  etc	  membrane	  reuse	  the	  4mL	  from	  the	  first	  two	  membranes	  	  
42. Incubate	  for	  5	  minutes	  with	  agitation	  at	  room	  temperature.	  
43. Place	  the	  Petri	  dish	  in	  the	  Gel	  Dock	  and	  run	  the	  ‘Auto	  Expose’	  function.	  Once	  the	  required	  
exposure	  time	  has	  been	  found,	  you	  can	  now	  manually	  adjust	  it	  until	  your	  bands	  become	  
saturated.	  Expose	  until	  the	  point	  where	  your	  bandings	  are	  not	  over-­‐saturated.	  (This	  can	  be	  
accomplished	  using	  the	  ‘Saturation’	  icon	  at	  the	  top	  of	  the	  screen)	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SOLUTIONS 
	  
1.	  Homogenization	  Buffer	  
250	  mM	  sucrose	  =	  21.4	  g	  
100	  mM	  KCl	  =	  1.865	  g	  
5	  mM	  EDTA	  =	  0.4695	  g	  (Dihydrate	  form)	  
Add	  to	  225	  ml	  dH2O,	  fix	  pH	  to	  6.8,	  top	  up	  to	  
250	  ml	  dH2O	  and	  mix	  well.	  Store	  at	  4°C.	  
2.	  Triton	  X-­‐100	  Buffer	  
175	  mM	  KCl	  =	  1.305	  g	  
0.5%	  Triton	  X-­‐100	  =	  0.5	  ml	  
Add	  to	  90	  ml	  dH2O,	  pH	  to	  6.8,	  top	  up	  to	  100	  
ml	  dH2O	  and	  mix	  well.	  Store	  at	  4°C.	  
3.	  Sample	  Buffer	  (SDS	  Reducing	  Buffer):	  
2.05	  dH2O	  
1.25ml	  1.5M	  Tris-­‐HCl,	  pH	  6.8	  
3	  ml	  glycerol	  
2.0ml	  of	  30%	  SDS	  (w/v)	  (3g	  SDS	  in	  10	  mL	  H20)	  
1.5ml	  Beta-­‐mercaptoethanol	  
0.2	  ml	  of	  0.5%	  w/v	  Bromphenol	  Blue	  
Mix	  well;	  store	  at	  4°C.	  	  
4.	  Dilution	  Buffer:	  
2.796g	  (150mM)	  KCl	  	  
0.6055g	  (20mM)	  Tris	  Base	  
Dilute	  in	  250ml	  of	  ddH2O;	  adjust	  pH	  to	  7.0.	  
	  
5.	  Separating	  Buffer:	  
27.23	   g	   Tris-­‐base	   (Boehringer	   Manneheim,	  
#604-­‐205)	  
80	  ml	  dH20	  
Adjust	  pH	  to	  8.8	  with	  HCl.	  	  Fill	  to	  150	  ml	  with	  
dH20	  and	  store	  at	  4
oC.	  
6.	  Stacking	  Buffer:	  
6	   g	   Tris	   base	   (Boehringer	   Manneheim,	   #604-­‐
205)	  
60	  ml	  dH20	  
Adjust	   to	   pH	   6.8	   with	   HCl	   and	   fill	   to	   100	   ml	  
with	  dH20.	  
	  
7.	  30%	  Acrylamide/8%	  Bis:	  
87.6	  g	  acrylamide	  (Gibco	  BRL,	  #15512-­‐031)	  
2.4	  g	  N’N’	  bis-­‐methylene	  acrylamide	  (BioShop,	  
#BIS-­‐001)	  
Fill	  to	  300	  ml	  with	  dH20	  and	  store	  in	  the	  dark	  at	  
4oC	  (i.e.	  wrap	  in	  aluminum	  foil).	  	  Re-­‐make	  fresh	  
each	  month.	  
8.	  10%	  Sodium	  Dodecyl	  Sulfate:	  
10	   g	   sodium	   lauryl	   sulfate	   (SDS)	   (BDH,	  
#B30175)	  
Add	  10	  g	  of	  SDS	  and	  fill	  to	  100	  ml	  with	  dH20.	  
Store	  at	  room	  temperature.	  
	  
9.	  Ammonium	  Persulfate:	  	  	  
0.06	  g	  ammonium	  persulfate	  (APS)	  (Sigma,	  #A-­‐
3578)	  
Weigh	  into	  an	  Eppendorf.	  	  Add	  600	  µl	  of	  dH20.	  	  
Make	  fresh	  daily.	  
10.	  10	  x	  Tris-­‐GlycineRunning	  Buffer:	  
30g	   Tris-­‐base	   (Boehringer	   Manneheim,	   #604-­‐
205)	  	  
144	  g	  glycine	  (BDH,	  #B10119)	  	  
10	  g	  SDS	  (BDH,	  #B30175)	  	  
Add	  1L	  dH20.	  	  Do	  not	  adjust	  pH.	  
16.	  Coomaisse	  Blue	  Stain	  for	  Gels	  and	  
Membranes	  for	  Protein	  Detection	  
40	  ml	  Methanol	  
10	  ml	  Acetic	  Acid	  
0.25	  g	  Coomassie	  Blue	  
50	  ml	  dH2O	  
12.	  Transfer	  Buffer	  (1000ml/buffer	  chamber):	  
Towban	  Buffer:	  
3.03	  g	  Tris	  Base	  
14.4	  g	  glycine	  
200	  ml	  methanol	  
800	  ml	  dH20	  
13.	  10	  x	  TBST:	  
24.28g	  Tris	  Base	  
80.06g	  NaCl	  
1	  L	  dH20	  
pH	  7.5	  
14.	  5%	  Blocking	  Solution:	  
BSA:	  Dissolve	  7.5	  g	  skim	  BSA	  (Sigma,	  A3059)	  in	  
150	  mL	  of	  TBST	  	  
Milk:	  Dissolve	  7.5	  g	  skim	  milk	  (from	  grocery	  
store)	  in	  150	  ml	  TBST	  (5g/100mL)	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